<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/C4C21A46-4769-4840-9098-B44A0423AC39"><gtr:id>C4C21A46-4769-4840-9098-B44A0423AC39</gtr:id><gtr:name>Global Lipids Genetic Consortium (GLGC)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/F58F9516-A785-440F-88C5-223CC7CB8CC3"><gtr:id>F58F9516-A785-440F-88C5-223CC7CB8CC3</gtr:id><gtr:name>International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/A511B41C-8529-49F7-84F8-1B4D71D4EC38"><gtr:id>A511B41C-8529-49F7-84F8-1B4D71D4EC38</gtr:id><gtr:name>Human Genetics; Wellcome Trust Sanger Institute</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/E7693B33-B414-465D-A3F7-3E442DCD8D59"><gtr:id>E7693B33-B414-465D-A3F7-3E442DCD8D59</gtr:id><gtr:name>Queen Mary University of London - Barts and the London School of Medicine &amp; Dentistry</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/D7900CE2-A312-427D-AB82-2F88341AE2B5"><gtr:id>D7900CE2-A312-427D-AB82-2F88341AE2B5</gtr:id><gtr:name>SomaLogic</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/DF2615B7-E41D-4ED6-B5B9-A728DB7FB772"><gtr:id>DF2615B7-E41D-4ED6-B5B9-A728DB7FB772</gtr:id><gtr:name>Cohorts for Heart and Aging Research in Genomic Epidemiology Consortium (CHARGE)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/F3879A64-1F19-4F1B-9F13-2148EFBEC73D"><gtr:id>F3879A64-1F19-4F1B-9F13-2148EFBEC73D</gtr:id><gtr:name>Massachusetts General Hospital</gtr:name><gtr:address><gtr:line1>Massachusetts General Hospital</gtr:line1><gtr:line2>55 Fruit STreet</gtr:line2><gtr:postCode>MA 02114</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/88077807-2572-4B6D-8467-0822C6A212BD"><gtr:id>88077807-2572-4B6D-8467-0822C6A212BD</gtr:id><gtr:name>NHS Blood and Transplant (NHSBT)</gtr:name><gtr:address><gtr:line1>Oak House
Reeds Crescent</gtr:line1><gtr:city>Watford</gtr:city><gtr:postCode>WD24 4QN</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/4D643118-D00D-43C5-A6C4-6035292F169C"><gtr:id>4D643118-D00D-43C5-A6C4-6035292F169C</gtr:id><gtr:name>Novartis</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/5A51966A-5E02-4F70-A0D3-68077A2C4C03"><gtr:id>5A51966A-5E02-4F70-A0D3-68077A2C4C03</gtr:id><gtr:name>Merck &amp; Co. Inc. (MSD)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/60FD543D-731C-483A-B74E-6D407660221C"><gtr:id>60FD543D-731C-483A-B74E-6D407660221C</gtr:id><gtr:name>Chinese Academy of Medical Sciences (CAMS)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/B75CE818-8A4C-4ACA-82E2-C952425212B2"><gtr:id>B75CE818-8A4C-4ACA-82E2-C952425212B2</gtr:id><gtr:name>Brainshake</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/941C2E74-C576-49DA-9987-CE40EF8A611D"><gtr:id>941C2E74-C576-49DA-9987-CE40EF8A611D</gtr:id><gtr:name>Pfizer</gtr:name><gtr:address><gtr:line1>235 East 42nd Street</gtr:line1><gtr:postCode>10017</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/5982AEC1-3C31-4F8A-8FE5-C52D859BFD9C"><gtr:id>5982AEC1-3C31-4F8A-8FE5-C52D859BFD9C</gtr:id><gtr:name>University of Luebeck</gtr:name><gtr:address><gtr:line1>University of Luebeck</gtr:line1><gtr:line2>Ratzeburger Allee 160</gtr:line2><gtr:postCode>D-23538</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/AB534209-3172-41E0-A85E-143F22107607"><gtr:id>AB534209-3172-41E0-A85E-143F22107607</gtr:id><gtr:name>Harvard School of Public Health</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/C842A34F-18F7-454D-A259-FED802368496"><gtr:id>C842A34F-18F7-454D-A259-FED802368496</gtr:id><gtr:name>University of Leicester</gtr:name><gtr:address><gtr:line1>University Road</gtr:line1><gtr:line4>Leicester</gtr:line4><gtr:line5>Leicestershire</gtr:line5><gtr:postCode>LE1 7RH</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:department>Public Health and Primary Care</gtr:department><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/C4C21A46-4769-4840-9098-B44A0423AC39"><gtr:id>C4C21A46-4769-4840-9098-B44A0423AC39</gtr:id><gtr:name>Global Lipids Genetic Consortium (GLGC)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/F58F9516-A785-440F-88C5-223CC7CB8CC3"><gtr:id>F58F9516-A785-440F-88C5-223CC7CB8CC3</gtr:id><gtr:name>International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/A511B41C-8529-49F7-84F8-1B4D71D4EC38"><gtr:id>A511B41C-8529-49F7-84F8-1B4D71D4EC38</gtr:id><gtr:name>Human Genetics; Wellcome Trust Sanger Institute</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/E7693B33-B414-465D-A3F7-3E442DCD8D59"><gtr:id>E7693B33-B414-465D-A3F7-3E442DCD8D59</gtr:id><gtr:name>Queen Mary University of London - Barts and the London School of Medicine &amp; Dentistry</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/D7900CE2-A312-427D-AB82-2F88341AE2B5"><gtr:id>D7900CE2-A312-427D-AB82-2F88341AE2B5</gtr:id><gtr:name>SomaLogic</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/DF2615B7-E41D-4ED6-B5B9-A728DB7FB772"><gtr:id>DF2615B7-E41D-4ED6-B5B9-A728DB7FB772</gtr:id><gtr:name>Cohorts for Heart and Aging Research in Genomic Epidemiology Consortium (CHARGE)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/F3879A64-1F19-4F1B-9F13-2148EFBEC73D"><gtr:id>F3879A64-1F19-4F1B-9F13-2148EFBEC73D</gtr:id><gtr:name>Massachusetts General Hospital</gtr:name><gtr:address><gtr:line1>Massachusetts General Hospital</gtr:line1><gtr:line2>55 Fruit STreet</gtr:line2><gtr:postCode>MA 02114</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/88077807-2572-4B6D-8467-0822C6A212BD"><gtr:id>88077807-2572-4B6D-8467-0822C6A212BD</gtr:id><gtr:name>NHS Blood and Transplant (NHSBT)</gtr:name><gtr:address><gtr:line1>Oak House
Reeds Crescent</gtr:line1><gtr:city>Watford</gtr:city><gtr:postCode>WD24 4QN</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/4D643118-D00D-43C5-A6C4-6035292F169C"><gtr:id>4D643118-D00D-43C5-A6C4-6035292F169C</gtr:id><gtr:name>Novartis</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/5A51966A-5E02-4F70-A0D3-68077A2C4C03"><gtr:id>5A51966A-5E02-4F70-A0D3-68077A2C4C03</gtr:id><gtr:name>Merck &amp; Co. Inc. (MSD)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/60FD543D-731C-483A-B74E-6D407660221C"><gtr:id>60FD543D-731C-483A-B74E-6D407660221C</gtr:id><gtr:name>Chinese Academy of Medical Sciences (CAMS)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/B75CE818-8A4C-4ACA-82E2-C952425212B2"><gtr:id>B75CE818-8A4C-4ACA-82E2-C952425212B2</gtr:id><gtr:name>Brainshake</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/941C2E74-C576-49DA-9987-CE40EF8A611D"><gtr:id>941C2E74-C576-49DA-9987-CE40EF8A611D</gtr:id><gtr:name>Pfizer</gtr:name><gtr:address><gtr:line1>235 East 42nd Street</gtr:line1><gtr:postCode>10017</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/5982AEC1-3C31-4F8A-8FE5-C52D859BFD9C"><gtr:id>5982AEC1-3C31-4F8A-8FE5-C52D859BFD9C</gtr:id><gtr:name>University of Luebeck</gtr:name><gtr:address><gtr:line1>University of Luebeck</gtr:line1><gtr:line2>Ratzeburger Allee 160</gtr:line2><gtr:postCode>D-23538</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/AB534209-3172-41E0-A85E-143F22107607"><gtr:id>AB534209-3172-41E0-A85E-143F22107607</gtr:id><gtr:name>Harvard School of Public Health</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/C842A34F-18F7-454D-A259-FED802368496"><gtr:id>C842A34F-18F7-454D-A259-FED802368496</gtr:id><gtr:name>University of Leicester</gtr:name><gtr:address><gtr:line1>University Road</gtr:line1><gtr:line4>Leicester</gtr:line4><gtr:line5>Leicestershire</gtr:line5><gtr:postCode>LE1 7RH</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/6AE041BE-E6CB-4A00-BC13-5A39FBE38A1C"><gtr:id>6AE041BE-E6CB-4A00-BC13-5A39FBE38A1C</gtr:id><gtr:firstName>Daniel</gtr:firstName><gtr:surname>Rader</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/DF8506CB-230A-48D3-AA66-0B728052F21B"><gtr:id>DF8506CB-230A-48D3-AA66-0B728052F21B</gtr:id><gtr:firstName>Rajiv</gtr:firstName><gtr:surname>Chowdhury</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/58C59323-03DF-4564-AADD-380022D5270B"><gtr:id>58C59323-03DF-4564-AADD-380022D5270B</gtr:id><gtr:firstName>Peter</gtr:firstName><gtr:surname>Willeit</gtr:surname><gtr:roles><gtr:role><gtr:name>RESEARCHER</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/39DFA6B4-D72F-444C-AA98-5252BB924F6B"><gtr:id>39DFA6B4-D72F-444C-AA98-5252BB924F6B</gtr:id><gtr:firstName>Sylvia</gtr:firstName><gtr:surname>Richardson</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/28FF9600-B048-408D-AFAA-EC5CC134F92E"><gtr:id>28FF9600-B048-408D-AFAA-EC5CC134F92E</gtr:id><gtr:firstName>Angela</gtr:firstName><gtr:surname>Wood</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/6212F721-84E6-4C8D-93B3-5D3A8D48E837"><gtr:id>6212F721-84E6-4C8D-93B3-5D3A8D48E837</gtr:id><gtr:firstName>Emanuele</gtr:firstName><gtr:surname>Di Angelantonio</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/720A262E-4D7B-4497-9B3D-6BB048A91BF9"><gtr:id>720A262E-4D7B-4497-9B3D-6BB048A91BF9</gtr:id><gtr:firstName>Daniel</gtr:firstName><gtr:surname>Freitag</gtr:surname><gtr:roles><gtr:role><gtr:name>RESEARCHER</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/9E72C8B3-6137-45DC-A650-FF9C45331610"><gtr:id>9E72C8B3-6137-45DC-A650-FF9C45331610</gtr:id><gtr:firstName>Adam</gtr:firstName><gtr:otherNames>Stuart</gtr:otherNames><gtr:surname>Butterworth</gtr:surname><gtr:orcidId>0000-0002-6915-9015</gtr:orcidId><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/B042C41B-2E13-4D01-BE9A-4BA6CF30E152"><gtr:id>B042C41B-2E13-4D01-BE9A-4BA6CF30E152</gtr:id><gtr:firstName>Claire</gtr:firstName><gtr:surname>Thomson</gtr:surname><gtr:roles><gtr:role><gtr:name>RESEARCHER</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/2AEFFE89-5F99-4D21-85C4-BF0D68238CE6"><gtr:id>2AEFFE89-5F99-4D21-85C4-BF0D68238CE6</gtr:id><gtr:firstName>Danish</gtr:firstName><gtr:surname>Saleheen</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/7B37377E-AAF0-4C32-BA3D-0395632DCBB7"><gtr:id>7B37377E-AAF0-4C32-BA3D-0395632DCBB7</gtr:id><gtr:firstName>Julian</gtr:firstName><gtr:otherNames>Leether</gtr:otherNames><gtr:surname>Griffin</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/2A11538A-4A54-4A63-AB9F-BDB95AD7D61C"><gtr:id>2A11538A-4A54-4A63-AB9F-BDB95AD7D61C</gtr:id><gtr:firstName>Elio</gtr:firstName><gtr:surname>Riboli</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/46FA1C3E-B12A-4FD1-B544-89BA1FA09F68"><gtr:id>46FA1C3E-B12A-4FD1-B544-89BA1FA09F68</gtr:id><gtr:firstName>John</gtr:firstName><gtr:surname>Danesh</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/BB15F060-9FA1-414F-968E-278542BC9DDA"><gtr:id>BB15F060-9FA1-414F-968E-278542BC9DDA</gtr:id><gtr:firstName>Stephen</gtr:firstName><gtr:otherNames>K</gtr:otherNames><gtr:surname>Kaptoge</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/B06AC12B-22BD-470D-AB98-966D7F053CAE"><gtr:id>B06AC12B-22BD-470D-AB98-966D7F053CAE</gtr:id><gtr:firstName>Robin</gtr:firstName><gtr:surname>Young</gtr:surname><gtr:roles><gtr:role><gtr:name>RESEARCHER</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/161DE809-8AE4-4978-9F68-F106C8C63ED0"><gtr:id>161DE809-8AE4-4978-9F68-F106C8C63ED0</gtr:id><gtr:firstName>Nicholas</gtr:firstName><gtr:otherNames>John</gtr:otherNames><gtr:surname>Wareham</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/442978BC-9830-4E3C-B3C6-DFD87E9F6E91"><gtr:id>442978BC-9830-4E3C-B3C6-DFD87E9F6E91</gtr:id><gtr:firstName>Lampros</gtr:firstName><gtr:surname>Bouranis</gtr:surname><gtr:roles><gtr:role><gtr:name>RESEARCHER</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/D4875E5B-C2B2-4BB4-BA70-E1170A00D2A7"><gtr:id>D4875E5B-C2B2-4BB4-BA70-E1170A00D2A7</gtr:id><gtr:firstName>Simon</gtr:firstName><gtr:surname>Thompson</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/D966BB61-3D36-4457-A5A8-2DE10449224D"><gtr:id>D966BB61-3D36-4457-A5A8-2DE10449224D</gtr:id><gtr:firstName>Paul</gtr:firstName><gtr:surname>Elliott</gtr:surname><gtr:orcidId>0000-0002-7511-5684</gtr:orcidId><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=MR%2FL003120%2F1"><gtr:id>74F1847D-8BC9-4E16-96FF-9D838B668736</gtr:id><gtr:title>Large-scale integrative studies of risk factors in coronary heart disease: from discovery to application</gtr:title><gtr:status>Active</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>MR/L003120/1</gtr:grantReference><gtr:abstractText>If medical studies can reliably demonstrate that a particular factor is relevant to heart disease, then this could have important implications for the prediction and prevention of disease, as, for example, is now the case with measurement and modification of blood LDL(&amp;quot;bad&amp;quot;)-cholesterol levels.

Unfortunately, attempts using conventional approaches to identify risk factors that have cause-and-effect relationships with heart disease have often yielded costly failures in drug trials of new medicines. 

Similarly, only modest improvements have been achieved in the prediction of heart disease with incremental modifications to conventional approaches.

Our research plan offers a fundamentally new approach to address these problems by combining the precision of molecular measurements with the power of large-scale population health studies. The deep integration of cutting-edge technologies for genetic and biochemical measurement technologies with extremely large and mature biomedical surveys (&amp;quot;epidemiological studies&amp;quot;) of heart disease will yield studies that combine unprecedented power and detail. 

In particular, for 50,000 people with heart attacks and 50,000 controls, we have for each participant, already recorded extensive detail about: 

-genetic make-up (eg, up to one million genetic variants or &amp;quot;letters&amp;quot;)
-blood biochemistry (eg, up to a few hundred analytes)
-lifestyle and other habits (eg, diet, physical activity, tobacco and alcohol consumption).

In the most informative subsets of these participants, we will conduct state-of-the-art measurements to supplement this extensive existing information. A key advantage of blood measurement methods called &amp;quot;lipidomics&amp;quot; and &amp;quot;metabonomics&amp;quot; should be that, although they relate to biochemical processes likely to be relevant to the causation of heart attacks (ie, fat and sugar metabolism, respectively), they cast wide scientific nets. This should avoid premature assumptions about the identity of the precise factors that might emerge to be relevant to heart disease. 

Furthermore, as funding has already been awarded for &amp;quot;lipidomics&amp;quot; and &amp;quot;metabonomics&amp;quot; assays in 15,000 &amp;quot;control&amp;quot; participants in one of our studies (which we share with a study of new-onset type 2 diabetes), we will achieve major scientific synergy and cost savings by conducting concurrently the same assays in patients with new onset heart disease.

To help harvest the complex and rich data that will emerge from our studies in a rigorous and principled manner, our team includes world leaders in biostatistics. We will build on innovative approaches that we have previously developed to help distinguish causal from non-causal factors in heart disease. 

The objective will be to discover entirely new causes of heart disease as well as to evaluate a variety of factors already suspected in heart disease, such as blood fats, sugar metabolism, &amp;quot;inflammation&amp;quot; (which is the body's response to injury), and nutritional factors.
 
We will use the same databases (supplemented by additional sources of information) to develop and test a range of approaches that have potential to improve the prediction of first-onset heart disease, such as those that: 

-maximise accuracy of the prediction of heart disease, such as detailed scores containing genetic and biochemical information, which may be especially relevant to young people contemplating a lifetime of preventive therapy or to people with a strong family history of heart disease

-promote efficiency for health services, eg, &amp;quot;sequential&amp;quot; screening, which initially involves comparatively simple tests for everyone, then focusing more costly and detailed measurements on individuals initially identified as being most likely to benefit from further assessment.</gtr:abstractText><gtr:technicalSummary>With separate funding, we have established a consortium of 50,000 first-onset CHD cases and 50,000 controls, including ~25,000 incident CHD cases and ~25,000 controls from &amp;quot;nested&amp;quot; case-control or case-cohort subsets in population-based prospective studies. All are sharing extensive individual participant data. 

For all 100,000 participants, we are assaying a novel gene array (Exome+), as well as CardioMetabochip and genomewide association arrays in ~60,000 participants. These arrays furnish complementary data, enabling: i) study of &amp;gt;310,000 coding variants ii) dense fine-mapping of 360 priority loci (eg, &amp;gt;100 loci nominated by pharma, reflecting industry's priorities) iii) deep replication of previously identified promising variants and iv) imputation of 15 million additional variants.

In large subsets, we are assaying ~200 soluble biomarkers of potential vascular relevance, eg: i) a panel of phospholipid fatty acids ii) pro-atherogenic and/or pro-inflammatory lipids iii) adipocytokines, endocrine factors iv) carotenoids and vitamins.

We now propose to conduct lipidomics, metabonomics, and detailed inflammation biomarker assays in key subsets of these participants, capitalising on recent strategic investment in MRC labs.

This combination of exceptional statistical power, access to individual-level data, extensive genotyping, and extensive phenotyping should provide great opportunities for: i) discovery ii) causal analysis (using Mendelian randomisation analysis) and iii) advancement of disease prediction strategies.

To meet the challenges of analysing such exceptionally large and detailed datasets, we have assembled a world-leading analytical team led by the current, and the recent former, Directors of the MRC Biostatistics Unit. To hasten translation of findings, we have made arrangements for a variety of follow-on studies. 

To execute our plan, we seek support to maintain a core subset of our existing scientific team.</gtr:technicalSummary><gtr:potentialImpactText>In addition to the academic benefits described above, this proposal has the potential to contribute to industry and public policy:

1) Industry

Our research will directly address three inter-related issues underlying the high rate of failure in medicines development: a) identification of new therapeutic targets b) validation of proposed therapeutic targets and c) stratified approaches to test new agents.

Our findings should feed swiftly into senior R&amp;amp;D decision-making, both at pharmaceutical companies and small and medium-sized enterprises in the biotechnology sector, because:

-industry partners (Merck, Novartis, Pfizer) have co-funded genetic assays for our 100,000-person consortium on a pre-competitive basis, and they will follow the results closely because we have regular meetings and other mechanisms in place (see Pathways to Impact)

-we will continue to work closely with industry to hasten medicines development, exemplified by establishment of the Pfizer-Cambridge Centre for CVD Genomics in our department in 2011 (which has attracted 2 MRC CASE industrial PhD awards and NIHR co-funding)

-we have regular opportunities to engage with senior industry decision-makers, eg: the CEU has strategic collaborations with several industry partners. As noted above, JD is on the international scientific advisory boards of pharmaceutical and biotechnology companies.

The enthusiasm of industry for our proposal is demonstrated by the attached letters of support from:

Merck: Dr M Mendelsohn, Global Franchise Head, Atherosclerosis and CVD, and Dr D Bloomfield, Global Head of CVD Discovery

Novartis: Dr L Letvak, Global Development Franchise Head, Critical Care, and Dr D Keefe, Global Program Head, Lipids

Pfizer: Dr T Rolph, Chief Scientific Officer, Global Cardiovascular Franchise, and Dr N Sarwar, Global Head of Population Research and CVD Genetics

Sanofi: Dr A Plump, Deputy Head of Research and Translational Medicine.

2) NHS, other healthcare providers, policy makers

Although the UK recently introduced a universal national CVD screening programme (NHS Health Check) for adults aged 40-74 years with an expected cost of &amp;pound;2 billion for the initial 5 years, it is acknowledged that many of its details have not been founded on robust evidence and could be optimised (or even re-designed) with emergence of new data. 

More generally, there are diverse (and often divergent) guidelines from international bodies about optimum approaches to CVD risk screening, partly because of the limitations in the underpinning epidemiological studies.

Our results should contribute to screening policy because: 

-we are closely engaged with translational initiatives of the UK NIHR, eg: JD is the leader of the Population Science theme of the NIHR Cambridge Biomedical Research Centre and of the stroke biomarkers theme of the NIHR Healthcare Technology Cooperative awarded to Cambridge in 2012.

-our previous results have influenced CVD screening guidelines in the USA (eg, AHA / American College of Cardiology) and in Europe (eg, European Society of Cardiology)

-we are contributing to EU initiatives in CVD risk screening as part of EC-FP7.</gtr:potentialImpactText><gtr:fund><gtr:end>2018-08-31</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2013-09-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>2017846</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Queen Mary University of London - Barts and the London School of Medicine &amp; Dentistry</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>CARDIoGRAMplusC4D consortium</gtr:description><gtr:id>FF59DE1E-7ED3-48C7-87BD-7584BD6F8CDA</gtr:id><gtr:impact>Large-scale association analysis identifies new risk loci for coronary artery disease - PMCID: PMC3679547

Genetic Variants from Lipid-Related Pathways and Risk for Incident Myocardial Infarction - PMCID: PMC3612051</gtr:impact><gtr:partnerContribution>contribution of data and analyses</gtr:partnerContribution><gtr:piContribution>Coordinating centre</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Leicester</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>CARDIoGRAMplusC4D consortium</gtr:description><gtr:id>C16C3877-5FFE-461E-80AA-DE04E61FF119</gtr:id><gtr:impact>Large-scale association analysis identifies new risk loci for coronary artery disease - PMCID: PMC3679547

Genetic Variants from Lipid-Related Pathways and Risk for Incident Myocardial Infarction - PMCID: PMC3612051</gtr:impact><gtr:partnerContribution>contribution of data and analyses</gtr:partnerContribution><gtr:piContribution>Coordinating centre</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Pfizer Global R &amp; D</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Exome Chip Consortium</gtr:description><gtr:id>09E07282-7B45-41EF-A7AF-EC129C6EFCF0</gtr:id><gtr:impact>N/A</gtr:impact><gtr:partnerContribution>funding, contribution of data and analyses</gtr:partnerContribution><gtr:piContribution>coordinating centre</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>INTERVAL</gtr:description><gtr:id>67B69FB3-EA3F-41B3-B6F0-BEDF4FDBF714</gtr:id><gtr:impact>INTERVAL is a randomised controlled trial in up to 50,000 whole-blood donors recruited at 25 locations across England. Participants are involved in a two-year intervention during which they are invited to give blood either at usual donation intervals or more often. The primary aim of the intervention is to establish whether donors can safely and acceptably give blood more often than is now collected by NHS Blood and Transplant. 

A further aim of INTERVAL is to create a national epidemiological bioresource, including a recall-by-genotype (phenotype) resource, which will enable detailed study of the health of blood donors and broader public health and biomedical issues. 

Participant recruitment commenced in June 2012. Our target of 50,000 study participants was reached two years later, in June 2014. Participants have consented to: use of their data and biological samples for a wide range of analyses, invitation to further biomedical studies, and long-term linkage to e-health records. Funding that has been awarded from NHSBT and NIHR will allow the study of the following factors in 50,000 participants i) extended haematological profile (&amp;gt;200 parameters) ii) lifestyle profiling, including assessment of smoking, alcohol consumption, dietary intake, and, in large subsets, monitoring of physical activity through the use of worn accelerometry devices; (iii) cognitive function traits related to different domains of mental function and well-being; and (iv) linkage with e-health records, eg, various morbidity registers, hospital discharge records (v) a novel gene array containing 850,000 single nucleotide variants (SNVs), which includes many functional SNVs and a GWAS scaffold to deliver imputation of ~20 million variants; (vi) ~200 candidate biomarkers related to haematological traits and other pathways for a wide range of disease processes (eg, liver and renal function; autoimmunity; hormonal status).</gtr:impact><gtr:partnerContribution>NHSBT provide funding and operational support.

The University of Oxford provide scientific leadership and operational support.</gtr:partnerContribution><gtr:piContribution>We provide scientific leadership and operational support.

We are the academic coordinating centre, running the administration and data management of the trial (including the helpline).</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Queen Mary University of London - Barts and the London School of Medicine &amp; Dentistry</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Exome Chip Consortium</gtr:description><gtr:id>0AEA8D11-25EB-4D75-94B7-A2AEFA45797C</gtr:id><gtr:impact>N/A</gtr:impact><gtr:partnerContribution>funding, contribution of data and analyses</gtr:partnerContribution><gtr:piContribution>coordinating centre</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Human Genetics; Wellcome Trust Sanger Institute</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Sanger Sequencing</gtr:description><gtr:id>97DD0A0D-C08A-4B6F-A235-541B3671C618</gtr:id><gtr:impact>Data received on ~4500 samples so far</gtr:impact><gtr:partnerContribution>Whole genome and whole exome sequencing of samples from the INTEVAL Study</gtr:partnerContribution><gtr:piContribution>Provision of samples from INTERVAL Study and collaboration on analysis and publication manuscript preparation</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of L?beck</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:description>CARDIoGRAMplusC4D consortium</gtr:description><gtr:id>72D83359-1C29-448C-967F-041F7D381018</gtr:id><gtr:impact>Large-scale association analysis identifies new risk loci for coronary artery disease - PMCID: PMC3679547

Genetic Variants from Lipid-Related Pathways and Risk for Incident Myocardial Infarction - PMCID: PMC3612051</gtr:impact><gtr:partnerContribution>contribution of data and analyses</gtr:partnerContribution><gtr:piContribution>Coordinating centre</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Harvard School of Public Health</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Exome Chip Consortium</gtr:description><gtr:id>AFBC4BE1-31F4-42C5-886F-B3866F449F15</gtr:id><gtr:impact>N/A</gtr:impact><gtr:partnerContribution>funding, contribution of data and analyses</gtr:partnerContribution><gtr:piContribution>coordinating centre</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Leicester</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Exome Chip Consortium</gtr:description><gtr:id>6769DECD-0A2D-4AF5-87D1-6A6BDFB28B80</gtr:id><gtr:impact>N/A</gtr:impact><gtr:partnerContribution>funding, contribution of data and analyses</gtr:partnerContribution><gtr:piContribution>coordinating centre</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Massachusetts General Hospital</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>CARDIoGRAMplusC4D consortium</gtr:description><gtr:id>B1A306C7-5B61-43C2-AB15-97477DE71823</gtr:id><gtr:impact>Large-scale association analysis identifies new risk loci for coronary artery disease - PMCID: PMC3679547

Genetic Variants from Lipid-Related Pathways and Risk for Incident Myocardial Infarction - PMCID: PMC3612051</gtr:impact><gtr:partnerContribution>contribution of data and analyses</gtr:partnerContribution><gtr:piContribution>Coordinating centre</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Global Lipids Genetic Consortium (GLGC)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Global Lipids Genetics Consortium (GLGC)</gtr:description><gtr:id>1A85FA6C-9121-4397-B76F-C97F9757251B</gtr:id><gtr:impact>Manuscript currently being drafted</gtr:impact><gtr:partnerContribution>GLGC Consortium leads this analyses</gtr:partnerContribution><gtr:piContribution>CHD Exome+ consortium contributed samples to the discovery meta-analyses.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Nuffield Division of Clinical Laboratory Sciences</gtr:department><gtr:description>NIHR BTRU in Donor Health and Genomics</gtr:description><gtr:id>5CF802C1-EE45-46E0-A59B-414BC1DBF465</gtr:id><gtr:impact>The goals of this new Unit are to combine cutting-edge tools from genomics, biology and population health science to address key questions about the aetiology of important disorders (such as the health consequences of iron deficiency), to improve the safety and precision of blood donation, and to build and use major genomic resources that enable the study of important chronic diseases of wider relevance.

This unit combined the disciplines of clinical studies, functional genetics, epidemiology and statistics/bioinformatics.</gtr:impact><gtr:partnerContribution>The Unit is building and exploiting exceptionally large and detailed &amp;quot;living laboratories&amp;quot; of healthy participants who consent to frequent and active engagement in research studies (eg, recall-by-genotype, periodic re-attendance, wearing of devices, linkage with e-health records). For example, leveraging our strategic relationship with NHSBT, we have commenced linkage of &amp;gt;1M blood donors to e-health records. As a proof-of-concept study, we have already enrolled 50,000 donors into the INTERVAL Study in which we have commenced cohort-wide 15X whole genome sequencing, measured &amp;gt;5000 molecular phenotypes (eg, lipids, metabolites, proteins), conducted an advanced analysis of the cellular composition of the blood, employed accelerometry devices at scale and measured genome-wide genotypes.</gtr:partnerContribution><gtr:piContribution>The National Institute for Health Research Blood and Transplant Unit (NIHR BTRU) in Donor Health and Genomics at the University of Cambridge is a cross-disciplinary unit established to address major questions about the health of blood donors and produce evidence-based strategies to enhance donor safety and ensure sustainability of blood supply. We are the grant holders and managers of this unit.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Human Nutrition Research Unit</gtr:department><gtr:description>Lipidomics - MRC-HNR</gtr:description><gtr:id>7DA90E2B-F0DE-4371-BF22-CDDA5C7FFA0C</gtr:id><gtr:impact>Data received at regular intervals</gtr:impact><gtr:partnerContribution>Analysis of all 50,000 samples in progress - 400 lipid species measured. Assays contributed in kind by MRC-HNR</gtr:partnerContribution><gtr:piContribution>We provided samples from 50,000 participants (whole cohort) from the INTERVAL study for analysis</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Cohorts for Heart and Aging Research in Genomic Epidemiology Consortium (CHARGE)</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:description>Genetic Association Study of Blood Pressure (BP Exome)</gtr:description><gtr:id>AC01124F-E1F5-4216-B935-5D6A7392178B</gtr:id><gtr:impact>Manuscript under consideration at Nature Genetics</gtr:impact><gtr:partnerContribution>ExomeBP and GoT2D Consortia contributed samples for the discovery meta-analyses and CHARGE+ consortium contributed replication samples.</gtr:partnerContribution><gtr:piContribution>CHD Exome+ consortium jointly led this research project and also contributed samples to the discovery meta-analyses.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Human Genetics; Wellcome Trust Sanger Institute</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Human Complex Traits</gtr:department><gtr:description>NIHR BTRU in Donor Health and Genomics</gtr:description><gtr:id>273619D8-B95E-4A19-816F-FF41B8202E2A</gtr:id><gtr:impact>The goals of this new Unit are to combine cutting-edge tools from genomics, biology and population health science to address key questions about the aetiology of important disorders (such as the health consequences of iron deficiency), to improve the safety and precision of blood donation, and to build and use major genomic resources that enable the study of important chronic diseases of wider relevance.

This unit combined the disciplines of clinical studies, functional genetics, epidemiology and statistics/bioinformatics.</gtr:impact><gtr:partnerContribution>The Unit is building and exploiting exceptionally large and detailed &amp;quot;living laboratories&amp;quot; of healthy participants who consent to frequent and active engagement in research studies (eg, recall-by-genotype, periodic re-attendance, wearing of devices, linkage with e-health records). For example, leveraging our strategic relationship with NHSBT, we have commenced linkage of &amp;gt;1M blood donors to e-health records. As a proof-of-concept study, we have already enrolled 50,000 donors into the INTERVAL Study in which we have commenced cohort-wide 15X whole genome sequencing, measured &amp;gt;5000 molecular phenotypes (eg, lipids, metabolites, proteins), conducted an advanced analysis of the cellular composition of the blood, employed accelerometry devices at scale and measured genome-wide genotypes.</gtr:partnerContribution><gtr:piContribution>The National Institute for Health Research Blood and Transplant Unit (NIHR BTRU) in Donor Health and Genomics at the University of Cambridge is a cross-disciplinary unit established to address major questions about the health of blood donors and produce evidence-based strategies to enhance donor safety and ensure sustainability of blood supply. We are the grant holders and managers of this unit.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Novartis</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:description>Exome Chip Consortium</gtr:description><gtr:id>5496F93A-D9FC-48B3-981D-C268B4152787</gtr:id><gtr:impact>N/A</gtr:impact><gtr:partnerContribution>funding, contribution of data and analyses</gtr:partnerContribution><gtr:piContribution>coordinating centre</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Chinese Academy of Medical Sciences (CAMS)</gtr:collaboratingOrganisation><gtr:country>China, People's Republic of</gtr:country><gtr:description>CARDIoGRAMplusC4D consortium</gtr:description><gtr:id>0499798C-B6EA-4FD7-ADB6-8C3B88E25E7D</gtr:id><gtr:impact>Large-scale association analysis identifies new risk loci for coronary artery disease - PMCID: PMC3679547

Genetic Variants from Lipid-Related Pathways and Risk for Incident Myocardial Infarction - PMCID: PMC3612051</gtr:impact><gtr:partnerContribution>contribution of data and analyses</gtr:partnerContribution><gtr:piContribution>Coordinating centre</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Brainshake</gtr:collaboratingOrganisation><gtr:country>Finland, Republic of</gtr:country><gtr:description>NMR Metabolomics</gtr:description><gtr:id>2699E836-5386-4758-8D99-045C87D5F030</gtr:id><gtr:impact>Publication manuscripts in preparation</gtr:impact><gtr:partnerContribution>Assays complete for all 50,000 samples, ~240 metabolites measured.</gtr:partnerContribution><gtr:piContribution>Provided samples from 50,000 participants in INTERVAL study.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Harvard School of Public Health</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Global BMI Mortality Collaboration</gtr:description><gtr:id>DC4F0EB8-FC87-49A7-99E8-BDBF6EE90456</gtr:id><gtr:impact>The Global BMI Mortality Collaboration was established to enable valid estimation of associations of overweight and obesity with all-cause mortality across populations in major global regions. The consortium involves data from large individual prospective studies (defined as =100,000 participants recruited at baseline) or large multi-cohort consortia (defined as involving a total of =100,000 participants recruited at baseline). A pre-specified analysis plan for combining individual-participant data from relevant cohorts was agreed among collaborators.</gtr:impact><gtr:partnerContribution>The Global BMI Mortality Collaboration was established to enable valid estimation of associations of overweight and obesity with all-cause mortality across populations in major global regions. The consortium involves data from large individual prospective studies (defined as =100,000 participants recruited at baseline) or large multi-cohort consortia (defined as involving a total of =100,000 participants recruited at baseline). A pre-specified analysis plan for combining individual-participant data from relevant cohorts was agreed among collaborators.</gtr:partnerContribution><gtr:piContribution>The Global BMI Mortality Collaboration was established to enable valid estimation of associations of overweight and obesity with all-cause mortality across populations in major global regions. The consortium involves data from large individual prospective studies (defined as =100,000 participants recruited at baseline) or large multi-cohort consortia (defined as involving a total of =100,000 participants recruited at baseline). A pre-specified analysis plan for combining individual-participant data from relevant cohorts was agreed among collaborators.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Merck &amp; Co. Inc. (MSD)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Exome Chip Consortium</gtr:description><gtr:id>6043AE63-2A8C-454B-904E-262D15DF5F6C</gtr:id><gtr:impact>N/A</gtr:impact><gtr:partnerContribution>funding, contribution of data and analyses</gtr:partnerContribution><gtr:piContribution>coordinating centre</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b)</gtr:collaboratingOrganisation><gtr:country>Bangladesh, People's Republic of</gtr:country><gtr:description>BRAVE</gtr:description><gtr:id>042B9DF0-1027-419E-99BC-20F1B1F39924</gtr:id><gtr:impact>Publications</gtr:impact><gtr:partnerContribution>Conduct of the protocol, use of resources and sample/data transport</gtr:partnerContribution><gtr:piContribution>Funding, protocol design and implementation support; analysis of data and publication manuscript preparation. Scientific leadership.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>SomaLogic</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Proteomics - SomaLogic</gtr:description><gtr:id>3E987614-C5B5-4C75-910B-4565E4820FBC</gtr:id><gtr:impact>Receiving data from platform; publication manuscripts in preparation</gtr:impact><gtr:partnerContribution>Analysis of 3500 samples at a discounted price</gtr:partnerContribution><gtr:piContribution>We have provided 3500 samples from the INTERVAL study for analysis on SomaLogic's platform (approx. 1129 proteins measured).</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Massachusetts General Hospital</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Exome Chip Consortium</gtr:description><gtr:id>7580B90E-A8BF-428E-8D1D-86BF961BB6D7</gtr:id><gtr:impact>N/A</gtr:impact><gtr:partnerContribution>funding, contribution of data and analyses</gtr:partnerContribution><gtr:piContribution>coordinating centre</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>NHS Blood and Transplant (NHSBT)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>INTERVAL</gtr:description><gtr:id>D009E255-CB4A-46B2-A0F0-62B66687CD84</gtr:id><gtr:impact>INTERVAL is a randomised controlled trial in up to 50,000 whole-blood donors recruited at 25 locations across England. Participants are involved in a two-year intervention during which they are invited to give blood either at usual donation intervals or more often. The primary aim of the intervention is to establish whether donors can safely and acceptably give blood more often than is now collected by NHS Blood and Transplant. 

A further aim of INTERVAL is to create a national epidemiological bioresource, including a recall-by-genotype (phenotype) resource, which will enable detailed study of the health of blood donors and broader public health and biomedical issues. 

Participant recruitment commenced in June 2012. Our target of 50,000 study participants was reached two years later, in June 2014. Participants have consented to: use of their data and biological samples for a wide range of analyses, invitation to further biomedical studies, and long-term linkage to e-health records. Funding that has been awarded from NHSBT and NIHR will allow the study of the following factors in 50,000 participants i) extended haematological profile (&amp;gt;200 parameters) ii) lifestyle profiling, including assessment of smoking, alcohol consumption, dietary intake, and, in large subsets, monitoring of physical activity through the use of worn accelerometry devices; (iii) cognitive function traits related to different domains of mental function and well-being; and (iv) linkage with e-health records, eg, various morbidity registers, hospital discharge records (v) a novel gene array containing 850,000 single nucleotide variants (SNVs), which includes many functional SNVs and a GWAS scaffold to deliver imputation of ~20 million variants; (vi) ~200 candidate biomarkers related to haematological traits and other pathways for a wide range of disease processes (eg, liver and renal function; autoimmunity; hormonal status).</gtr:impact><gtr:partnerContribution>NHSBT provide funding and operational support.

The University of Oxford provide scientific leadership and operational support.</gtr:partnerContribution><gtr:piContribution>We provide scientific leadership and operational support.

We are the academic coordinating centre, running the administration and data management of the trial (including the helpline).</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Imperial College London (ICL)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Imperial College of Science Technology and Medicine (ICSTM)</gtr:department><gtr:description>CARDIoGRAMplusC4D consortium</gtr:description><gtr:id>78D3E392-8C03-45AF-9F71-87F200DF18A7</gtr:id><gtr:impact>Large-scale association analysis identifies new risk loci for coronary artery disease - PMCID: PMC3679547

Genetic Variants from Lipid-Related Pathways and Risk for Incident Myocardial Infarction - PMCID: PMC3612051</gtr:impact><gtr:partnerContribution>contribution of data and analyses</gtr:partnerContribution><gtr:piContribution>Coordinating centre</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>NHS Blood and Transplant (NHSBT)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>National Blood Service</gtr:department><gtr:description>NIHR BTRU in Donor Health and Genomics</gtr:description><gtr:id>C4E46ED1-6F19-4036-833E-3F498E6242D0</gtr:id><gtr:impact>The goals of this new Unit are to combine cutting-edge tools from genomics, biology and population health science to address key questions about the aetiology of important disorders (such as the health consequences of iron deficiency), to improve the safety and precision of blood donation, and to build and use major genomic resources that enable the study of important chronic diseases of wider relevance.

This unit combined the disciplines of clinical studies, functional genetics, epidemiology and statistics/bioinformatics.</gtr:impact><gtr:partnerContribution>The Unit is building and exploiting exceptionally large and detailed &amp;quot;living laboratories&amp;quot; of healthy participants who consent to frequent and active engagement in research studies (eg, recall-by-genotype, periodic re-attendance, wearing of devices, linkage with e-health records). For example, leveraging our strategic relationship with NHSBT, we have commenced linkage of &amp;gt;1M blood donors to e-health records. As a proof-of-concept study, we have already enrolled 50,000 donors into the INTERVAL Study in which we have commenced cohort-wide 15X whole genome sequencing, measured &amp;gt;5000 molecular phenotypes (eg, lipids, metabolites, proteins), conducted an advanced analysis of the cellular composition of the blood, employed accelerometry devices at scale and measured genome-wide genotypes.</gtr:partnerContribution><gtr:piContribution>The National Institute for Health Research Blood and Transplant Unit (NIHR BTRU) in Donor Health and Genomics at the University of Cambridge is a cross-disciplinary unit established to address major questions about the health of blood donors and produce evidence-based strategies to enhance donor safety and ensure sustainability of blood supply. We are the grant holders and managers of this unit.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>A short talk on the genetics of heart disease and risk calculation both for environmental and genetic factors at the Cambridge Science Festival 2017.</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>BDF45CC3-DB81-4D41-855D-4D446A27D57C</gtr:id><gtr:impact>A short talk on the genetics of heart disease and risk calculation both for environmental and genetic factors at the Cambridge Science Festival 2017. Intended to disseminate research to the general public.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>European Society of Human Genetics (Barcelona)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>3DC8873F-7BF3-4761-A607-B1D575A345B3</gtr:id><gtr:impact>Oral presentation at the European Society of Human Genetics (Barcelona, 2016).</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Third sector organisations</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Collaborative workshop MRC Biostatistics</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>674D267B-0201-48D8-95E9-BE4959B27ED1</gtr:id><gtr:impact>Presentation of findings from scientific research</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Presentation to Takeda</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>457775F8-0FBF-4154-92CE-AF9A388FC0B6</gtr:id><gtr:impact>Presentation of findings from scientific research</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Industry/Business</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Clinical Grand Rounds</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>19A21F58-108F-4EB4-B55E-631AEA50AD4B</gtr:id><gtr:impact>Presented work on key findings

Raised awareness of topic and/or instigated discussion</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2010,2011,2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>British Heart Foundation, Health Informatics presentation</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>0D9CB2B6-1A0F-4DB5-BD7A-6F6FBAAD3910</gtr:id><gtr:impact>Presented work on key findings on published papers

Raised awareness of topic and/or instigated discussion/further research</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>HDL Causality Genetics</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>6D9F9977-674D-4355-B5A4-9996D977E77B</gtr:id><gtr:impact>Presented work on key findings on published papers

Raised awareness of topic and/or instigated discussion/further research</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Institute of Public Health Showcase</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>B8FD9B8C-B10F-4CA9-BD66-189A0491C7B7</gtr:id><gtr:impact>Presented work on key findings and published papers.

Raised awareness of topic and/or instigated discussion/further research</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2012,2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Alan Turing Institute presentation</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>B7B1644F-D9C3-4400-B966-7C49707A080F</gtr:id><gtr:impact>Presentation of findings from scientific research</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Presentation at BHF Centre of Excellence meeting</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>363BDC07-8DF3-4D14-9A1A-C92870D4A2E2</gtr:id><gtr:impact>Presentation of findings from scientific research</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Wellcome Trust Sanger Institute</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>DA0B72EE-5F43-4B73-AA92-0E4F453EBEBC</gtr:id><gtr:impact>Presented work on key findings.

Raised awareness of topic and/or instigated discussion/further research</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2011,2012,2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Presentation at BRC Scientific Advisory Board</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>C4EEB550-823B-4B6D-B1CA-F1D67E4F7F51</gtr:id><gtr:impact>Presentation of findings from scientific research</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Presentation at the European Bioinformatics Institute</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>B2660FD7-D7CD-43D4-AB3D-B0F0D13B3532</gtr:id><gtr:impact>Presentation of findings from scientific research</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Workshop on genetic studies in the Bangladeshi population</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>B74F5C61-BFC8-4A88-899F-A3B9C328CC84</gtr:id><gtr:impact>Presented work on key findings on published papers

Raised awareness of topic and/or instigated discussion/further research</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>International Genetic Epidemiology Conference, Toronto</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>84A7BDBA-A6E1-4E4F-8A23-1DF9A1553586</gtr:id><gtr:impact>Presentation of research findings at the International Genetic Epidemiology Conference, Toronto.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Third sector organisations</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>PROCARDIS Lp(a) Workshop</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>901FAAF2-F869-437E-A281-0937E525B64C</gtr:id><gtr:impact>Presented work on key findings and published papers.

Raised awareness of topic and/or instigated discussion/further research</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>MRC presentation</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>BFB18C9E-1BC3-47A8-8F2E-C189479DB6BE</gtr:id><gtr:impact>Presentation of findings from scientific research</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Workshop on genetic studies in the Pakistani population</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>D0505B87-8E4D-4E1B-B444-86E05C100FD9</gtr:id><gtr:impact>Presented work on key findings and published papers.

Raised awareness of topic and/or instigated discussion/further research</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Presentation at Wellcome Trust Target Validation Conference</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>07AE0D27-5421-49A9-B654-A4A1BC2BAC2B</gtr:id><gtr:impact>Presentation of findings from scientific research</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Talk at AstraZeneca</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>BA867C93-4F9A-4A69-BCCD-FE174B473456</gtr:id><gtr:impact>Presentation of findings from scientific research</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Industry/Business</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Media Interviews</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>1D5B881D-8F31-4232-BCAF-B7A67CE67C08</gtr:id><gtr:impact>Presented work on key findings on published papers.

Raised awareness of topic and/or instigated discussion/further research</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2008,2009,2010,2011,2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Cardiovascular Medicine Series, University of Oxford</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>63F4FE7D-5A21-4759-9E14-853B4D9B6E74</gtr:id><gtr:impact>Presented work on key findings and published papers.

Raised awareness of topic and/or instigated discussion/further research</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Cochrane Lecture</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>68350CE7-15C6-4930-B659-6AD607FE2502</gtr:id><gtr:impact>Presented work on key findings on published papers

Raised awareness of topic and/or instigated discussion/further research</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Harvard School of  Public Medicine</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>9CE9C846-34F9-40F8-8EEF-0DD5B2796DA5</gtr:id><gtr:impact>Presented work on key findings on published papers.

Raised awareness of topic and/or instigated discussion/further research</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description> Mendelian Randomization Conference From Population Health to Pharmaceutical Developments</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>BA0E87C6-AE65-401A-8EDD-E92901D484E3</gtr:id><gtr:impact>A conference on aetiological epidemiology and causality in population health and clinical medicine</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description> Briefing pharmaceutical companies</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>F64D7FBB-887E-4E21-B3CF-68032319C8E8</gtr:id><gtr:impact>Presented work on key findings and published papers.

Raised awareness of topic and/or instigated discussion/further research/funding</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Industry/Business</gtr:primaryAudience><gtr:year>2010,2011,2012,2013,2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Genomics of Common Diseases conference (Baltimore)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>06196DB9-FA1B-4AF5-BA28-45FE259DC0F1</gtr:id><gtr:impact>Oral presentation at Genomics of Common Diseases conference (Baltimore)</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other audiences</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>115759</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BHF CoE funding for Parsa Akbari</gtr:description><gtr:end>2019-09-02</gtr:end><gtr:fundingOrg>British Heart Foundation (BHF)</gtr:fundingOrg><gtr:fundingRef>RG68639</gtr:fundingRef><gtr:id>B8D6C272-F4AC-47C6-8C8C-85785CC9FA48</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>84915</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BHF CoE funding for James Peters</gtr:description><gtr:end>2017-11-02</gtr:end><gtr:fundingOrg>British Heart Foundation (BHF)</gtr:fundingOrg><gtr:fundingRef>RG68639</gtr:fundingRef><gtr:id>AA96818F-9AFC-43CB-88B9-9C048D848720</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>47443</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BHF, Centre of Excellence - Pump Priming (D Freitag)</gtr:description><gtr:end>2019-03-02</gtr:end><gtr:fundingOrg>British Heart Foundation (BHF)</gtr:fundingOrg><gtr:id>3B09D452-76C7-489F-A090-D6FF49CAA9CD</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>49950</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BHF, Centre of Excellence - Pump Priming (E Harshfield)</gtr:description><gtr:end>2016-04-02</gtr:end><gtr:fundingOrg>British Heart Foundation (BHF)</gtr:fundingOrg><gtr:id>4F768F76-E133-41F0-AD34-829AACF330A0</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>4099619</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>National Institute for Health Research (NIHR)</gtr:department><gtr:description>Blood Transplant Research Unit (NIHR - BTRU)</gtr:description><gtr:end>2020-09-02</gtr:end><gtr:fundingOrg>University College London Hospitals Charity (UCLH)</gtr:fundingOrg><gtr:id>222668F3-0893-46FE-A99B-4D52D4B91FF1</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2015-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>15000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Association between personal exposure to air pollution and adverse health consequences in South</gtr:description><gtr:end>2017-03-02</gtr:end><gtr:fundingOrg>Engineering and Physical Sciences Research Council (EPSRC)</gtr:fundingOrg><gtr:fundingRef>RG85685</gtr:fundingRef><gtr:id>3A5DC6DD-AFAD-4DA9-B924-76F9BDE94D53</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>49050</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BHF, Centre of Excellence - Pump Priming (E Di Angelantonio)</gtr:description><gtr:end>2016-07-02</gtr:end><gtr:fundingOrg>British Heart Foundation (BHF)</gtr:fundingOrg><gtr:id>BB6DD7D5-40DB-416B-8D36-ED30ADB303D6</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>54676</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BHF CoE funding for Jonathan Evans</gtr:description><gtr:end>2017-08-02</gtr:end><gtr:fundingOrg>British Heart Foundation (BHF)</gtr:fundingOrg><gtr:fundingRef>RG68639</gtr:fundingRef><gtr:id>3BCB0B43-6367-4F60-82E4-037A7B841854</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>45000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BHF, Centre of Excellence - Pump Priming (D Paul)</gtr:description><gtr:end>2017-12-02</gtr:end><gtr:fundingOrg>British Heart Foundation (BHF)</gtr:fundingOrg><gtr:id>8538F847-A345-48CB-90EB-C8E02C178B38</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>53556</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Support to enhance phenotyping in the NIHR/NHSBT INTERVAL Bioresource</gtr:description><gtr:end>2017-03-02</gtr:end><gtr:fundingOrg>Cambridge University Hospitals NHS Foundation Trust</gtr:fundingOrg><gtr:fundingRef>RG86292</gtr:fundingRef><gtr:id>9F7577D8-CA68-433F-A1A8-0A540BFC2E80</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2016-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>50000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BHF, Centre of Excellence - Pump Priming (A Butterworth)</gtr:description><gtr:end>2015-12-02</gtr:end><gtr:fundingOrg>British Heart Foundation (BHF)</gtr:fundingOrg><gtr:id>D43195BB-F204-4F42-9B82-832A4D081F10</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>80000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Isaac Newton Trust / Wellcome Trust ISSF / University of Cambridge Joint Research Grant Scheme</gtr:description><gtr:fundingOrg>The Wellcome Trust Ltd</gtr:fundingOrg><gtr:id>E1540C4F-FD48-4FDA-BB87-58D7E110FDFD</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>299000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Improving Donor Health (NHSBT)</gtr:description><gtr:end>2016-03-02</gtr:end><gtr:fundingOrg>National Health Service (England)</gtr:fundingOrg><gtr:fundingRef>WP13-02</gtr:fundingRef><gtr:id>B2909497-B184-4EDA-A510-E6D641B9AD7D</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2014-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>49813</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BHF, Centre of Excellence - Pump Priming (A Wood)</gtr:description><gtr:end>2019-03-02</gtr:end><gtr:fundingOrg>British Heart Foundation (BHF)</gtr:fundingOrg><gtr:id>A1C4B526-8064-4B53-B8FA-83D313A4E11F</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>140000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Biogen</gtr:description><gtr:end>2016-06-02</gtr:end><gtr:fundingOrg>Biogen Idec</gtr:fundingOrg><gtr:id>5A49FF7C-05FD-45ED-A84A-812A9757B49F</gtr:id><gtr:sector>Private</gtr:sector><gtr:start>2015-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>400000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>THE MALAYSIAN ACUTE VASCULAR EVENTS RISK (MAVERIK) STUDY</gtr:description><gtr:end>2018-12-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>RG85814</gtr:fundingRef><gtr:id>1F784679-4AD2-432A-A592-C4CC4300FF27</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2017-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1365496</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Biomedical Research Centre grant - Population Science Theme</gtr:description><gtr:end>2017-03-02</gtr:end><gtr:fundingOrg>National Institute for Health Research (NIHR)</gtr:fundingOrg><gtr:id>8381A00D-9BA7-4F4F-BCCB-1E35581D88CE</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2012-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>463767</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Biomedical Research Centre grant - Cardiovascular Theme</gtr:description><gtr:end>2017-03-02</gtr:end><gtr:fundingOrg>National Institutes of Health Research</gtr:fundingOrg><gtr:id>D8E167C0-18BF-4591-9452-E75FD46D8DB9</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2012-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>115759</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BHF CoE funding for Lisa Schmunk</gtr:description><gtr:end>2019-03-02</gtr:end><gtr:fundingOrg>British Heart Foundation (BHF)</gtr:fundingOrg><gtr:fundingRef>RG68639</gtr:fundingRef><gtr:id>4FB96119-8FD6-43FA-825B-0383E1ACA108</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>94369</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Using Genetics to explore the pathophysiology of Cerebral Small Vessel Disease</gtr:description><gtr:end>2021-08-02</gtr:end><gtr:fundingOrg>British Heart Foundation (BHF)</gtr:fundingOrg><gtr:fundingRef>RG83983</gtr:fundingRef><gtr:id>1ADA4DFA-F80A-464B-AD85-D070BDB8CAFE</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-09-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Translational research tools in the analysis of individual participant data from multiple studies</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>F587FA38-7196-47CA-9073-BFBFB31F8726</gtr:id><gtr:type>Participation in a advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>ACC/AHA Guideline on the Assessment of Cardiovascular Risk</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:guidelineTitle>ACC/AHA Guideline on the Assessment of Cardiovascular Risk</gtr:guidelineTitle><gtr:id>1917E79C-D8AD-40FA-8733-DE433C466457</gtr:id><gtr:type>Citation in clinical guidelines</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Citation of published protocol manuscript</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>6128FE39-100D-4BFF-9D45-CC0489B4CA09</gtr:id><gtr:impact>We have influenced international cardiovascular guidelines through evaluation of the incremental value of assessing established and emerging risk factors for risk assessment, including inflammation biomarkers (NEJM 2012), lipids and lipoproteins (JAMA 2012, Lancet 2010), adiposity measures (Lancet 2011), and carotid ultrasound (Lancet 2012).</gtr:impact><gtr:type>Citation in other policy documents</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Successfully embedded research protocols within routine framework of National Blood Service</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>4AA22BA7-CF6A-4D49-83AE-0EF0F744F810</gtr:id><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>ERFC - influenced training of practioners or researchers</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>8A44F69F-1D8E-4F34-A2DF-C3C783E034C8</gtr:id><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Association between C reactive protein and coronary heart disease: mendelian randomisation analysis based on individual participant data</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>75A14AF8-7F46-40A8-AB91-7701C24C01EA</gtr:id><gtr:type>Citation in other policy documents</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Helped to define genetic and biological determinants of lipid and inflammatory related markers</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>7C0DCDEB-58C0-4D04-A033-CD74C2A06606</gtr:id><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>ERFC - major lipids</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>76851253-14AF-4A71-9BAE-BBAB8FBA1381</gtr:id><gtr:impact>The ERFC paper on major lipids has been cited in the 2011 ESC / EAS Guidelines for the management of dyslipidaemias, in the 2012 ESC Guidelines, the 2011 American Association of Clinical Endocrinologists Medical Guidelines, and the 2011 AHA Statement on Triglycerides and cardiovascular disease. The ERFC publication on the causal relevance of triglyceride-related pathways to coronary disease has been cited in the following guidelines to support the rationale for diagnosis and treatment of hypertriglyceridaemia: the 2012 Endocrine Society Clinical Practice Guideline, the 2011 ESC / EAS Guidelines for the management of dyslipidaemias, and the 2011 AHA Statement on Triglycerides and cardiovascular disease.</gtr:impact><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>High-level engagement with industry, exemplified by recent global board meetings with Takeda, Sanofi, Pfizer, Merck and Novartis</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>DC1648BD-9D3C-4E69-87B2-1D957A2FDCCC</gtr:id><gtr:type>Participation in a advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Citation of published protocol manuscript</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>0AC4ABD1-C74B-4E42-A10B-1518FDD03D62</gtr:id><gtr:type>Citation in clinical reviews</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>LpPLA2 Studies Collaboration</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>DA5B94D0-715C-4BE5-A273-855F4A27B683</gtr:id><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Training in the analysis of individual participant data from multiple studies</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>E85E73C6-C0BD-4840-A858-BFF44E0B1CCD</gtr:id><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs><gtr:researchDatabaseAndModelOutput><gtr:description>The EPIC-Heart phenotype database is being expanded to stroke outcomes (~9000 incident cases), rather than just coronary disease, adding further value to the initial investment</gtr:description><gtr:id>AB0B4273-25F9-496D-86E1-ED1208671212</gtr:id><gtr:impact>N/A</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>EPIC-CVD database</gtr:title><gtr:type>Database/Collection of data</gtr:type><gtr:yearFirstProvided>2014</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput><gtr:researchDatabaseAndModelOutput><gtr:description>A database has been created of harmonised individual participant data records from over 2 million individuals</gtr:description><gtr:id>91DE48AF-A334-4205-930C-DEF15388D003</gtr:id><gtr:impact>Published article PMID: 19903920</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Emerging Risk Factors Collaboration Database</gtr:title><gtr:type>Database/Collection of data</gtr:type><gtr:url>http://europepmc.org/abstract/MED/19903920</gtr:url></gtr:researchDatabaseAndModelOutput><gtr:researchDatabaseAndModelOutput><gtr:description>Genetic consortium</gtr:description><gtr:id>B6469C06-00F9-4742-99BB-52D5C36ED318</gtr:id><gtr:impact>Large-scale association analysis identifies new risk loci for coronary artery disease - PMCID: PMC3679547</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>CARDIoGRAMplusC4D consortium</gtr:title><gtr:type>Database/Collection of data</gtr:type></gtr:researchDatabaseAndModelOutput><gtr:researchDatabaseAndModelOutput><gtr:description>Correcting for Optimistic Prediction in Small Data Sets</gtr:description><gtr:id>D6DCE73D-AFE8-4415-8F4C-2EE72EED86E3</gtr:id><gtr:impact>N/A</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Statistical methodology (optimistic prediction)</gtr:title><gtr:type>Data analysis technique</gtr:type><gtr:yearFirstProvided>2014</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput><gtr:researchDatabaseAndModelOutput><gtr:description>Dataset from &amp;gt;130 studies with over 2.3M individuals and 100,000 cases of cardiovascular disease with information on conventional risk factors for CVD and other circulating biomarkers and lifestyle factors.</gtr:description><gtr:id>D79C5C11-68D3-48D7-88FE-E4A608B0ED42</gtr:id><gtr:impact>N/A</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Large-scale Research Database Established</gtr:title><gtr:type>Database/Collection of data</gtr:type><gtr:yearFirstProvided>2009</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput><gtr:researchDatabaseAndModelOutput><gtr:description>Exome chip consortium</gtr:description><gtr:id>4443B01F-B0DD-4541-99AB-5A53ED9AC4D0</gtr:id><gtr:impact>N/A</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Exome Chip Consortium</gtr:title><gtr:type>Database/Collection of data</gtr:type></gtr:researchDatabaseAndModelOutput><gtr:researchDatabaseAndModelOutput><gtr:description>INTERVAL is a randomised controlled trial in up to 50,000 whole-blood donors recruited at 25 locations across England. Participants are involved in a two-year intervention during which they are invited to give blood either at usual donation intervals or more often. The primary aim of the intervention is to establish whether donors can safely and acceptably give blood more often than is now collected by NHS Blood and Transplant. 

A further aim of INTERVAL is to create a national epidemiological bioresource, including a recall-by-genotype (phenotype) resource, which will enable detailed study of the health of blood donors and broader public health and biomedical issues. 

Participant recruitment commenced in June 2012. Our target of 50,000 study participants was reached two years later, in June 2014. Participants have consented to: use of their data and biological samples for a wide range of analyses, invitation to further biomedical studies, and long-term linkage to e-health records. Funding that has been awarded from NHSBT and NIHR will allow the study of the following factors in 50,000 participants i) extended haematological profile (&amp;gt;200 parameters) ii) lifestyle profiling, including assessment of smoking, alcohol consumption, dietary intake, and, in large subsets, monitoring of physical activity through the use of worn accelerometry devices; (iii) cognitive function traits related to different domains of mental function and well-being; and (iv) linkage with e-health records, eg, various morbidity registers, hospital discharge records (v) a novel gene array containing 850,000 single nucleotide variants (SNVs), which includes many functional SNVs and a GWAS scaffold to deliver imputation of ~20 million variants; (vi) ~200 candidate biomarkers related to haematological traits and other pathways for a wide range of disease processes (eg, liver and renal function; autoimmunity; hormonal status).</gtr:description><gtr:id>210D2E66-BFD1-4157-BA31-A8446EF315CA</gtr:id><gtr:impact>Further collaboration, most notably with the Wellcome Trust Sanger Institute</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>INTERVAL Bioresource</gtr:title><gtr:type>Database/Collection of data</gtr:type><gtr:url>http://www.intervalstudy.org.uk/</gtr:url><gtr:yearFirstProvided>2014</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput><gtr:researchDatabaseAndModelOutput><gtr:description>Dataset of over 40,000 cases of CHD in over 180,000 participants from 47 studies with data on CRP genetic variants, circulating CRP and other biomarkers.

Statistical methods for further developing the methodology for Mendelian randomization analyses.</gtr:description><gtr:id>1374D027-A3EA-444F-9268-3D4D2D4D24F5</gtr:id><gtr:impact>N/A</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Mendelian Randomisation Method</gtr:title><gtr:type>Data analysis technique</gtr:type><gtr:yearFirstProvided>2014</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput><gtr:researchDatabaseAndModelOutput><gtr:description>Mendelian Randomisation (MR) Catalogue is a curated database of publicly available results from large-scale genetic association studies. This tool aims to facilitate &amp;quot;phoneme scans&amp;quot;, the cross-referencing of genetic variants with many phenotypes, to help aid understanding of disease pathways and biology as well as inform MR studies. The catalogue currently contains over 300 million association results and over 10 million unique genetic variants, mostly single nucleotide polymorphisms. It is accompanied by a web-based tool that queries the database for associations with user-specified variants, providing results aligned according to the alleles of each input variant. The tool provides the option of searching for trait associations with proxies of the input variants, calculated using the European samples from 1000 Genomes phase 3.</gtr:description><gtr:id>8F60C31B-79C2-493C-BBF2-12842DF78CC1</gtr:id><gtr:impact>MR Catalogue has been used extensively within the Cardiovascular Epidemiology Unit, University of Cambridge, and has been used in a few high profile papers currently under review. We recently released MR Catalogue to the wider scientific community and we have had over 1,000 usages of the website already. We anticipate that this tool will be widely used within the genetics community.</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Phenoscanner</gtr:title><gtr:type>Database/Collection of data</gtr:type><gtr:url>http://www.phenoscanner.medschl.cam.ac.uk/phenoscanner</gtr:url><gtr:yearFirstProvided>2016</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput><gtr:researchDatabaseAndModelOutput><gtr:description>Metabochip Consortium database</gtr:description><gtr:id>A853485D-366B-4DE8-B003-A61B045A9837</gtr:id><gtr:impact>N/A</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Metabochip Consortium</gtr:title><gtr:type>Database/Collection of data</gtr:type></gtr:researchDatabaseAndModelOutput><gtr:researchDatabaseAndModelOutput><gtr:description>Collection of data from Bangladesh Risk of Acute Vascular Events (BRAVE) study:

Commenced in 2011, BRAVE is being implemented locally in collaboration with National Institute of Cardiovascular Disease Bangladesh, and Chronic Non-Communicable Diseases Unit of icddr,b. As of 2015, BRAVE has already recruited over 6000 first-ever myocardial infarction cases and 6000 healthy controls from capital Dhaka city. Information and biological specimen routinely collected include data using a 400-item questionnaire, physical measurements, blood, toe-nail and extracted DNA samples from all participants.

 The main objectives of this study are to:

?assess the role of potential CVD risk factors (highly prevalent in Bangladeshis) that are yet to be characterized in detail, including: long-term arsenic and other toxic metal contaminations (both separately and in combination), indigenous tobacco consumption; sub-optimal nutrition and genetic variation.
?estimate the impact of modifiable conventional vascular risk factors (eg, smoking, history of hypertension, diabetes, physical inactivity, obesity, lipid fractions) on vascular disease in Bangladesh.
?evaluate the important local lifestyle, socioeconomic and nutritional exposures on CVD risk, such as diet (eg, local intake patterns of various oil, spices, dairy and fish) and different socio-economic groups;
?collect reliable information on knowledge, perception and practice to prevent CVD among participants in order to better understand public health awareness of vascular disease in Bangladesh; and
?collect detailed information on the economic burden of CVD events in Bangladesh better understand health economic impact of vascular disease in Bangladesh.</gtr:description><gtr:id>05CD74DF-F3A6-4257-86B9-D697D0D62160</gtr:id><gtr:impact>Publications</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>BRAVE</gtr:title><gtr:type>Database/Collection of data</gtr:type><gtr:yearFirstProvided>2015</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput><gtr:researchDatabaseAndModelOutput><gtr:description>COMPARE is a study of 30,000 English blood donors set up to determine for NHS Blood and Transplant the most effective way of measuring haemaglobin levels in blood donors. Additionally, participants in the study have consented to have the blood samples used in research and data from genetic and biomarker assays and through linkage with electronic health records will be used across a range of research projects.</gtr:description><gtr:id>749B3344-F54B-4D90-BD2C-2FB25BDA7116</gtr:id><gtr:impact>No impact yet, participants still being recruited.</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>COMPARE</gtr:title><gtr:type>Database/Collection of data</gtr:type><gtr:url>http://www.comparestudy.org.uk/about-the-study/</gtr:url></gtr:researchDatabaseAndModelOutput><gtr:researchDatabaseAndModelOutput><gtr:description>Collection of data from the BangladEsh Longitudinal Investigation of Emerging Vascular Events (BELIEVE) study:

The study, in collaboration with National Heart Foundation in Bangladesh, aims to recruit up to 50,000 community-based individuals (age &amp;gt;5 years) from households in Bangladesh. The study population will be recruited through household survey (initially in urban areas of Capital Dhaka, and then from a semi-rural Sylhet region) to ensure maximum and generalizable participation, particularly from individuals with shared environmental and genetic background.

The key objectives of the BELIEVE prospective cohort study are to create a re-callable population and bio-resource involving a general South Asian population to: (1) enable genetic discovery using diverse phenotypes (particularly those related to nutrition such as anaemia, infection, or environment-related aspects such as air and toxic metal pollution), causal evaluation and functional genomics; (2) assess reliably the roles of established and unique locally-relevant risk factors on incident NCDs such as cardiovascular, cancer, diabetes and kidney diseases (ascertained by clinical records and standardised validation); (3) help study discrepant risk factor patterns unique to this population (eg, unusually high tobacco usage, lowest average body mass index, highest physical inactivity rates) over time, in various age groups as a life-course approach; and their heritability; and (4) create a well-characterised population base to set-up innovative and cost-effective behaviour modification and pharmaceutical interventions, suitable from a South-Asian context.</gtr:description><gtr:id>53759832-6A8F-4BD3-9068-DCFBD3D846FD</gtr:id><gtr:impact>N/A - commenced 2016</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>BELIEVE</gtr:title><gtr:type>Database/Collection of data</gtr:type></gtr:researchDatabaseAndModelOutput></gtr:researchDatabaseAndModelOutputs><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Several novel statistical methods have been developed to enable maximal exploitation of the Emerging Risk Factors Collaboration database.</gtr:description><gtr:id>B1915BA4-66F8-40DF-9B51-8111513627BD</gtr:id><gtr:impact>Publication of article PMID: 19903920</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Emerging Risk Factors Collaboration statistical methods</gtr:title><gtr:type>Improvements to research infrastructure</gtr:type><gtr:url>http://europepmc.org/abstract/MED/19903920</gtr:url></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Collection of samples from the BangladEsh Longitudinal Investigation of Emerging Vascular Events (BELIEVE) study:

The study, in collaboration with National Heart Foundation in Bangladesh, aims to recruit up to 50,000 community-based individuals (age &amp;gt;5 years) from households in Bangladesh. The study population will be recruited through household survey (initially in urban areas of Capital Dhaka, and then from a semi-rural Sylhet region) to ensure maximum and generalizable participation, particularly from individuals with shared environmental and genetic background.

The key objectives of the BELIEVE prospective cohort study are to create a re-callable population and bio-resource involving a general South Asian population to: (1) enable genetic discovery using diverse phenotypes (particularly those related to nutrition such as anaemia, infection, or environment-related aspects such as air and toxic metal pollution), causal evaluation and functional genomics; (2) assess reliably the roles of established and unique locally-relevant risk factors on incident NCDs such as cardiovascular, cancer, diabetes and kidney diseases (ascertained by clinical records and standardised validation); (3) help study discrepant risk factor patterns unique to this population (eg, unusually high tobacco usage, lowest average body mass index, highest physical inactivity rates) over time, in various age groups as a life-course approach; and their heritability; and (4) create a well-characterised population base to set-up innovative and cost-effective behaviour modification and pharmaceutical interventions, suitable from a South-Asian context.</gtr:description><gtr:id>50BD43A1-4E1D-494A-B025-450CC96594D6</gtr:id><gtr:impact>None - study commenced 2016</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>BELIEVE</gtr:title><gtr:type>Biological samples</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Assays have now been completed in all EPIC-Heart participants on the following phenotypes:
- 22 clinical chemistry biomarkers
- 210,000 genetic variants
- a further 450,000 genetic variants
- a panel of 37 fatty acids

Assays are near completion in these participants for vitamins C and D, a panel of 6 carotenoids and telomere length. These assays are also being extended to stroke cases identified under the FP7 funded project, EPIC-CVD, adding further value to the EPIC-Heart project.</gtr:description><gtr:id>B19CA1F4-C40B-42B1-BA35-53508C6B321B</gtr:id><gtr:impact>N/A</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>EPIC-Heart Assays</gtr:title><gtr:type>Physiological assessment or outcome measure</gtr:type><gtr:yearFirstProvided>2012</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>A database has been created of harmonised individual participant data records from over 110,000 individuals</gtr:description><gtr:id>0AFD4E49-3570-4113-99D3-EAE4426604EF</gtr:id><gtr:impact>n/a</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>The Lp-PLA2 Studies Collaboration database</gtr:title><gtr:type>Improvements to research infrastructure</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Collection of samples from The Pakistan Risk of Myocardial Infarction Study (PROMIS): 

35,000 participants have been recruited for this study aged 30-80 years (both male and female) with a first-ever confirmed myocardial infarction (MI) and &amp;quot;frequency-matched&amp;quot; controls (on age and sex) free from cardiovascular or other chronic diseases. Information collected on each participant includes a detailed questionnaire (including extensive information on lifestyle and dietary habits tailored to local dietary patterns), blood samples (including serum, plasma and whole blood) and DNA extracted from white blood cells. Samples are transported to the core laboratory at the Department of Public Health and Primary Care, University of Cambridge, for long-term storage and subsequent genetic and biochemical analyses.

PROMIS will help to identify and understand the separate and combined influences of genetic and major lifestyle factors on the risk of MI, and to help elucidate intermediate causal pathways. Investigations underway in the available cases and controls already collected include assessment of candidate gene, biochemical, dietary and lifestyle influences as well as genome wide association studies. We are exploring collection of more detailed information in a sizeable subset of participants to enable more detailed investigations, such as the establishment of cell-lines and studies of gene expression (using RNA samples from monocytes, lipid biopsies and other sources).</gtr:description><gtr:id>68589CE2-6D5D-43C1-8E1F-97A67C2696AD</gtr:id><gtr:impact>Publications</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>PROMIS</gtr:title><gtr:type>Biological samples</gtr:type><gtr:yearFirstProvided>2012</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>A framework for quantifying net benefits of alternative prognostic models</gtr:description><gtr:id>15FE71D4-1883-4799-88BC-B1C69773A70A</gtr:id><gtr:impact>Publication 21905066</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Quantifying net benefits</gtr:title><gtr:type>Improvements to research infrastructure</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>INTERVAL is a randomised controlled trial in up to 50,000 whole-blood donors recruited at 25 locations across England. Participants are involved in a two-year intervention during which they are invited to give blood either at usual donation intervals or more often. The primary aim of the intervention is to establish whether donors can safely and acceptably give blood more often than is now collected by NHS Blood and Transplant. 

A further aim of INTERVAL is to create a national epidemiological bioresource, including a recall-by-genotype (phenotype) resource, which will enable detailed study of the health of blood donors and broader public health and biomedical issues. 

Participant recruitment commenced in June 2012. Our target of 50,000 study participants was reached two years later, in June 2014. Participants have consented to: use of their data and biological samples for a wide range of analyses, invitation to further biomedical studies, and long-term linkage to e-health records. Funding that has been awarded from NHSBT and NIHR will allow the study of the following factors in 50,000 participants i) extended haematological profile (&amp;gt;200 parameters) ii) lifestyle profiling, including assessment of smoking, alcohol consumption, dietary intake, and, in large subsets, monitoring of physical activity through the use of worn accelerometry devices; (iii) cognitive function traits related to different domains of mental function and well-being; and (iv) linkage with e-health records, eg, various morbidity registers, hospital discharge records (v) a novel gene array containing 850,000 single nucleotide variants (SNVs), which includes many functional SNVs and a GWAS scaffold to deliver imputation of ~20 million variants; (vi) ~200 candidate biomarkers related to haematological traits and other pathways for a wide range of disease processes (eg, liver and renal function; autoimmunity; hormonal status).</gtr:description><gtr:id>8A59752B-55FD-4793-B90E-EAAE00B3E13A</gtr:id><gtr:impact>Serum samples collected during the study have been used to measure the levels of ferritin in participants.

DNA has been used in a genome-wide association study of haemoglobin concentration and related parameters, and genotyping of the HFE gene.</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>INTERVAL Bioresource</gtr:title><gtr:type>Biological samples</gtr:type><gtr:yearFirstProvided>2011</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>COMPARE is a study of 30,000 English blood donors set up to determine for NHS Blood and Transplant the most effective way of measuring haemaglobin levels in blood donors. Additionally, participants in the study have consented to have the blood samples used in research and data from genetic and biomarker assays and through linkage with electronic health records will be used across a range of research projects.</gtr:description><gtr:id>AFA66F4B-E763-4BAD-9E91-CD36A0EF27FC</gtr:id><gtr:impact>No impact yet, samples still being collected.</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>COMPARE</gtr:title><gtr:type>Biological samples</gtr:type><gtr:url>http://www.comparestudy.org.uk/about-the-study/</gtr:url></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Bespoke statistical programs for the meta-analysis of individual participant data have been made freely available to researchers via the ERFC website</gtr:description><gtr:id>D30911CD-CBAE-44D4-B4CA-B8E040D85736</gtr:id><gtr:impact>N/A</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Statistical programs made freely available to researchers</gtr:title><gtr:type>Improvements to research infrastructure</gtr:type><gtr:url>http://www.phpc.cam.ac.uk/ceu/research/erfc/stata/</gtr:url><gtr:yearFirstProvided>2009</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>To allow the assessment of risk prediction in a multi-centre case-cohort study, novel statistical methods have been developed at the EPIC-Heart Coordinating Centre</gtr:description><gtr:id>7E4E3562-0C56-4F8F-BBCD-2DF89DDF3519</gtr:id><gtr:impact>A Publication: &amp;quot;Derivation and assessment of risk prediction models using case-cohort data&amp;quot;. Sanderson J, Thompson SG, White IR, Aspelund T, Pennells L. BMC Med Res Methodol. 2013 Sep 13;13(1):113</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Methods</gtr:title><gtr:type>Improvements to research infrastructure</gtr:type><gtr:yearFirstProvided>2011</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>A database has been created of harmonised individual participant data records from over 2 million individuals</gtr:description><gtr:id>73A7FB55-BAC7-4158-B47F-DDBB05AEEB59</gtr:id><gtr:impact>Published article PMID: 19903920</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Emerging Risk Factors Collaboration database</gtr:title><gtr:type>Improvements to research infrastructure</gtr:type><gtr:url>http://europepmc.org/abstract/MED/19903920</gtr:url></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Collection of biological samples from Bangladesh Risk of Acute Vascular Events (BRAVE) study:

Commenced in 2011, BRAVE is being implemented locally in collaboration with National Institute of Cardiovascular Disease Bangladesh, and Chronic Non-Communicable Diseases Unit of icddr,b. As of 2015, BRAVE has already recruited over 6000 first-ever myocardial infarction cases and 6000 healthy controls from capital Dhaka city. Information and biological specimen routinely collected include data using a 400-item questionnaire, physical measurements, blood, toe-nail and extracted DNA samples from all participants.

 

The main objectives of this study are to:

?assess the role of potential CVD risk factors (highly prevalent in Bangladeshis) that are yet to be characterized in detail, including: long-term arsenic and other toxic metal contaminations (both separately and in combination), indigenous tobacco consumption; sub-optimal nutrition and genetic variation.
?estimate the impact of modifiable conventional vascular risk factors (eg, smoking, history of hypertension, diabetes, physical inactivity, obesity, lipid fractions) on vascular disease in Bangladesh.
?evaluate the important local lifestyle, socioeconomic and nutritional exposures on CVD risk, such as diet (eg, local intake patterns of various oil, spices, dairy and fish) and different socio-economic groups;
?collect reliable information on knowledge, perception and practice to prevent CVD among participants in order to better understand public health awareness of vascular disease in Bangladesh; and
?collect detailed information on the economic burden of CVD events in Bangladesh better understand health economic impact of vascular disease in Bangladesh.</gtr:description><gtr:id>F0E4AA26-FFBE-4C91-8542-3AB611B9CA15</gtr:id><gtr:impact>Publications</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>BRAVE</gtr:title><gtr:type>Biological samples</gtr:type><gtr:yearFirstProvided>2015</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E737535C-83E9-47B5-BD4F-442C895440B2"><gtr:id>E737535C-83E9-47B5-BD4F-442C895440B2</gtr:id><gtr:title>Lack of identification in semiparametric instrumental variable models with binary outcomes.</gtr:title><gtr:parentPublicationTitle>American journal of epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/056163b112d2b291ecc076d094a1b4e8"><gtr:id>056163b112d2b291ecc076d094a1b4e8</gtr:id><gtr:otherNames>Burgess S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0002-9262</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C985F120-8BAD-4158-AEC9-1D22DC0B4DD2"><gtr:id>C985F120-8BAD-4158-AEC9-1D22DC0B4DD2</gtr:id><gtr:title>Hemostatic factors and risk of coronary heart disease in general populations: new prospective study and updated meta-analyses.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c14d384b5a87c9bc3c358b7461f53714"><gtr:id>c14d384b5a87c9bc3c358b7461f53714</gtr:id><gtr:otherNames>Willeit P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/CAE1D7C4-5E5B-4911-BDBA-09826FD22E69"><gtr:id>CAE1D7C4-5E5B-4911-BDBA-09826FD22E69</gtr:id><gtr:title>Carotid intima-media thickness progression and risk of vascular events in people with diabetes: results from the PROG-IMT collaboration.</gtr:title><gtr:parentPublicationTitle>Diabetes care</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/6e5a812ab92706244446252fe2bc5b88"><gtr:id>6e5a812ab92706244446252fe2bc5b88</gtr:id><gtr:otherNames>Lorenz MW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0149-5992</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/53EEEFEF-4D73-4265-B7E9-C254282F4F04"><gtr:id>53EEEFEF-4D73-4265-B7E9-C254282F4F04</gtr:id><gtr:title>Network Mendelian randomization: using genetic variants as instrumental variables to investigate mediation in causal pathways.</gtr:title><gtr:parentPublicationTitle>International journal of epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/056163b112d2b291ecc076d094a1b4e8"><gtr:id>056163b112d2b291ecc076d094a1b4e8</gtr:id><gtr:otherNames>Burgess S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0300-5771</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C1A575A3-4B60-47A3-A10F-B77FF7A32FAF"><gtr:id>C1A575A3-4B60-47A3-A10F-B77FF7A32FAF</gtr:id><gtr:title>GUESS-ing polygenic associations with multiple phenotypes using a GPU-based evolutionary stochastic search algorithm.</gtr:title><gtr:parentPublicationTitle>PLoS genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a1b790133d8f4391f0d11eec9285bc81"><gtr:id>a1b790133d8f4391f0d11eec9285bc81</gtr:id><gtr:otherNames>Bottolo L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1553-7390</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/9E763793-8308-4887-859F-29C485992194"><gtr:id>9E763793-8308-4887-859F-29C485992194</gtr:id><gtr:title>PhenoScanner: a database of human genotype-phenotype associations.</gtr:title><gtr:parentPublicationTitle>Bioinformatics (Oxford, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4f01fc7d80dc77023aafc31741f1e082"><gtr:id>4f01fc7d80dc77023aafc31741f1e082</gtr:id><gtr:otherNames>Staley JR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1367-4803</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/7138BF33-0EB3-4636-A768-1C2DE77AA8F4"><gtr:id>7138BF33-0EB3-4636-A768-1C2DE77AA8F4</gtr:id><gtr:title>Longitudinal association of C-reactive protein and Haemoglobin A1c over 13 years: the European Prospective Investigation into Cancer--Norfolk study.</gtr:title><gtr:parentPublicationTitle>Cardiovascular diabetology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b7a2d7e799abf9e6aec1bec645a41fb4"><gtr:id>b7a2d7e799abf9e6aec1bec645a41fb4</gtr:id><gtr:otherNames>Ahmadi-Abhari S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1475-2840</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/269586AB-56AC-4698-8631-86B94223FCA9"><gtr:id>269586AB-56AC-4698-8631-86B94223FCA9</gtr:id><gtr:title>Discovery and refinement of loci associated with lipid levels.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/e03e206b167fce79060e932a8719994b"><gtr:id>e03e206b167fce79060e932a8719994b</gtr:id><gtr:otherNames>Global Lipids Genetics Consortium</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/778B7E19-11EC-44B0-A885-C28E1232DCE5"><gtr:id>778B7E19-11EC-44B0-A885-C28E1232DCE5</gtr:id><gtr:title>Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/5dcf65ffbc7714fff0c7307b71614ddd"><gtr:id>5dcf65ffbc7714fff0c7307b71614ddd</gtr:id><gtr:otherNames>GBD 2013 DALYs and HALE Collaborators</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E57F0EF1-31CE-49A3-90EC-07820E8A4725"><gtr:id>E57F0EF1-31CE-49A3-90EC-07820E8A4725</gtr:id><gtr:title>Detection and correction of artefacts in estimation of rare copy number variants and analysis of rare deletions in type 1 diabetes.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/5980a4ac6bee6701a23bfdadb2397e8d"><gtr:id>5980a4ac6bee6701a23bfdadb2397e8d</gtr:id><gtr:otherNames>Cooper NJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/09964002-4E78-4095-A594-2DEFEE0E410F"><gtr:id>09964002-4E78-4095-A594-2DEFEE0E410F</gtr:id><gtr:title>Vasomotor symptoms in women and cardiovascular risk markers: Systematic review and meta-analysis.</gtr:title><gtr:parentPublicationTitle>Maturitas</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8ecb2281513a936a91957e04ee639286"><gtr:id>8ecb2281513a936a91957e04ee639286</gtr:id><gtr:otherNames>Franco OH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0378-5122</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/87D27DB2-84EB-416A-960E-88895FBA072E"><gtr:id>87D27DB2-84EB-416A-960E-88895FBA072E</gtr:id><gtr:title>Meta-analysis of ventricular premature complexes and their relation to cardiac mortality in general populations.</gtr:title><gtr:parentPublicationTitle>The American journal of cardiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/108c4b19a7cb47063ab3ba6e4d3218a8"><gtr:id>108c4b19a7cb47063ab3ba6e4d3218a8</gtr:id><gtr:otherNames>Ataklte F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0002-9149</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D4DCA0EE-8110-4865-AC5F-3DAF3A0090A7"><gtr:id>D4DCA0EE-8110-4865-AC5F-3DAF3A0090A7</gtr:id><gtr:title>Using Mendelian randomization to assess and develop clinical interventions: limitations and benefits.</gtr:title><gtr:parentPublicationTitle>Journal of comparative effectiveness research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/056163b112d2b291ecc076d094a1b4e8"><gtr:id>056163b112d2b291ecc076d094a1b4e8</gtr:id><gtr:otherNames>Burgess S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2042-6305</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/49C27734-DFC7-4A0E-B2E7-510E3AC15F84"><gtr:id>49C27734-DFC7-4A0E-B2E7-510E3AC15F84</gtr:id><gtr:title>Functional interpretation of non-coding sequence variation: concepts and challenges.</gtr:title><gtr:parentPublicationTitle>BioEssays : news and reviews in molecular, cellular and developmental biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b159c2fdc40bd9f1b680388b2982bc9d"><gtr:id>b159c2fdc40bd9f1b680388b2982bc9d</gtr:id><gtr:otherNames>Paul DS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0265-9247</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B348EB7E-E93D-4107-AF0C-225F6A4BE60E"><gtr:id>B348EB7E-E93D-4107-AF0C-225F6A4BE60E</gtr:id><gtr:title>Joint modelling of repeated measurements and time-to-event outcomes: flexible model specification and exact likelihood inference.</gtr:title><gtr:parentPublicationTitle>Journal of the Royal Statistical Society. Series B, Statistical methodology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/746d6e4c7a1e8580f69066c5c55eb1b5"><gtr:id>746d6e4c7a1e8580f69066c5c55eb1b5</gtr:id><gtr:otherNames>Barrett J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1369-7412</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/AF19C7A4-0F22-4CBB-B32B-C06E65099AFF"><gtr:id>AF19C7A4-0F22-4CBB-B32B-C06E65099AFF</gtr:id><gtr:title>Glycated hemoglobin measurement and prediction of cardiovascular disease.</gtr:title><gtr:parentPublicationTitle>JAMA</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/00954130f581451305ebfe461866731f"><gtr:id>00954130f581451305ebfe461866731f</gtr:id><gtr:otherNames>Emerging Risk Factors Collaboration</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0098-7484</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/447E7003-A63F-4A6C-BD24-7F41A35932F1"><gtr:id>447E7003-A63F-4A6C-BD24-7F41A35932F1</gtr:id><gtr:title>Global, regional, and national levels of neonatal, infant, and under-5 mortality during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f88cc0b3857e4454158c5b9ddf455220"><gtr:id>f88cc0b3857e4454158c5b9ddf455220</gtr:id><gtr:otherNames>Wang H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/05C8F3C6-A654-4924-A035-7295BD449632"><gtr:id>05C8F3C6-A654-4924-A035-7295BD449632</gtr:id><gtr:title>A review of instrumental variable estimators for Mendelian randomization.</gtr:title><gtr:parentPublicationTitle>Statistical methods in medical research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/056163b112d2b291ecc076d094a1b4e8"><gtr:id>056163b112d2b291ecc076d094a1b4e8</gtr:id><gtr:otherNames>Burgess S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0962-2802</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/36354976-74A7-40D5-83D5-3BE95C76111E"><gtr:id>36354976-74A7-40D5-83D5-3BE95C76111E</gtr:id><gtr:title>Vertebral Scheuermann's disease in Europe: prevalence, geographic variation and radiological correlates in men and women aged 50 and over.</gtr:title><gtr:parentPublicationTitle>Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/5a240d564c8d852ec95aa9467d15177a"><gtr:id>5a240d564c8d852ec95aa9467d15177a</gtr:id><gtr:otherNames>Armbrecht G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0937-941X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/970411C9-CE78-406E-A9A4-866777291F47"><gtr:id>970411C9-CE78-406E-A9A4-866777291F47</gtr:id><gtr:title>Endovascular strategy or open repair for ruptured abdominal aortic aneurysm: one-year outcomes from the IMPROVE randomized trial.</gtr:title><gtr:parentPublicationTitle>European heart journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/2cffb654bd9173c86d37537f9b57d18c"><gtr:id>2cffb654bd9173c86d37537f9b57d18c</gtr:id><gtr:otherNames>IMPROVE Trial Investigators</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0195-668X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/20361782-4F63-4A0B-AC49-D22CB52A09DA"><gtr:id>20361782-4F63-4A0B-AC49-D22CB52A09DA</gtr:id><gtr:title>Modelling semi-attributable toxicity in dual-agent phase I trials with non-concurrent drug administration.</gtr:title><gtr:parentPublicationTitle>Statistics in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ef3dd8d7b6622717fa234ee9778dc93f"><gtr:id>ef3dd8d7b6622717fa234ee9778dc93f</gtr:id><gtr:otherNames>Wheeler GM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0277-6715</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F3321342-D761-46A6-9905-2580B0574DA3"><gtr:id>F3321342-D761-46A6-9905-2580B0574DA3</gtr:id><gtr:title>Adaptive designs for dual-agent phase I dose-escalation studies.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Clinical oncology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f934bfb665c483ff80c32902af6a6d3f"><gtr:id>f934bfb665c483ff80c32902af6a6d3f</gtr:id><gtr:otherNames>Harrington JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1759-4774</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/49551B56-E869-4599-9FF8-4BB1FC322E22"><gtr:id>49551B56-E869-4599-9FF8-4BB1FC322E22</gtr:id><gtr:title>Observations from the IMPROVE trial concerning the clinical care of patients with ruptured abdominal aortic aneurysm.</gtr:title><gtr:parentPublicationTitle>The British journal of surgery</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/74710d1a979eac24ad82650940f17f9f"><gtr:id>74710d1a979eac24ad82650940f17f9f</gtr:id><gtr:otherNames>IMPROVE trial investigators</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0007-1323</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0C345C62-A1F1-4FCF-966C-83519B3FF225"><gtr:id>0C345C62-A1F1-4FCF-966C-83519B3FF225</gtr:id><gtr:title>The INTERVAL trial to determine whether intervals between blood donations can be safely and acceptably decreased to optimise blood supply: study protocol for a randomised controlled trial.</gtr:title><gtr:parentPublicationTitle>Trials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/89054595f3e8c6d961598d722c9df7c5"><gtr:id>89054595f3e8c6d961598d722c9df7c5</gtr:id><gtr:otherNames>Moore C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1745-6215</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/9DCDED17-1775-4BD1-B0DF-BAA1159DE0FF"><gtr:id>9DCDED17-1775-4BD1-B0DF-BAA1159DE0FF</gtr:id><gtr:title>Exome sequencing identifies rare LDLR and APOA5 alleles conferring risk for myocardial infarction.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/6daa1058761b1f7343dc0121c98d2a04"><gtr:id>6daa1058761b1f7343dc0121c98d2a04</gtr:id><gtr:otherNames>Do R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/1AFDBE16-6DC1-4D16-ADB2-DD782CC6711C"><gtr:id>1AFDBE16-6DC1-4D16-ADB2-DD782CC6711C</gtr:id><gtr:title>The clinical effectiveness and cost-effectiveness of brief intervention for excessive alcohol consumption among people attending sexual health clinics: a randomised controlled trial (SHEAR).</gtr:title><gtr:parentPublicationTitle>Health technology assessment (Winchester, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/98e43f68bd12f393678f99322da358ab"><gtr:id>98e43f68bd12f393678f99322da358ab</gtr:id><gtr:otherNames>Crawford MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1366-5278</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/ABB21393-3986-4312-B4F2-B55CA5A63B24"><gtr:id>ABB21393-3986-4312-B4F2-B55CA5A63B24</gtr:id><gtr:title>C-reactive protein, fibrinogen, and cardiovascular risk.</gtr:title><gtr:parentPublicationTitle>The New England journal of medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d73869c379526148bf219bce3bd5ecba"><gtr:id>d73869c379526148bf219bce3bd5ecba</gtr:id><gtr:otherNames>Kaptoge S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0028-4793</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5D9AB415-C2FB-4E63-A3C0-E1CAD6327DC9"><gtr:id>5D9AB415-C2FB-4E63-A3C0-E1CAD6327DC9</gtr:id><gtr:title>Left ventricular mass and the risk of sudden cardiac death: a population-based study.</gtr:title><gtr:parentPublicationTitle>Journal of the American Heart Association</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/bc70ab8da1391ea96a453ecc1f8551b1"><gtr:id>bc70ab8da1391ea96a453ecc1f8551b1</gtr:id><gtr:otherNames>Laukkanen JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2047-9980</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3BA3D308-4309-41B7-A7D4-AD282CF5EAC4"><gtr:id>3BA3D308-4309-41B7-A7D4-AD282CF5EAC4</gtr:id><gtr:title>A hybrid qPCR/SNP array approach allows cost efficient assessment of KIR gene copy numbers in large samples.</gtr:title><gtr:parentPublicationTitle>BMC genomics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ff367b188f493da912c48dd100b9b92e"><gtr:id>ff367b188f493da912c48dd100b9b92e</gtr:id><gtr:otherNames>Pontikos N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1471-2164</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E33A24AF-510A-42CA-B4D0-2BD68309587F"><gtr:id>E33A24AF-510A-42CA-B4D0-2BD68309587F</gtr:id><gtr:title>Assessing causality in associations between cannabis use and schizophrenia risk: a two-sample Mendelian randomization study.</gtr:title><gtr:parentPublicationTitle>Psychological medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8f4e2610836a71803b87994e3e46760d"><gtr:id>8f4e2610836a71803b87994e3e46760d</gtr:id><gtr:otherNames>Gage SH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0033-2917</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/2CD11CB9-5C98-4FAC-9FE6-EAD60B1DBE66"><gtr:id>2CD11CB9-5C98-4FAC-9FE6-EAD60B1DBE66</gtr:id><gtr:title>A donor-specific epigenetic classifier for acute graft-versus-host disease severity in hematopoietic stem cell transplantation.</gtr:title><gtr:parentPublicationTitle>Genome medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b159c2fdc40bd9f1b680388b2982bc9d"><gtr:id>b159c2fdc40bd9f1b680388b2982bc9d</gtr:id><gtr:otherNames>Paul DS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1756-994X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/ACF263BB-6F10-48AD-8F96-A4FEE7EA6878"><gtr:id>ACF263BB-6F10-48AD-8F96-A4FEE7EA6878</gtr:id><gtr:title>A comprehensive 1,000 Genomes-based genome-wide association meta-analysis of coronary artery disease.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/bed44bb349fa0c3006192e1e5aed381e"><gtr:id>bed44bb349fa0c3006192e1e5aed381e</gtr:id><gtr:otherNames>Nikpay M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5074D8CA-855F-4B41-AE09-839C8BA88F81"><gtr:id>5074D8CA-855F-4B41-AE09-839C8BA88F81</gtr:id><gtr:title>The role of global and regional DNA methylation and histone modifications in glycemic traits and type 2 diabetes: A systematic review.</gtr:title><gtr:parentPublicationTitle>Nutrition, metabolism, and cardiovascular diseases : NMCD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ea1e5ba889fd0cca140aeff5b41e4684"><gtr:id>ea1e5ba889fd0cca140aeff5b41e4684</gtr:id><gtr:otherNames>Muka T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0939-4753</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/71AD1C41-00F3-4E56-AC51-5A5B3F956276"><gtr:id>71AD1C41-00F3-4E56-AC51-5A5B3F956276</gtr:id><gtr:title>Inflammatory cytokines and risk of coronary heart disease: new prospective study and updated meta-analysis.</gtr:title><gtr:parentPublicationTitle>European heart journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d73869c379526148bf219bce3bd5ecba"><gtr:id>d73869c379526148bf219bce3bd5ecba</gtr:id><gtr:otherNames>Kaptoge S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0195-668X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/7CBF532E-8BBF-48AB-84D5-6290B4DBF0B7"><gtr:id>7CBF532E-8BBF-48AB-84D5-6290B4DBF0B7</gtr:id><gtr:title>Mendelian randomization analysis with multiple genetic variants using summarized data.</gtr:title><gtr:parentPublicationTitle>Genetic epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/056163b112d2b291ecc076d094a1b4e8"><gtr:id>056163b112d2b291ecc076d094a1b4e8</gtr:id><gtr:otherNames>Burgess S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0741-0395</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E3F0EDC9-6D80-4451-A27D-4ED4445450B8"><gtr:id>E3F0EDC9-6D80-4451-A27D-4ED4445450B8</gtr:id><gtr:title>Trans fatty acid isomers in mortality and incident coronary heart disease risk.</gtr:title><gtr:parentPublicationTitle>Journal of the American Heart Association</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/e6174ca4b9befe9d94477e7180f705a2"><gtr:id>e6174ca4b9befe9d94477e7180f705a2</gtr:id><gtr:otherNames>Chowdhury R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2047-9980</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/BA684680-6E5B-4BFA-8163-03E140C5B84B"><gtr:id>BA684680-6E5B-4BFA-8163-03E140C5B84B</gtr:id><gtr:title>Endovascular versus open repair of abdominal aortic aneurysm in 15-years' follow-up of the UK endovascular aneurysm repair trial 1 (EVAR trial 1): a randomised controlled trial</gtr:title><gtr:parentPublicationTitle>The Lancet</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/10db95fd56b961dd90153cd3acb87a32"><gtr:id>10db95fd56b961dd90153cd3acb87a32</gtr:id><gtr:otherNames>Patel R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/90BB49C9-9D95-4501-991A-EFC4B822DCB5"><gtr:id>90BB49C9-9D95-4501-991A-EFC4B822DCB5</gtr:id><gtr:title>Malaria and macronutrient deficiency as correlates of anemia in young children: a systematic review of observational studies.</gtr:title><gtr:parentPublicationTitle>Annals of global health</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/37494d8e3c00d3abea799b018b10103d"><gtr:id>37494d8e3c00d3abea799b018b10103d</gtr:id><gtr:otherNames>McCuskee S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2214-9996</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F9948DCB-AA5D-4037-9445-7881EDABDE38"><gtr:id>F9948DCB-AA5D-4037-9445-7881EDABDE38</gtr:id><gtr:title>Previous miscarriage and the subsequent risk of preterm birth in Scotland, 1980-2008: a historical cohort study.</gtr:title><gtr:parentPublicationTitle>BJOG : an international journal of obstetrics and gynaecology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ac371cf7bf4dfadaafa05292c91b5f5e"><gtr:id>ac371cf7bf4dfadaafa05292c91b5f5e</gtr:id><gtr:otherNames>Oliver-Williams C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1470-0328</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B3602BC1-52B7-475F-86FC-4B28EDC99971"><gtr:id>B3602BC1-52B7-475F-86FC-4B28EDC99971</gtr:id><gtr:title>Effects of choline on health across the life course: a systematic review.</gtr:title><gtr:parentPublicationTitle>Nutrition reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0c92ead5daee18cc45083f882186f775"><gtr:id>0c92ead5daee18cc45083f882186f775</gtr:id><gtr:otherNames>Leermakers ET</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0029-6643</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E2FDDF11-C4B2-4C37-A11D-2C8B40FF06FF"><gtr:id>E2FDDF11-C4B2-4C37-A11D-2C8B40FF06FF</gtr:id><gtr:title>Instrumental variable analysis with a nonlinear exposure-outcome relationship.</gtr:title><gtr:parentPublicationTitle>Epidemiology (Cambridge, Mass.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/056163b112d2b291ecc076d094a1b4e8"><gtr:id>056163b112d2b291ecc076d094a1b4e8</gtr:id><gtr:otherNames>Burgess S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1044-3983</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0A865F0A-C2D3-4451-BD5E-83D7F23AC669"><gtr:id>0A865F0A-C2D3-4451-BD5E-83D7F23AC669</gtr:id><gtr:title>Functional IL6R 358Ala allele impairs classical IL-6 receptor signaling and influences risk of diverse inflammatory diseases.</gtr:title><gtr:parentPublicationTitle>PLoS genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/e03bbbdbc229918cd5fca71a613cecfc"><gtr:id>e03bbbdbc229918cd5fca71a613cecfc</gtr:id><gtr:otherNames>Ferreira RC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1553-7390</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/6CB88548-76D5-4A17-8E04-2F34C56B1258"><gtr:id>6CB88548-76D5-4A17-8E04-2F34C56B1258</gtr:id><gtr:title>Parity, breastfeeding and risk of coronary heart disease: A pan-European case-cohort study.</gtr:title><gtr:parentPublicationTitle>European journal of preventive cardiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b7daee98c7d288fe9d8420024484dc3e"><gtr:id>b7daee98c7d288fe9d8420024484dc3e</gtr:id><gtr:otherNames>Peters SA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2047-4873</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/2E6F49DC-80F1-4B84-8D8C-61F9B059161A"><gtr:id>2E6F49DC-80F1-4B84-8D8C-61F9B059161A</gtr:id><gtr:title>Advances in epigenome-wide association studies for common diseases.</gtr:title><gtr:parentPublicationTitle>Trends in molecular medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b159c2fdc40bd9f1b680388b2982bc9d"><gtr:id>b159c2fdc40bd9f1b680388b2982bc9d</gtr:id><gtr:otherNames>Paul DS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1471-4914</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E8DA4C3A-CFA6-478D-8731-533A925AA930"><gtr:id>E8DA4C3A-CFA6-478D-8731-533A925AA930</gtr:id><gtr:title>Causal Assessment of Serum Urate Levels in Cardiometabolic Diseases Through a Mendelian Randomization Study.</gtr:title><gtr:parentPublicationTitle>Journal of the American College of Cardiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/2cfd48bb498b4794423c87418acd7778"><gtr:id>2cfd48bb498b4794423c87418acd7778</gtr:id><gtr:otherNames>Keenan T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0735-1097</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D671ABC8-C61C-46CE-BEE8-082A2E0B879D"><gtr:id>D671ABC8-C61C-46CE-BEE8-082A2E0B879D</gtr:id><gtr:title>Ruptured Aneurysm Trials: The Importance of Longer-term Outcomes and Meta-analysis for 1-year Mortality.</gtr:title><gtr:parentPublicationTitle>European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/08c22c62d0cf7146e7a5119404c7ca83"><gtr:id>08c22c62d0cf7146e7a5119404c7ca83</gtr:id><gtr:otherNames>Sweeting MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1078-5884</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/BC45751F-7DDC-4C22-AC8F-C55ACD296040"><gtr:id>BC45751F-7DDC-4C22-AC8F-C55ACD296040</gtr:id><gtr:title>Combining multiple imputation and meta-analysis with individual participant data.</gtr:title><gtr:parentPublicationTitle>Statistics in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/056163b112d2b291ecc076d094a1b4e8"><gtr:id>056163b112d2b291ecc076d094a1b4e8</gtr:id><gtr:otherNames>Burgess S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0277-6715</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/BBBA828A-5123-4AE1-BD85-DDE90E09ABD3"><gtr:id>BBBA828A-5123-4AE1-BD85-DDE90E09ABD3</gtr:id><gtr:title>Commentary: Consistency and collapsibility: are they crucial for instrumental variable analysis with a survival outcome in mendelian randomization?</gtr:title><gtr:parentPublicationTitle>Epidemiology (Cambridge, Mass.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/056163b112d2b291ecc076d094a1b4e8"><gtr:id>056163b112d2b291ecc076d094a1b4e8</gtr:id><gtr:otherNames>Burgess S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1044-3983</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/60C13889-DA91-4E09-832E-81243F0D14B4"><gtr:id>60C13889-DA91-4E09-832E-81243F0D14B4</gtr:id><gtr:title>Epigenome-wide association of DNA methylation markers in peripheral blood from Indian Asians and Europeans with incident type 2 diabetes: a nested case-control study.</gtr:title><gtr:parentPublicationTitle>The lancet. Diabetes &amp; endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a6331e598a783832f88337f69a52dc44"><gtr:id>a6331e598a783832f88337f69a52dc44</gtr:id><gtr:otherNames>Chambers JC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2213-8587</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/FA861E08-EB8B-4A2A-ABBA-8A0916F709E5"><gtr:id>FA861E08-EB8B-4A2A-ABBA-8A0916F709E5</gtr:id><gtr:title>Covariate-adjusted measures of discrimination for survival data.</gtr:title><gtr:parentPublicationTitle>Biometrical journal. Biometrische Zeitschrift</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/9bd522716636d6c40c2c616ae992e297"><gtr:id>9bd522716636d6c40c2c616ae992e297</gtr:id><gtr:otherNames>White IR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0323-3847</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D472B16C-8168-4FFD-8FE1-53ADB2E07CD8"><gtr:id>D472B16C-8168-4FFD-8FE1-53ADB2E07CD8</gtr:id><gtr:title>Anticoagulant vs. antiplatelet therapy in patients with cryptogenic stroke and patent foramen ovale: an individual participant data meta-analysis.</gtr:title><gtr:parentPublicationTitle>European heart journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/227c02c48c31336cf884824c38bb8212"><gtr:id>227c02c48c31336cf884824c38bb8212</gtr:id><gtr:otherNames>Kent DM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0195-668X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/AA6D1A42-B607-406B-9B04-D84D53D3DF19"><gtr:id>AA6D1A42-B607-406B-9B04-D84D53D3DF19</gtr:id><gtr:title>Multilevel models for cost-effectiveness analyses that use cluster randomised trial data: An approach to model choice.</gtr:title><gtr:parentPublicationTitle>Statistical methods in medical research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d7f2350ac4c2ff3aab33140e1197b2ea"><gtr:id>d7f2350ac4c2ff3aab33140e1197b2ea</gtr:id><gtr:otherNames>Ng ES</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0962-2802</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0437D96D-8E40-4372-A234-263E7AB9D384"><gtr:id>0437D96D-8E40-4372-A234-263E7AB9D384</gtr:id><gtr:title>Investigating causality in the association between 25(OH)D and schizophrenia.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0ae09499f509debb276bcc0365bb8918"><gtr:id>0ae09499f509debb276bcc0365bb8918</gtr:id><gtr:otherNames>Taylor AE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/9525AF99-5BDB-4656-A107-DE973FD42EC8"><gtr:id>9525AF99-5BDB-4656-A107-DE973FD42EC8</gtr:id><gtr:title>Incidence estimation using a single cross-sectional age-specific prevalence survey with differential mortality.</gtr:title><gtr:parentPublicationTitle>Statistics in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/fb38dd2c1c90a8bbec025b677dec0f1e"><gtr:id>fb38dd2c1c90a8bbec025b677dec0f1e</gtr:id><gtr:otherNames>Turner EL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0277-6715</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/7C7B7BE6-D2BB-418A-BF78-0F0D718AF8F8"><gtr:id>7C7B7BE6-D2BB-418A-BF78-0F0D718AF8F8</gtr:id><gtr:title>Fully Bayesian hierarchical modelling in two stages, with application to meta-analysis.</gtr:title><gtr:parentPublicationTitle>Journal of the Royal Statistical Society. Series C, Applied statistics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f51cc174ef8771b1384b46e0e479bc4c"><gtr:id>f51cc174ef8771b1384b46e0e479bc4c</gtr:id><gtr:otherNames>Lunn D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0035-9254</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/6CB93F7B-59D2-4340-91A9-16252806F2BE"><gtr:id>6CB93F7B-59D2-4340-91A9-16252806F2BE</gtr:id><gtr:title>Multiple imputation for an incomplete covariate that is a ratio.</gtr:title><gtr:parentPublicationTitle>Statistics in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0b1d9399bd3eb60d72d90806cff36fc5"><gtr:id>0b1d9399bd3eb60d72d90806cff36fc5</gtr:id><gtr:otherNames>Morris TP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0277-6715</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/195BE12B-B49F-40BB-A530-D7816DE346B7"><gtr:id>195BE12B-B49F-40BB-A530-D7816DE346B7</gtr:id><gtr:title>Association of Multiple Biomarkers of Iron Metabolism and Type 2 Diabetes: The EPIC-InterAct Study.</gtr:title><gtr:parentPublicationTitle>Diabetes care</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f7e395f3d1d4bf26598536bd293a9e4b"><gtr:id>f7e395f3d1d4bf26598536bd293a9e4b</gtr:id><gtr:otherNames>Podmore C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0149-5992</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/18BD12B2-E4B9-4972-81D9-BC58B23F143A"><gtr:id>18BD12B2-E4B9-4972-81D9-BC58B23F143A</gtr:id><gtr:title>The age-specific quantitative effects of metabolic risk factors on cardiovascular diseases and diabetes: a pooled analysis.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8d012057abe1ab26dba98c429a2e7b82"><gtr:id>8d012057abe1ab26dba98c429a2e7b82</gtr:id><gtr:otherNames>Singh GM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/95A90B34-26B3-4908-BF90-A52A43FEE23E"><gtr:id>95A90B34-26B3-4908-BF90-A52A43FEE23E</gtr:id><gtr:title>Association of hypertension and hyperglycaemia with socioeconomic contexts in resource-poor settings: the Bangladesh Demographic and Health Survey.</gtr:title><gtr:parentPublicationTitle>International journal of epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a80f0960b95a4fd7940801b0fc958e6c"><gtr:id>a80f0960b95a4fd7940801b0fc958e6c</gtr:id><gtr:otherNames>Harshfield E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0300-5771</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/7487222E-B473-4FEC-9ADD-0513C54105F6"><gtr:id>7487222E-B473-4FEC-9ADD-0513C54105F6</gtr:id><gtr:title>Asymmetric dimethylarginine and cardiovascular risk: systematic review and meta-analysis of 22 prospective studies.</gtr:title><gtr:parentPublicationTitle>Journal of the American Heart Association</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c14d384b5a87c9bc3c358b7461f53714"><gtr:id>c14d384b5a87c9bc3c358b7461f53714</gtr:id><gtr:otherNames>Willeit P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2047-9980</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/8F9F0E13-D79B-4D2E-B116-F30654A6ED14"><gtr:id>8F9F0E13-D79B-4D2E-B116-F30654A6ED14</gtr:id><gtr:title>Circulating total bilirubin and risk of incident cardiovascular disease in the general population.</gtr:title><gtr:parentPublicationTitle>Arteriosclerosis, thrombosis, and vascular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8fbda2f0b84566eec04bf63cde9ad5b6"><gtr:id>8fbda2f0b84566eec04bf63cde9ad5b6</gtr:id><gtr:otherNames>Kunutsor SK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1079-5642</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F824299A-8B4F-4E56-9B22-A06356AEBC73"><gtr:id>F824299A-8B4F-4E56-9B22-A06356AEBC73</gtr:id><gtr:title>Trans-ancestry genome-wide association study identifies 12 genetic loci influencing blood pressure and implicates a role for DNA methylation.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/eb094f6bdc37c8484868410c6dce353d"><gtr:id>eb094f6bdc37c8484868410c6dce353d</gtr:id><gtr:otherNames>Kato N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A608A1B1-4891-4248-8982-7A61D79F3E40"><gtr:id>A608A1B1-4891-4248-8982-7A61D79F3E40</gtr:id><gtr:title>Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/6f7befc4aeca1b83d865212c59a1dc02"><gtr:id>6f7befc4aeca1b83d865212c59a1dc02</gtr:id><gtr:otherNames>GBD 2013 Risk Factors Collaborators</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/CB43EF48-2B24-4E85-9339-BFA818819AB4"><gtr:id>CB43EF48-2B24-4E85-9339-BFA818819AB4</gtr:id><gtr:title>Psychosocial Factors Associated With Withdrawal From the United Kingdom Collaborative Trial of Ovarian Cancer Screening After 1 Episode of Repeat Screening.</gtr:title><gtr:parentPublicationTitle>International journal of gynecological cancer : official journal of the International Gynecological Cancer Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c3d9fcac32bedd45dca8329d4ad63648"><gtr:id>c3d9fcac32bedd45dca8329d4ad63648</gtr:id><gtr:otherNames>Jenkins V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1048-891X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/32AD10D5-9C16-42D6-8BB2-B5A62DB92D40"><gtr:id>32AD10D5-9C16-42D6-8BB2-B5A62DB92D40</gtr:id><gtr:title>Mendelian randomization: where are we now and where are we going?</gtr:title><gtr:parentPublicationTitle>International journal of epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/056163b112d2b291ecc076d094a1b4e8"><gtr:id>056163b112d2b291ecc076d094a1b4e8</gtr:id><gtr:otherNames>Burgess S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0300-5771</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/68A33BB7-2108-46FE-A60B-A2B6DD17BF67"><gtr:id>68A33BB7-2108-46FE-A60B-A2B6DD17BF67</gtr:id><gtr:title>The role of epigenetic modifications in cardiovascular disease: A systematic review.</gtr:title><gtr:parentPublicationTitle>International journal of cardiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ea1e5ba889fd0cca140aeff5b41e4684"><gtr:id>ea1e5ba889fd0cca140aeff5b41e4684</gtr:id><gtr:otherNames>Muka T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0167-5273</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A50CDF9F-B412-4C69-AC06-590E85FF807F"><gtr:id>A50CDF9F-B412-4C69-AC06-590E85FF807F</gtr:id><gtr:title>Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression.</gtr:title><gtr:parentPublicationTitle>International journal of epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/1e7b9f88de7989208d17352d3514ca24"><gtr:id>1e7b9f88de7989208d17352d3514ca24</gtr:id><gtr:otherNames>Bowden J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0300-5771</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/153DD4B1-2D78-465F-899B-A193F690E914"><gtr:id>153DD4B1-2D78-465F-899B-A193F690E914</gtr:id><gtr:title>Retrospective Studies.</gtr:title><gtr:parentPublicationTitle>European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/fb46d5a2908901f6dd48363c51b7295f"><gtr:id>fb46d5a2908901f6dd48363c51b7295f</gtr:id><gtr:otherNames>Powell JT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1078-5884</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F748025C-2C28-4A70-AEC1-0843814599F3"><gtr:id>F748025C-2C28-4A70-AEC1-0843814599F3</gtr:id><gtr:title>Burden of undiagnosed hypertension in sub-saharan Africa: a systematic review and meta-analysis.</gtr:title><gtr:parentPublicationTitle>Hypertension (Dallas, Tex. : 1979)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/108c4b19a7cb47063ab3ba6e4d3218a8"><gtr:id>108c4b19a7cb47063ab3ba6e4d3218a8</gtr:id><gtr:otherNames>Ataklte F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0194-911X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/64E55AAD-51A2-4924-B0AD-D7DDBC5DAE19"><gtr:id>64E55AAD-51A2-4924-B0AD-D7DDBC5DAE19</gtr:id><gtr:title>Patient reactions to a web-based cardiovascular risk calculator in type 2 diabetes: a qualitative study in primary care.</gtr:title><gtr:parentPublicationTitle>The British journal of general practice : the journal of the Royal College of General Practitioners</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/fb679e724c8814407d030ea406ffb186"><gtr:id>fb679e724c8814407d030ea406ffb186</gtr:id><gtr:otherNames>Nolan T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0960-1643</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E065D8BE-952E-417B-A656-0F98255D4227"><gtr:id>E065D8BE-952E-417B-A656-0F98255D4227</gtr:id><gtr:title>Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents</gtr:title><gtr:parentPublicationTitle>The Lancet</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/113cc7e7df5287e13471822ad7fcaea6"><gtr:id>113cc7e7df5287e13471822ad7fcaea6</gtr:id><gtr:otherNames>Di Angelantonio E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/59D4649B-79CD-466A-BC46-D67C717B1D00"><gtr:id>59D4649B-79CD-466A-BC46-D67C717B1D00</gtr:id><gtr:title>Psychological morbidity associated with ovarian cancer screening: results from more than 23,000 women in the randomised trial of ovarian cancer screening (UKCTOCS).</gtr:title><gtr:parentPublicationTitle>BJOG : an international journal of obstetrics and gynaecology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/746d6e4c7a1e8580f69066c5c55eb1b5"><gtr:id>746d6e4c7a1e8580f69066c5c55eb1b5</gtr:id><gtr:otherNames>Barrett J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1470-0328</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/34A2ECD5-A8EB-47BE-B99C-074147285D70"><gtr:id>34A2ECD5-A8EB-47BE-B99C-074147285D70</gtr:id><gtr:title>Adherence to cardiovascular therapy: a meta-analysis of prevalence and clinical consequences.</gtr:title><gtr:parentPublicationTitle>European heart journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/e6174ca4b9befe9d94477e7180f705a2"><gtr:id>e6174ca4b9befe9d94477e7180f705a2</gtr:id><gtr:otherNames>Chowdhury R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0195-668X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/599760A0-89D3-4BD2-9867-6042B2199BD3"><gtr:id>599760A0-89D3-4BD2-9867-6042B2199BD3</gtr:id><gtr:title>Serum gamma-glutamyl transferase and risk of type 2 diabetes in the general Korean population: a Mendelian randomization study.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/fb04737da24f4df127b02dabcb33fd7c"><gtr:id>fb04737da24f4df127b02dabcb33fd7c</gtr:id><gtr:otherNames>Lee YS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/CF5D31FB-5978-4F5B-B3C4-165D475C69DF"><gtr:id>CF5D31FB-5978-4F5B-B3C4-165D475C69DF</gtr:id><gtr:title>Candidate gene association study of coronary artery calcification in chronic kidney disease: findings from the CRIC study (Chronic Renal Insufficiency Cohort).</gtr:title><gtr:parentPublicationTitle>Journal of the American College of Cardiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a87c693123aa2ea668dffbc177a9e54c"><gtr:id>a87c693123aa2ea668dffbc177a9e54c</gtr:id><gtr:otherNames>Ferguson JF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0735-1097</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F933803F-2026-4407-9D01-2F7911268B25"><gtr:id>F933803F-2026-4407-9D01-2F7911268B25</gtr:id><gtr:title>Association Between Low-Density Lipoprotein Cholesterol-Lowering Genetic Variants and Risk of Type 2 Diabetes: A Meta-analysis.</gtr:title><gtr:parentPublicationTitle>JAMA</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/590c8a9618b273cc7c1e0848dd49db27"><gtr:id>590c8a9618b273cc7c1e0848dd49db27</gtr:id><gtr:otherNames>Lotta LA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0098-7484</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D66427B3-9DD2-447D-8DBE-389721A0D0E5"><gtr:id>D66427B3-9DD2-447D-8DBE-389721A0D0E5</gtr:id><gtr:title>Life, health, and safety of industrial workers in bangladesh: should they be driven by economic rationale or moral imperative?</gtr:title><gtr:parentPublicationTitle>Journal of occupational and environmental medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/e6174ca4b9befe9d94477e7180f705a2"><gtr:id>e6174ca4b9befe9d94477e7180f705a2</gtr:id><gtr:otherNames>Chowdhury R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1076-2752</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/64A4F9F4-FD2C-40F4-A628-7A6DC71EDD87"><gtr:id>64A4F9F4-FD2C-40F4-A628-7A6DC71EDD87</gtr:id><gtr:title>An endovascular strategy for suspected ruptured abdominal aortic aneurysm brings earlier home discharge but not early survival or cost benefits.</gtr:title><gtr:parentPublicationTitle>European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/2cffb654bd9173c86d37537f9b57d18c"><gtr:id>2cffb654bd9173c86d37537f9b57d18c</gtr:id><gtr:otherNames>IMPROVE Trial Investigators</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1078-5884</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/6AD7C81C-D9C3-4934-8EC0-4248B16D08D1"><gtr:id>6AD7C81C-D9C3-4934-8EC0-4248B16D08D1</gtr:id><gtr:title>Surveillance intervals for small abdominal aortic aneurysms: a meta-analysis.</gtr:title><gtr:parentPublicationTitle>JAMA</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/7878e7a70b12f49b60ba98bee4650111"><gtr:id>7878e7a70b12f49b60ba98bee4650111</gtr:id><gtr:otherNames>RESCAN Collaborators</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0098-7484</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A5580912-F721-41FF-847B-D0534F595BD7"><gtr:id>A5580912-F721-41FF-847B-D0534F595BD7</gtr:id><gtr:title>The use of repeated blood pressure measures for cardiovascular risk prediction: a comparison of statistical models in the ARIC study.</gtr:title><gtr:parentPublicationTitle>Statistics in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/08c22c62d0cf7146e7a5119404c7ca83"><gtr:id>08c22c62d0cf7146e7a5119404c7ca83</gtr:id><gtr:otherNames>Sweeting MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0277-6715</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A4408975-2DB2-4B5E-96B8-C1900F803365"><gtr:id>A4408975-2DB2-4B5E-96B8-C1900F803365</gtr:id><gtr:title>Natriuretic peptides and integrated risk assessment for cardiovascular disease: an individual-participant-data meta-analysis</gtr:title><gtr:parentPublicationTitle>The Lancet Diabetes &amp; Endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c14d384b5a87c9bc3c358b7461f53714"><gtr:id>c14d384b5a87c9bc3c358b7461f53714</gtr:id><gtr:otherNames>Willeit P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/6DF897EF-4911-4E93-87E7-2047968C3FD6"><gtr:id>6DF897EF-4911-4E93-87E7-2047968C3FD6</gtr:id><gtr:title>Within-person variability in calculated risk factors: comparing the aetiological association of adiposity ratios with risk of coronary heart disease.</gtr:title><gtr:parentPublicationTitle>International journal of epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/97686a913ac915d9fd3904c6a2ba9d07"><gtr:id>97686a913ac915d9fd3904c6a2ba9d07</gtr:id><gtr:otherNames>Wormser D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0300-5771</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/2655164B-F121-46A2-AFD7-F9E30C3A3D60"><gtr:id>2655164B-F121-46A2-AFD7-F9E30C3A3D60</gtr:id><gtr:title>Best (but oft-forgotten) practices: the design, analysis, and interpretation of Mendelian randomization studies.</gtr:title><gtr:parentPublicationTitle>The American journal of clinical nutrition</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/360a808324aad78098cb2db35a75a186"><gtr:id>360a808324aad78098cb2db35a75a186</gtr:id><gtr:otherNames>Haycock PC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0002-9165</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/76E2E426-E6D9-46A2-8022-3A25FED4D7DD"><gtr:id>76E2E426-E6D9-46A2-8022-3A25FED4D7DD</gtr:id><gtr:title>Plasma urate and coronary heart disease: fingerprint match, but no smoking gun</gtr:title><gtr:parentPublicationTitle>The Lancet Diabetes &amp; Endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/056163b112d2b291ecc076d094a1b4e8"><gtr:id>056163b112d2b291ecc076d094a1b4e8</gtr:id><gtr:otherNames>Burgess S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/7C7F8AE1-6295-4144-B424-7A7B5F2F4945"><gtr:id>7C7F8AE1-6295-4144-B424-7A7B5F2F4945</gtr:id><gtr:title>Genome-wide meta-analysis identifies six novel loci associated with habitual coffee consumption.</gtr:title><gtr:parentPublicationTitle>Molecular psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/998989c017dbba0596a945f62d0f5827"><gtr:id>998989c017dbba0596a945f62d0f5827</gtr:id><gtr:otherNames>Coffee and Caffeine Genetics Consortium</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1359-4184</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/041C130A-6DB7-4AA7-BF52-6EA0F1B9D9D1"><gtr:id>041C130A-6DB7-4AA7-BF52-6EA0F1B9D9D1</gtr:id><gtr:title>Systematic review and meta-analysis of the growth and rupture rates of small abdominal aortic aneurysms: implications for surveillance intervals and their cost-effectiveness.</gtr:title><gtr:parentPublicationTitle>Health technology assessment (Winchester, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/15c5374ef8a578b00e6064775f6534b4"><gtr:id>15c5374ef8a578b00e6064775f6534b4</gtr:id><gtr:otherNames>Thompson SG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1366-5278</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/003D2869-B677-48DF-A573-091709109C11"><gtr:id>003D2869-B677-48DF-A573-091709109C11</gtr:id><gtr:title>Changes in association between previous therapeutic abortion and preterm birth in Scotland, 1980 to 2008: a historical cohort study.</gtr:title><gtr:parentPublicationTitle>PLoS medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ac371cf7bf4dfadaafa05292c91b5f5e"><gtr:id>ac371cf7bf4dfadaafa05292c91b5f5e</gtr:id><gtr:otherNames>Oliver-Williams C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1549-1277</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D69773B8-CE10-4333-B288-F768C507E9F4"><gtr:id>D69773B8-CE10-4333-B288-F768C507E9F4</gtr:id><gtr:title>The effect of rare variants on inflation of the test statistics in case-control analyses.</gtr:title><gtr:parentPublicationTitle>BMC bioinformatics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0d432f0c2362aa4af7c2c90db843dcd9"><gtr:id>0d432f0c2362aa4af7c2c90db843dcd9</gtr:id><gtr:otherNames>Pirie A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1471-2105</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/09B8A98B-3F7E-4D3A-8BE1-3EAFDADC60CF"><gtr:id>09B8A98B-3F7E-4D3A-8BE1-3EAFDADC60CF</gtr:id><gtr:title>Changes in health in England, with analysis by English regions and areas of deprivation, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/fd5e1114ebf1e734252f03fa14eb4e2e"><gtr:id>fd5e1114ebf1e734252f03fa14eb4e2e</gtr:id><gtr:otherNames>Newton JN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/685B24BE-33B8-4BA2-AAA1-3BC01847C48C"><gtr:id>685B24BE-33B8-4BA2-AAA1-3BC01847C48C</gtr:id><gtr:title>Use of Plant-Based Therapies and Menopausal Symptoms: A Systematic Review and Meta-analysis.</gtr:title><gtr:parentPublicationTitle>JAMA</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8ecb2281513a936a91957e04ee639286"><gtr:id>8ecb2281513a936a91957e04ee639286</gtr:id><gtr:otherNames>Franco OH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0098-7484</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/016A7C53-F48D-4E64-B382-E5F32EE00625"><gtr:id>016A7C53-F48D-4E64-B382-E5F32EE00625</gtr:id><gtr:title>Doubly Robust Estimation of Optimal Dynamic Treatment Regimes.</gtr:title><gtr:parentPublicationTitle>Statistics in biosciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f68e615d9c2624ac665554735c88462e"><gtr:id>f68e615d9c2624ac665554735c88462e</gtr:id><gtr:otherNames>Barrett JK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1867-1764</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/AB3A361E-27E4-4CE3-B14A-64F69758C4EE"><gtr:id>AB3A361E-27E4-4CE3-B14A-64F69758C4EE</gtr:id><gtr:title>The functional MICA-129 polymorphism is associated with skin but not joint manifestations of psoriatic disease independently of HLA-B and HLA-C.</gtr:title><gtr:parentPublicationTitle>Tissue antigens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/e9302aea9f20f195e1a5df6d711fac8b"><gtr:id>e9302aea9f20f195e1a5df6d711fac8b</gtr:id><gtr:otherNames>Pollock RA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0001-2815</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/AF314CFC-A08A-429E-A2EB-35B13C9249DF"><gtr:id>AF314CFC-A08A-429E-A2EB-35B13C9249DF</gtr:id><gtr:title>Meta-analysis identifies common and rare variants influencing blood pressure and overlapping with metabolic trait loci.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b7a1e6c1d76e70702a15effb81f63589"><gtr:id>b7a1e6c1d76e70702a15effb81f63589</gtr:id><gtr:otherNames>Liu C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/FB4CD1BD-B464-4CE5-A7A3-7860F700BD9D"><gtr:id>FB4CD1BD-B464-4CE5-A7A3-7860F700BD9D</gtr:id><gtr:title>HeLP-Diabetes: randomised controlled trial protocol.</gtr:title><gtr:parentPublicationTitle>BMC health services research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ba1cfb671d7d37216c6c9683c9dff756"><gtr:id>ba1cfb671d7d37216c6c9683c9dff756</gtr:id><gtr:otherNames>Murray E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1472-6963</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/16315AE5-144E-4CD5-B1BE-EA8520054155"><gtr:id>16315AE5-144E-4CD5-B1BE-EA8520054155</gtr:id><gtr:title>Coding Variation in ANGPTL4, LPL, and SVEP1 and the Risk of Coronary Disease.</gtr:title><gtr:parentPublicationTitle>The New England journal of medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4e724be049eb36843b02b64126be3760"><gtr:id>4e724be049eb36843b02b64126be3760</gtr:id><gtr:otherNames>Myocardial Infarction Genetics and CARDIoGRAM Exome Consortia Investigators</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0028-4793</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/807BC1A9-A91B-42E2-8F23-59C671041AA5"><gtr:id>807BC1A9-A91B-42E2-8F23-59C671041AA5</gtr:id><gtr:title>A product of independent beta probabilities dose escalation design for dual-agent phase I trials.</gtr:title><gtr:parentPublicationTitle>Statistics in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4fecdd706ba0621caf2c9730b2ad217d"><gtr:id>4fecdd706ba0621caf2c9730b2ad217d</gtr:id><gtr:otherNames>Mander AP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0277-6715</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/14339926-4E2E-4DE5-B1D2-6101112BC5C9"><gtr:id>14339926-4E2E-4DE5-B1D2-6101112BC5C9</gtr:id><gtr:title>Longitudinal association of C-reactive protein and lung function over 13 years: The EPIC-Norfolk study.</gtr:title><gtr:parentPublicationTitle>American journal of epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b7a2d7e799abf9e6aec1bec645a41fb4"><gtr:id>b7a2d7e799abf9e6aec1bec645a41fb4</gtr:id><gtr:otherNames>Ahmadi-Abhari S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0002-9262</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/34A48938-1382-406F-A3CF-0A4B6E198482"><gtr:id>34A48938-1382-406F-A3CF-0A4B6E198482</gtr:id><gtr:title>Using multivariable Mendelian randomization to disentangle the causal effects of lipid fractions.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/056163b112d2b291ecc076d094a1b4e8"><gtr:id>056163b112d2b291ecc076d094a1b4e8</gtr:id><gtr:otherNames>Burgess S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/193BFB1E-AB93-4135-B193-840B7E3FB04C"><gtr:id>193BFB1E-AB93-4135-B193-840B7E3FB04C</gtr:id><gtr:title>BMPR2 mutations and survival in pulmonary arterial hypertension: an individual participant data meta-analysis.</gtr:title><gtr:parentPublicationTitle>The Lancet. Respiratory medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/40d98d0d2b382445c41bf8f9c7fc28dc"><gtr:id>40d98d0d2b382445c41bf8f9c7fc28dc</gtr:id><gtr:otherNames>Evans JD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2213-2600</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/67275E6C-1E9E-499F-9CA0-AE1C32494116"><gtr:id>67275E6C-1E9E-499F-9CA0-AE1C32494116</gtr:id><gtr:title>eFORGE: A Tool for Identifying Cell Type-Specific Signal in Epigenomic Data.</gtr:title><gtr:parentPublicationTitle>Cell reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/366870b4b9c4e0bc2e3adff3feb2d866"><gtr:id>366870b4b9c4e0bc2e3adff3feb2d866</gtr:id><gtr:otherNames>Breeze CE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/79C2F967-F14D-4CB5-A9D4-4BCD82A77E82"><gtr:id>79C2F967-F14D-4CB5-A9D4-4BCD82A77E82</gtr:id><gtr:title>Correlation of an epigenetic mitotic clock with cancer risk.</gtr:title><gtr:parentPublicationTitle>Genome biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/bf9c2d3260e115f51a5ebf8d4d07d149"><gtr:id>bf9c2d3260e115f51a5ebf8d4d07d149</gtr:id><gtr:otherNames>Yang Z</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1474-7596</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/EED78635-CC76-442D-B3D8-E1815D046BC1"><gtr:id>EED78635-CC76-442D-B3D8-E1815D046BC1</gtr:id><gtr:title>Development and validation of a clinical and computerised decision support system for management of hypertension (DSS-HTN) at a primary health care (PHC) setting.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/02c22722a2f97aa0c00935b9e4b72da3"><gtr:id>02c22722a2f97aa0c00935b9e4b72da3</gtr:id><gtr:otherNames>Anchala R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/AF012308-A5B5-47BA-9DD0-B45B824B0811"><gtr:id>AF012308-A5B5-47BA-9DD0-B45B824B0811</gtr:id><gtr:title>Assessing risk prediction models using individual participant data from multiple studies.</gtr:title><gtr:parentPublicationTitle>American journal of epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/06604b6e3b810c3a3d29dc9dc30fa1d9"><gtr:id>06604b6e3b810c3a3d29dc9dc30fa1d9</gtr:id><gtr:otherNames>Pennells L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0002-9262</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/93DBE5BB-78E4-4D51-B279-5D98371A85BD"><gtr:id>93DBE5BB-78E4-4D51-B279-5D98371A85BD</gtr:id><gtr:title>Discovery and refinement of genetic loci associated with cardiometabolic risk using dense imputation maps.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/7cf8ebbb626acee433700d8f65aab007"><gtr:id>7cf8ebbb626acee433700d8f65aab007</gtr:id><gtr:otherNames>Iotchkova V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/57FAFBB7-1C93-4D39-9BF2-883941297E06"><gtr:id>57FAFBB7-1C93-4D39-9BF2-883941297E06</gtr:id><gtr:title>Plasma concentrations of soluble IL-2 receptor a (CD25) are increased in type 1 diabetes and associated with reduced C-peptide levels in young patients.</gtr:title><gtr:parentPublicationTitle>Diabetologia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/548c522953d728af80333559c4a9437b"><gtr:id>548c522953d728af80333559c4a9437b</gtr:id><gtr:otherNames>Downes K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0012-186X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D890D1EC-04EE-4667-B047-F15BB13A18A6"><gtr:id>D890D1EC-04EE-4667-B047-F15BB13A18A6</gtr:id><gtr:title>Genetic determinants of telomere length and risk of common cancers: a Mendelian randomization study.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f2d31a05ff149de838f7af04b5a46315"><gtr:id>f2d31a05ff149de838f7af04b5a46315</gtr:id><gtr:otherNames>Zhang C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A5A0D6E5-3AF1-4499-9AC8-6ED9EFB975B8"><gtr:id>A5A0D6E5-3AF1-4499-9AC8-6ED9EFB975B8</gtr:id><gtr:title>A genomic approach to therapeutic target validation identifies a glucose-lowering GLP1R variant protective for coronary heart disease.</gtr:title><gtr:parentPublicationTitle>Science translational medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4069f6f80abc3dca900b1ffc9ba77f6f"><gtr:id>4069f6f80abc3dca900b1ffc9ba77f6f</gtr:id><gtr:otherNames>Scott RA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1946-6234</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F07441CD-0436-40C1-95CC-ACA81294BBBB"><gtr:id>F07441CD-0436-40C1-95CC-ACA81294BBBB</gtr:id><gtr:title>Genetic Drivers of Epigenetic and Transcriptional Variation in Human Immune Cells.</gtr:title><gtr:parentPublicationTitle>Cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/fbfd9fb6e692d07596464ca94848bf67"><gtr:id>fbfd9fb6e692d07596464ca94848bf67</gtr:id><gtr:otherNames>Chen L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0092-8674</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/761D4E05-22F5-42A9-9A3F-F131C77CFBAA"><gtr:id>761D4E05-22F5-42A9-9A3F-F131C77CFBAA</gtr:id><gtr:title>Cost-effectiveness of the National Health Service Abdominal Aortic Aneurysm Screening Programme in England.</gtr:title><gtr:parentPublicationTitle>The British journal of surgery</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/27a40e47d8b91f92277e87bf1b63d234"><gtr:id>27a40e47d8b91f92277e87bf1b63d234</gtr:id><gtr:otherNames>Glover MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0007-1323</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/956D1EA6-D776-43D5-83F2-3B26EABE2C75"><gtr:id>956D1EA6-D776-43D5-83F2-3B26EABE2C75</gtr:id><gtr:title>Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/75149bcb09e016b39d935e5c9c86f191"><gtr:id>75149bcb09e016b39d935e5c9c86f191</gtr:id><gtr:otherNames>GBD 2013 Mortality and Causes of Death Collaborators</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/EEC23A48-8AC2-42ED-AE81-953754AB9111"><gtr:id>EEC23A48-8AC2-42ED-AE81-953754AB9111</gtr:id><gtr:title>Vitamin D and high blood pressure: causal association or epiphenomenon?</gtr:title><gtr:parentPublicationTitle>European journal of epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8fbda2f0b84566eec04bf63cde9ad5b6"><gtr:id>8fbda2f0b84566eec04bf63cde9ad5b6</gtr:id><gtr:otherNames>Kunutsor SK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0393-2990</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/534677E0-5035-4576-BDAB-7D75B0F43BB6"><gtr:id>534677E0-5035-4576-BDAB-7D75B0F43BB6</gtr:id><gtr:title>A gain-of-function variant in DIAPH1 causes dominant macrothrombocytopenia and hearing loss.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ad517b46218a425c2709298b75184e34"><gtr:id>ad517b46218a425c2709298b75184e34</gtr:id><gtr:otherNames>Stritt S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/71FC48E5-701A-48CD-BAA2-42AAAD5117F1"><gtr:id>71FC48E5-701A-48CD-BAA2-42AAAD5117F1</gtr:id><gtr:title>Association of Cardiometabolic Multimorbidity With Mortality.</gtr:title><gtr:parentPublicationTitle>JAMA</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/00954130f581451305ebfe461866731f"><gtr:id>00954130f581451305ebfe461866731f</gtr:id><gtr:otherNames>Emerging Risk Factors Collaboration</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0098-7484</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/26483856-3136-47A7-81F1-B6275D8723A6"><gtr:id>26483856-3136-47A7-81F1-B6275D8723A6</gtr:id><gtr:title>Transesophageal echocardiography in cryptogenic stroke and patent foramen ovale: analysis of putative high-risk features from the risk of paradoxical embolism database.</gtr:title><gtr:parentPublicationTitle>Circulation. Cardiovascular imaging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/04b2c20720459e07195d853c825dd73f"><gtr:id>04b2c20720459e07195d853c825dd73f</gtr:id><gtr:otherNames>Wessler BS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1941-9651</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/6767FEE5-54AA-4169-9198-A2B95C82BBB1"><gtr:id>6767FEE5-54AA-4169-9198-A2B95C82BBB1</gtr:id><gtr:title>Individual-patient meta-analysis of three randomized trials comparing endovascular versus open repair for ruptured abdominal aortic aneurysm.</gtr:title><gtr:parentPublicationTitle>The British journal of surgery</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/08c22c62d0cf7146e7a5119404c7ca83"><gtr:id>08c22c62d0cf7146e7a5119404c7ca83</gtr:id><gtr:otherNames>Sweeting MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0007-1323</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B1986990-8192-4950-B1BE-9FFAC5BFE741"><gtr:id>B1986990-8192-4950-B1BE-9FFAC5BFE741</gtr:id><gtr:title>Iron and hepcidin as risk factors in atherosclerosis: what do the genes say?</gtr:title><gtr:parentPublicationTitle>BMC genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/1fac9978ee0d87fff067b9ac205f357a"><gtr:id>1fac9978ee0d87fff067b9ac205f357a</gtr:id><gtr:otherNames>Galesloot TE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1471-2156</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/BDE1196C-8580-4056-A30E-BE9B3D40BA24"><gtr:id>BDE1196C-8580-4056-A30E-BE9B3D40BA24</gtr:id><gtr:title>Use of allele scores as instrumental variables for Mendelian randomization.</gtr:title><gtr:parentPublicationTitle>International journal of epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/056163b112d2b291ecc076d094a1b4e8"><gtr:id>056163b112d2b291ecc076d094a1b4e8</gtr:id><gtr:otherNames>Burgess S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0300-5771</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/727623AC-595A-414C-8563-472320E9D5FE"><gtr:id>727623AC-595A-414C-8563-472320E9D5FE</gtr:id><gtr:title>Genetic associations at 53 loci highlight cell types and biological pathways relevant for kidney function.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/87d790de652f8364d93c11ebda0e9ec4"><gtr:id>87d790de652f8364d93c11ebda0e9ec4</gtr:id><gtr:otherNames>Pattaro C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B0647300-6D0A-4E4F-8A18-2378B78181E8"><gtr:id>B0647300-6D0A-4E4F-8A18-2378B78181E8</gtr:id><gtr:title>The global impact of non-communicable diseases on healthcare spending and national income: a systematic review.</gtr:title><gtr:parentPublicationTitle>European journal of epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ea1e5ba889fd0cca140aeff5b41e4684"><gtr:id>ea1e5ba889fd0cca140aeff5b41e4684</gtr:id><gtr:otherNames>Muka T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0393-2990</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/DF1181B7-6404-4ECD-B886-ABCAB8FB5F33"><gtr:id>DF1181B7-6404-4ECD-B886-ABCAB8FB5F33</gtr:id><gtr:title>Consistent Estimation in Mendelian Randomization with Some Invalid Instruments Using a Weighted Median Estimator.</gtr:title><gtr:parentPublicationTitle>Genetic epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/1e7b9f88de7989208d17352d3514ca24"><gtr:id>1e7b9f88de7989208d17352d3514ca24</gtr:id><gtr:otherNames>Bowden J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0741-0395</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D567E5D7-A556-4B7F-BA9A-3BFE0BA370C1"><gtr:id>D567E5D7-A556-4B7F-BA9A-3BFE0BA370C1</gtr:id><gtr:title>Derivation and assessment of risk prediction models using case-cohort data.</gtr:title><gtr:parentPublicationTitle>BMC medical research methodology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/2d9829eb284f15497e3e21d2a57302b4"><gtr:id>2d9829eb284f15497e3e21d2a57302b4</gtr:id><gtr:otherNames>Sanderson J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1471-2288</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/952B70E9-CBFC-4B68-A692-25405C80533A"><gtr:id>952B70E9-CBFC-4B68-A692-25405C80533A</gtr:id><gtr:title>Predictive ability of heel quantitative ultrasound for incident fractures: an individual-level meta-analysis.</gtr:title><gtr:parentPublicationTitle>Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/e9e4ac7b891ffc090fdcfde0a03ae864"><gtr:id>e9e4ac7b891ffc090fdcfde0a03ae864</gtr:id><gtr:otherNames>McCloskey EV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0937-941X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C57C63E3-AEAB-412C-A743-56D62BB0DD1E"><gtr:id>C57C63E3-AEAB-412C-A743-56D62BB0DD1E</gtr:id><gtr:title>Genome-wide association study for radiographic vertebral fractures: a potential role for the 16q24 BMD locus.</gtr:title><gtr:parentPublicationTitle>Bone</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c0734904168866ce25d99a18252e044a"><gtr:id>c0734904168866ce25d99a18252e044a</gtr:id><gtr:otherNames>Oei L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1873-2763</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/8933636E-D6F4-43F5-B27E-9BA17E134B2B"><gtr:id>8933636E-D6F4-43F5-B27E-9BA17E134B2B</gtr:id><gtr:title>Association of dietary, circulating, and supplement fatty acids with coronary risk: a systematic review and meta-analysis.</gtr:title><gtr:parentPublicationTitle>Annals of internal medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/e6174ca4b9befe9d94477e7180f705a2"><gtr:id>e6174ca4b9befe9d94477e7180f705a2</gtr:id><gtr:otherNames>Chowdhury R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0003-4819</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/EAABBE90-C19B-4027-96A3-193F199E2839"><gtr:id>EAABBE90-C19B-4027-96A3-193F199E2839</gtr:id><gtr:title>Association between circulating 25-hydroxyvitamin D and incident type 2 diabetes: a mendelian randomisation study.</gtr:title><gtr:parentPublicationTitle>The lancet. Diabetes &amp; endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0737230de95b4af7036a0056f2039d97"><gtr:id>0737230de95b4af7036a0056f2039d97</gtr:id><gtr:otherNames>Ye Z</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2213-8587</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/58827DFA-D99D-4502-B827-9360517010F2"><gtr:id>58827DFA-D99D-4502-B827-9360517010F2</gtr:id><gtr:title>Determinants of antithrombotic choice for patent foramen ovale in cryptogenic stroke.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/bdfd1197611e2c4f067931f1a080f60b"><gtr:id>bdfd1197611e2c4f067931f1a080f60b</gtr:id><gtr:otherNames>Thaler DE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/CAFB5BD0-0DCC-4144-A361-C39FC454865C"><gtr:id>CAFB5BD0-0DCC-4144-A361-C39FC454865C</gtr:id><gtr:title>Cardiovascular disease risk by assigned treatment using the 2013 and 1998 obesity guidelines.</gtr:title><gtr:parentPublicationTitle>Obesity (Silver Spring, Md.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/bef6f03e1cdc8eff88441b13925befab"><gtr:id>bef6f03e1cdc8eff88441b13925befab</gtr:id><gtr:otherNames>Stevens J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1930-7381</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/FF4BD2A4-4896-498A-878A-FF569339017A"><gtr:id>FF4BD2A4-4896-498A-878A-FF569339017A</gtr:id><gtr:title>Socioeconomic Deprivation and Survival After Heart Transplantation in England: An Analysis of the United Kingdom Transplant Registry.</gtr:title><gtr:parentPublicationTitle>Circulation. Cardiovascular quality and outcomes</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/40d98d0d2b382445c41bf8f9c7fc28dc"><gtr:id>40d98d0d2b382445c41bf8f9c7fc28dc</gtr:id><gtr:otherNames>Evans JD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1941-7713</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/54EB315E-DFDC-422E-AD85-BC88FAEB6160"><gtr:id>54EB315E-DFDC-422E-AD85-BC88FAEB6160</gtr:id><gtr:title>BMI as a Modifiable Risk Factor for Type 2 Diabetes: Refining and Understanding Causal Estimates Using Mendelian Randomization.</gtr:title><gtr:parentPublicationTitle>Diabetes</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/86b06e84c16348e51e6de58d42fbcc00"><gtr:id>86b06e84c16348e51e6de58d42fbcc00</gtr:id><gtr:otherNames>Corbin LJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0012-1797</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E2D60EC9-02DD-4524-8967-F12D5455EC1A"><gtr:id>E2D60EC9-02DD-4524-8967-F12D5455EC1A</gtr:id><gtr:title>Oral or parenteral iron supplementation to reduce deferral, iron deficiency and/or anaemia in blood donors.</gtr:title><gtr:parentPublicationTitle>The Cochrane database of systematic reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/e3ada9a6cb7f0de1fb0a23e59fee81af"><gtr:id>e3ada9a6cb7f0de1fb0a23e59fee81af</gtr:id><gtr:otherNames>Smith GA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1361-6137</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/DD9006E3-A33C-4B3B-8554-F24A6E5B1091"><gtr:id>DD9006E3-A33C-4B3B-8554-F24A6E5B1091</gtr:id><gtr:title>The Bangladesh Risk of Acute Vascular Events (BRAVE) Study: objectives and design.</gtr:title><gtr:parentPublicationTitle>European journal of epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/e6174ca4b9befe9d94477e7180f705a2"><gtr:id>e6174ca4b9befe9d94477e7180f705a2</gtr:id><gtr:otherNames>Chowdhury R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0393-2990</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/2CD8897B-9C61-4AED-BA92-5175C0587D6A"><gtr:id>2CD8897B-9C61-4AED-BA92-5175C0587D6A</gtr:id><gtr:title>Assessment of patient-derived tumour xenografts (PDXs) as a discovery tool for cancer epigenomics.</gtr:title><gtr:parentPublicationTitle>Genome medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/6262e1d7793c3f47ea5062a7b0342fc1"><gtr:id>6262e1d7793c3f47ea5062a7b0342fc1</gtr:id><gtr:otherNames>Guilhamon P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1756-994X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/97C10E2B-D575-4FD5-A8D4-55D575EE33A9"><gtr:id>97C10E2B-D575-4FD5-A8D4-55D575EE33A9</gtr:id><gtr:title>Previous Cesarean Delivery and the Risk of Unexplained Stillbirth</gtr:title><gtr:parentPublicationTitle>Obstetrical &amp; Gynecological Survey</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/75b4bfa474000acf738254a7d69df937"><gtr:id>75b4bfa474000acf738254a7d69df937</gtr:id><gtr:otherNames>Moraitis A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/9CF6D9A7-68A4-4176-BF19-0D482C7F552B"><gtr:id>9CF6D9A7-68A4-4176-BF19-0D482C7F552B</gtr:id><gtr:title>Leucocyte telomere length and risk of type 2 diabetes mellitus: new prospective cohort study and literature-based meta-analysis.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c14d384b5a87c9bc3c358b7461f53714"><gtr:id>c14d384b5a87c9bc3c358b7461f53714</gtr:id><gtr:otherNames>Willeit P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/9863E961-4FF3-47A7-9467-B3A8FEC1F7D2"><gtr:id>9863E961-4FF3-47A7-9467-B3A8FEC1F7D2</gtr:id><gtr:title>Issues relating to confounding and meta-analysis when including non-randomized studies in systematic reviews on the effects of interventions.</gtr:title><gtr:parentPublicationTitle>Research synthesis methods</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/cbc1943f9b38739d0d5fa6a4c1c40429"><gtr:id>cbc1943f9b38739d0d5fa6a4c1c40429</gtr:id><gtr:otherNames>Valentine JC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1759-2879</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/6D5B9466-A98A-4101-B129-8822370CF336"><gtr:id>6D5B9466-A98A-4101-B129-8822370CF336</gtr:id><gtr:title>Predicting the Direction of Causal Effect Based on an Instrumental Variable Analysis: A Cautionary Tale</gtr:title><gtr:parentPublicationTitle>Journal of Causal Inference</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/056163b112d2b291ecc076d094a1b4e8"><gtr:id>056163b112d2b291ecc076d094a1b4e8</gtr:id><gtr:otherNames>Burgess S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/17A9C837-E5D4-4C21-927E-10CA30AA6802"><gtr:id>17A9C837-E5D4-4C21-927E-10CA30AA6802</gtr:id><gtr:title>A review of published analyses of case-cohort studies and recommendations for future reporting.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/02cdd1b81d6df42a82ec19819c9751dd"><gtr:id>02cdd1b81d6df42a82ec19819c9751dd</gtr:id><gtr:otherNames>Sharp SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D7AB41DB-972E-45C2-B353-955B0296D646"><gtr:id>D7AB41DB-972E-45C2-B353-955B0296D646</gtr:id><gtr:title>Moderate alcohol drinking in pregnancy increases risk for children's persistent conduct problems: causal effects in a Mendelian randomisation study.</gtr:title><gtr:parentPublicationTitle>Journal of child psychology and psychiatry, and allied disciplines</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/48f9e807a5a3d172a99e55c8de68ea6a"><gtr:id>48f9e807a5a3d172a99e55c8de68ea6a</gtr:id><gtr:otherNames>Murray J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0021-9630</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/85BC965D-F8C6-423D-9A3B-70B3A51A5BE7"><gtr:id>85BC965D-F8C6-423D-9A3B-70B3A51A5BE7</gtr:id><gtr:title>UK Biobank comes of age</gtr:title><gtr:parentPublicationTitle>The Lancet</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4c0254f5b7f14f6e240f08790ae6c527"><gtr:id>4c0254f5b7f14f6e240f08790ae6c527</gtr:id><gtr:otherNames>Thompson S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D6AD8684-316C-43F7-A9E3-2B7B16815153"><gtr:id>D6AD8684-316C-43F7-A9E3-2B7B16815153</gtr:id><gtr:title>Genetic invalidation of Lp-PLA2 as a therapeutic target: Large-scale study of five functional Lp-PLA2-lowering alleles.</gtr:title><gtr:parentPublicationTitle>European journal of preventive cardiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/06552a4b792277499d1f97dd583ddfee"><gtr:id>06552a4b792277499d1f97dd583ddfee</gtr:id><gtr:otherNames>Gregson JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2047-4873</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/2388267B-1416-4329-979A-353829DD5CB2"><gtr:id>2388267B-1416-4329-979A-353829DD5CB2</gtr:id><gtr:title>The effect of aortic morphology on peri-operative mortality of ruptured abdominal aortic aneurysm.</gtr:title><gtr:parentPublicationTitle>European heart journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/2cffb654bd9173c86d37537f9b57d18c"><gtr:id>2cffb654bd9173c86d37537f9b57d18c</gtr:id><gtr:otherNames>IMPROVE Trial Investigators</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0195-668X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/2398C42E-F8E2-41EC-8E04-5910E97ABCCB"><gtr:id>2398C42E-F8E2-41EC-8E04-5910E97ABCCB</gtr:id><gtr:title>Modeling the costs and long-term health benefits of screening the general population for risks of cardiovascular disease: a review of methods used in the literature.</gtr:title><gtr:parentPublicationTitle>The European journal of health economics : HEPAC : health economics in prevention and care</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/1e5ddbd88c7baa76c088b9c1561fcd4e"><gtr:id>1e5ddbd88c7baa76c088b9c1561fcd4e</gtr:id><gtr:otherNames>Epstein D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1618-7598</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/CCE3CAD6-963F-4385-B4D7-FC706DB548F3"><gtr:id>CCE3CAD6-963F-4385-B4D7-FC706DB548F3</gtr:id><gtr:title>Prevalence of Depression and Depressive Symptoms Among Resident Physicians: A Systematic Review and Meta-analysis.</gtr:title><gtr:parentPublicationTitle>JAMA</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/1176557158e24d901d2a9772d426aa88"><gtr:id>1176557158e24d901d2a9772d426aa88</gtr:id><gtr:otherNames>Mata DA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0098-7484</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/997AE135-243D-4693-9A4B-7EA8C3AAF432"><gtr:id>997AE135-243D-4693-9A4B-7EA8C3AAF432</gtr:id><gtr:title>Interventions to reduce vasovagal reactions in blood donors: a systematic review and meta-analysis.</gtr:title><gtr:parentPublicationTitle>Transfusion medicine (Oxford, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/08112693a12b70debb270f3297d29147"><gtr:id>08112693a12b70debb270f3297d29147</gtr:id><gtr:otherNames>Fisher SA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0958-7578</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/DE170B5A-0107-431D-A737-8D2DBA44ECC2"><gtr:id>DE170B5A-0107-431D-A737-8D2DBA44ECC2</gtr:id><gtr:title>Mendelian randomization to assess causal effects of blood lipids on coronary heart disease: lessons from the past and applications to the future.</gtr:title><gtr:parentPublicationTitle>Current opinion in endocrinology, diabetes, and obesity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/056163b112d2b291ecc076d094a1b4e8"><gtr:id>056163b112d2b291ecc076d094a1b4e8</gtr:id><gtr:otherNames>Burgess S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1752-296X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/2AAF2F0A-6B68-47F5-B1A2-E3A773C35F80"><gtr:id>2AAF2F0A-6B68-47F5-B1A2-E3A773C35F80</gtr:id><gtr:title>Long-term cost-effectiveness analysis of endovascular versus open repair for abdominal aortic aneurysm based on four randomized clinical trials.</gtr:title><gtr:parentPublicationTitle>The British journal of surgery</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/1e5ddbd88c7baa76c088b9c1561fcd4e"><gtr:id>1e5ddbd88c7baa76c088b9c1561fcd4e</gtr:id><gtr:otherNames>Epstein D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0007-1323</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/793A1A6C-6196-4B5A-8556-30701C3D0DA8"><gtr:id>793A1A6C-6196-4B5A-8556-30701C3D0DA8</gtr:id><gtr:title>A method making fewer assumptions gave the most reliable estimates of exposure-outcome associations in stratified case-cohort studies.</gtr:title><gtr:parentPublicationTitle>Journal of clinical epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/7e050bd6475c7c807ec5722cb9a2cc56"><gtr:id>7e050bd6475c7c807ec5722cb9a2cc56</gtr:id><gtr:otherNames>Jones E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0895-4356</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/2BA9D1A7-81B5-41C5-ADBE-D16C8993967E"><gtr:id>2BA9D1A7-81B5-41C5-ADBE-D16C8993967E</gtr:id><gtr:title>Trans-ancestry meta-analyses identify rare and common variants associated with blood pressure and hypertension.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4fc4eefd621187bd6531525a0d279e47"><gtr:id>4fc4eefd621187bd6531525a0d279e47</gtr:id><gtr:otherNames>Surendran P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/BFB3B97A-904E-404E-9EEC-2E5C7E966840"><gtr:id>BFB3B97A-904E-404E-9EEC-2E5C7E966840</gtr:id><gtr:title>Global and National Burden of Diseases and Injuries Among Children and Adolescents Between 1990 and 2013: Findings From the Global Burden of Disease 2013 Study.</gtr:title><gtr:parentPublicationTitle>JAMA pediatrics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b5aaae5b464e30fdab98f17e4f5f58a4"><gtr:id>b5aaae5b464e30fdab98f17e4f5f58a4</gtr:id><gtr:otherNames>Global Burden of Disease Pediatrics Collaboration</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2168-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/CEC44ACE-BB75-4F38-8FEA-57AB475A5FA0"><gtr:id>CEC44ACE-BB75-4F38-8FEA-57AB475A5FA0</gtr:id><gtr:title>Multiple imputation for handling systematically missing confounders in meta-analysis of individual participant data.</gtr:title><gtr:parentPublicationTitle>Statistics in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/58a183887ce6a5ed15933a92e78d08b9"><gtr:id>58a183887ce6a5ed15933a92e78d08b9</gtr:id><gtr:otherNames>Resche-Rigon M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0277-6715</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/86A6AC2D-A450-4999-A6AB-76A6AA0686C5"><gtr:id>86A6AC2D-A450-4999-A6AB-76A6AA0686C5</gtr:id><gtr:title>Additive and interaction effects at three amino acid positions in HLA-DQ and HLA-DR molecules drive type 1 diabetes risk.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/70f77b80c333e741944096e10150cb96"><gtr:id>70f77b80c333e741944096e10150cb96</gtr:id><gtr:otherNames>Hu X</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/461C04C0-D4E7-45DF-99D6-F50FAC987368"><gtr:id>461C04C0-D4E7-45DF-99D6-F50FAC987368</gtr:id><gtr:title>Global, regional, and national levels of neonatal, infant, and under-5 mortality during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f88cc0b3857e4454158c5b9ddf455220"><gtr:id>f88cc0b3857e4454158c5b9ddf455220</gtr:id><gtr:otherNames>Wang H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/36C19AF8-0A3C-45AE-B873-58541F6E3E81"><gtr:id>36C19AF8-0A3C-45AE-B873-58541F6E3E81</gtr:id><gtr:title>Combining information on multiple instrumental variables in Mendelian randomization: comparison of allele score and summarized data methods.</gtr:title><gtr:parentPublicationTitle>Statistics in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/056163b112d2b291ecc076d094a1b4e8"><gtr:id>056163b112d2b291ecc076d094a1b4e8</gtr:id><gtr:otherNames>Burgess S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0277-6715</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/55B4FD26-C374-4DA3-AD4A-9E155002B472"><gtr:id>55B4FD26-C374-4DA3-AD4A-9E155002B472</gtr:id><gtr:title>Hypertension in India: a systematic review and meta-analysis of prevalence, awareness, and control of hypertension.</gtr:title><gtr:parentPublicationTitle>Journal of hypertension</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/02c22722a2f97aa0c00935b9e4b72da3"><gtr:id>02c22722a2f97aa0c00935b9e4b72da3</gtr:id><gtr:otherNames>Anchala R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0263-6352</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3D6EAF6E-5462-4826-BEBD-4952C8FD2403"><gtr:id>3D6EAF6E-5462-4826-BEBD-4952C8FD2403</gtr:id><gtr:title>Assessment of RainDrop BS-seq as a method for large-scale, targeted bisulfite sequencing.</gtr:title><gtr:parentPublicationTitle>Epigenetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b159c2fdc40bd9f1b680388b2982bc9d"><gtr:id>b159c2fdc40bd9f1b680388b2982bc9d</gtr:id><gtr:otherNames>Paul DS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1559-2294</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C90DA729-4A16-439C-BD26-DC6E206B10BD"><gtr:id>C90DA729-4A16-439C-BD26-DC6E206B10BD</gtr:id><gtr:title>Types of stroke recurrence in patients with ischemic stroke: a substudy from the PRoFESS trial.</gtr:title><gtr:parentPublicationTitle>International journal of stroke : official journal of the International Stroke Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/97f9fbee6170a38f185db838988c4aef"><gtr:id>97f9fbee6170a38f185db838988c4aef</gtr:id><gtr:otherNames>Toni D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1747-4930</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/CBC63E53-E165-44C8-81D2-018C4B6DB128"><gtr:id>CBC63E53-E165-44C8-81D2-018C4B6DB128</gtr:id><gtr:title>Evaluation of effectiveness and cost-effectiveness of a clinical decision support system in managing hypertension in resource constrained primary health care settings: results from a cluster randomized trial.</gtr:title><gtr:parentPublicationTitle>Journal of the American Heart Association</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/02c22722a2f97aa0c00935b9e4b72da3"><gtr:id>02c22722a2f97aa0c00935b9e4b72da3</gtr:id><gtr:otherNames>Anchala R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2047-9980</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/FE79DBF5-6C52-49FE-9EFF-F438B914DCF7"><gtr:id>FE79DBF5-6C52-49FE-9EFF-F438B914DCF7</gtr:id><gtr:title>A genome-wide copy number association study of osteoporotic fractures points to the 6p25.1 locus.</gtr:title><gtr:parentPublicationTitle>Journal of medical genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c0734904168866ce25d99a18252e044a"><gtr:id>c0734904168866ce25d99a18252e044a</gtr:id><gtr:otherNames>Oei L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-2593</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/63F7BAEB-0C2A-4396-A707-0E4A9173B899"><gtr:id>63F7BAEB-0C2A-4396-A707-0E4A9173B899</gtr:id><gtr:title>Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/86cb2e985db2d60f385d7605cc2c5775"><gtr:id>86cb2e985db2d60f385d7605cc2c5775</gtr:id><gtr:otherNames>Global Burden of Disease Study 2013 Collaborators</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/80219816-BD7E-46C4-BEFA-F4A807EBCD23"><gtr:id>80219816-BD7E-46C4-BEFA-F4A807EBCD23</gtr:id><gtr:title>Miscarriage and future maternal cardiovascular disease: a systematic review and meta-analysis.</gtr:title><gtr:parentPublicationTitle>Heart (British Cardiac Society)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/aa2bd2250111b7f44a89f220ab8b2366"><gtr:id>aa2bd2250111b7f44a89f220ab8b2366</gtr:id><gtr:otherNames>Oliver-Williams CT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1355-6037</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/40BC347F-27F7-4CF6-A3F2-215F4390D7FB"><gtr:id>40BC347F-27F7-4CF6-A3F2-215F4390D7FB</gtr:id><gtr:title>Common variants associated with plasma triglycerides and risk for coronary artery disease.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/6daa1058761b1f7343dc0121c98d2a04"><gtr:id>6daa1058761b1f7343dc0121c98d2a04</gtr:id><gtr:otherNames>Do R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/1185E568-948D-4673-A6AD-A5B989B037F7"><gtr:id>1185E568-948D-4673-A6AD-A5B989B037F7</gtr:id><gtr:title>Height and Breast Cancer Risk: Evidence From Prospective Studies and Mendelian Randomization.</gtr:title><gtr:parentPublicationTitle>Journal of the National Cancer Institute</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/37ad02443c8a13325ab1a72e307dd092"><gtr:id>37ad02443c8a13325ab1a72e307dd092</gtr:id><gtr:otherNames>Zhang B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0027-8874</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/EA8C8A4A-9263-45EE-A16C-89CE00808F38"><gtr:id>EA8C8A4A-9263-45EE-A16C-89CE00808F38</gtr:id><gtr:title>Cost effective interventions for the prevention of cardiovascular disease in low and middle income countries: a systematic review.</gtr:title><gtr:parentPublicationTitle>BMC public health</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d40f91d0a8cf6c39d2a56e6add6bfaba"><gtr:id>d40f91d0a8cf6c39d2a56e6add6bfaba</gtr:id><gtr:otherNames>Shroufi A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1471-2458</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C86223BC-B856-49F3-B100-F8672511D99F"><gtr:id>C86223BC-B856-49F3-B100-F8672511D99F</gtr:id><gtr:title>Screening for chronic comorbid diseases in people with HIV: the need for a strategic approach.</gtr:title><gtr:parentPublicationTitle>HIV medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/82767ac5410e3e55d732f64506183c5d"><gtr:id>82767ac5410e3e55d732f64506183c5d</gtr:id><gtr:otherNames>Peters B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1464-2662</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B3DD9D71-1992-4BB5-BE16-AB280B6AB58F"><gtr:id>B3DD9D71-1992-4BB5-BE16-AB280B6AB58F</gtr:id><gtr:title>Sensitivity Analyses for Robust Causal Inference from Mendelian Randomization Analyses with Multiple Genetic Variants.</gtr:title><gtr:parentPublicationTitle>Epidemiology (Cambridge, Mass.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/056163b112d2b291ecc076d094a1b4e8"><gtr:id>056163b112d2b291ecc076d094a1b4e8</gtr:id><gtr:otherNames>Burgess S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1044-3983</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/6EC0BA80-5AA5-40F6-9D25-8CFE913C7922"><gtr:id>6EC0BA80-5AA5-40F6-9D25-8CFE913C7922</gtr:id><gtr:title>Genetically determined height and coronary artery disease.</gtr:title><gtr:parentPublicationTitle>The New England journal of medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/27ab42a94bafa274f6486233c637c714"><gtr:id>27ab42a94bafa274f6486233c637c714</gtr:id><gtr:otherNames>Nelson CP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0028-4793</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/6FF1E9D6-C9CA-4C17-872F-402345A2F39D"><gtr:id>6FF1E9D6-C9CA-4C17-872F-402345A2F39D</gtr:id><gtr:title>Review: vitamin D3 supplementation may reduce mortality in adults; vitamin D2 does not.</gtr:title><gtr:parentPublicationTitle>Annals of internal medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/9a9a6f3f98a07d2f2547a56f3db76dc0"><gtr:id>9a9a6f3f98a07d2f2547a56f3db76dc0</gtr:id><gtr:otherNames>Fletcher RH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0003-4819</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D2238489-D6D9-4FB1-9ACD-0F8460761CE6"><gtr:id>D2238489-D6D9-4FB1-9ACD-0F8460761CE6</gtr:id><gtr:title>UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age.</gtr:title><gtr:parentPublicationTitle>PLoS medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/56022eb4712f9703d94edab35e2b236b"><gtr:id>56022eb4712f9703d94edab35e2b236b</gtr:id><gtr:otherNames>Sudlow C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1549-1277</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C556E5E6-0D94-49F5-AAFE-0753723C0DDE"><gtr:id>C556E5E6-0D94-49F5-AAFE-0753723C0DDE</gtr:id><gtr:title>Contribution of common non-synonymous variants in PCSK1 to body mass index variation and risk of obesity: a systematic review and meta-analysis with evidence from up to 331 175 individuals.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/accd2cf572f74cffdba0a6bb8afdeaff"><gtr:id>accd2cf572f74cffdba0a6bb8afdeaff</gtr:id><gtr:otherNames>Nead KT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/429A3552-0645-4623-8F96-153DD0C6A83C"><gtr:id>429A3552-0645-4623-8F96-153DD0C6A83C</gtr:id><gtr:title>The global impact of non-communicable diseases on macro-economic productivity: a systematic review.</gtr:title><gtr:parentPublicationTitle>European journal of epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/56f2da1a311eaceb738e712fb213be75"><gtr:id>56f2da1a311eaceb738e712fb213be75</gtr:id><gtr:otherNames>Chaker L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0393-2990</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/212D2837-AB6E-48BC-B14F-FC48258B1BB3"><gtr:id>212D2837-AB6E-48BC-B14F-FC48258B1BB3</gtr:id><gtr:title>Predictors and outcome impact of perioperative serum sodium changes in a high-risk population.</gtr:title><gtr:parentPublicationTitle>British journal of anaesthesia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/2b6b4ef1649758f6ae7a74898f205b7a"><gtr:id>2b6b4ef1649758f6ae7a74898f205b7a</gtr:id><gtr:otherNames>Klinck J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0007-0912</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/9329DD52-CC1F-466C-BE8A-2D848B267AD4"><gtr:id>9329DD52-CC1F-466C-BE8A-2D848B267AD4</gtr:id><gtr:title>Genetic determinants of heel bone properties: genome-wide association meta-analysis and replication in the GEFOS/GENOMOS consortium.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/af2419e95dd4de50093486778583ffa2"><gtr:id>af2419e95dd4de50093486778583ffa2</gtr:id><gtr:otherNames>Moayyeri A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/CC0769BD-64B2-4951-97F9-8560E5AE7AEE"><gtr:id>CC0769BD-64B2-4951-97F9-8560E5AE7AEE</gtr:id><gtr:title>Sample size and power calculations in Mendelian randomization with a single instrumental variable and a binary outcome.</gtr:title><gtr:parentPublicationTitle>International journal of epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/056163b112d2b291ecc076d094a1b4e8"><gtr:id>056163b112d2b291ecc076d094a1b4e8</gtr:id><gtr:otherNames>Burgess S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0300-5771</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/20C86B10-3C9E-47CE-A42F-53F7C3E9FF1C"><gtr:id>20C86B10-3C9E-47CE-A42F-53F7C3E9FF1C</gtr:id><gtr:title>The benefits and harms of breast cancer screening: an independent review.</gtr:title><gtr:parentPublicationTitle>British journal of cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/91035f631b3755159816f7162f6b2edc"><gtr:id>91035f631b3755159816f7162f6b2edc</gtr:id><gtr:otherNames>Marmot MG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0007-0920</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/8C889A19-206A-45A5-B1A0-92108D121810"><gtr:id>8C889A19-206A-45A5-B1A0-92108D121810</gtr:id><gtr:title>Efficient design for Mendelian randomization studies: subsample and 2-sample instrumental variable estimators.</gtr:title><gtr:parentPublicationTitle>American journal of epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/bd83ccb8bfb1aa5e6785aa6d5ba0f4f9"><gtr:id>bd83ccb8bfb1aa5e6785aa6d5ba0f4f9</gtr:id><gtr:otherNames>Pierce BL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0002-9262</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/40BED4E1-0083-428D-8F9A-3970B9B02A51"><gtr:id>40BED4E1-0083-428D-8F9A-3970B9B02A51</gtr:id><gtr:title>The effects of lutein on cardiometabolic health across the life course: a systematic review and meta-analysis.</gtr:title><gtr:parentPublicationTitle>The American journal of clinical nutrition</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0c92ead5daee18cc45083f882186f775"><gtr:id>0c92ead5daee18cc45083f882186f775</gtr:id><gtr:otherNames>Leermakers ET</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0002-9165</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/47BD4DFF-82F6-4299-97F2-C8E4364813C9"><gtr:id>47BD4DFF-82F6-4299-97F2-C8E4364813C9</gtr:id><gtr:title>Comparative validity of vitamin C and carotenoids as indicators of fruit and vegetable intake: a systematic review and meta-analysis of randomised controlled trials.</gtr:title><gtr:parentPublicationTitle>The British journal of nutrition</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/783a1a1910d70519c37242956f10c439"><gtr:id>783a1a1910d70519c37242956f10c439</gtr:id><gtr:otherNames>Pennant M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0007-1145</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3AAA9830-2198-41C4-9990-E2B00D2384A5"><gtr:id>3AAA9830-2198-41C4-9990-E2B00D2384A5</gtr:id><gtr:title>Cochrane Database of Systematic Reviews</gtr:title><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a1b1cd6ce5473fecb238aa3084832068"><gtr:id>a1b1cd6ce5473fecb238aa3084832068</gtr:id><gtr:otherNames>Dumville J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/1AAFF4DB-F694-4AC5-892B-A9093772397A"><gtr:id>1AAFF4DB-F694-4AC5-892B-A9093772397A</gtr:id><gtr:title>HLA class II gene associations in African American type 1 diabetes reveal a protective HLA-DRB1*03 haplotype.</gtr:title><gtr:parentPublicationTitle>Diabetic medicine : a journal of the British Diabetic Association</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a1980804c74726dc80d0fad26df66c00"><gtr:id>a1980804c74726dc80d0fad26df66c00</gtr:id><gtr:otherNames>Howson JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0742-3071</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/48FD91C4-B908-48D5-A6FB-AD51E6FDF4D7"><gtr:id>48FD91C4-B908-48D5-A6FB-AD51E6FDF4D7</gtr:id><gtr:title>Using published data in Mendelian randomization: a blueprint for efficient identification of causal risk factors.</gtr:title><gtr:parentPublicationTitle>European journal of epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/056163b112d2b291ecc076d094a1b4e8"><gtr:id>056163b112d2b291ecc076d094a1b4e8</gtr:id><gtr:otherNames>Burgess S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0393-2990</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/512BBE76-AFE6-49F2-AD68-4EEADBE6C908"><gtr:id>512BBE76-AFE6-49F2-AD68-4EEADBE6C908</gtr:id><gtr:title>Beyond Mendelian randomization: how to interpret evidence of shared genetic predictors.</gtr:title><gtr:parentPublicationTitle>Journal of clinical epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/056163b112d2b291ecc076d094a1b4e8"><gtr:id>056163b112d2b291ecc076d094a1b4e8</gtr:id><gtr:otherNames>Burgess S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0895-4356</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/07F6E53B-8771-47BC-80B6-8AF931C9FB21"><gtr:id>07F6E53B-8771-47BC-80B6-8AF931C9FB21</gtr:id><gtr:title>Neuroimaging findings in cryptogenic stroke patients with and without patent foramen ovale.</gtr:title><gtr:parentPublicationTitle>Stroke</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/bdfd1197611e2c4f067931f1a080f60b"><gtr:id>bdfd1197611e2c4f067931f1a080f60b</gtr:id><gtr:otherNames>Thaler DE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0039-2499</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F9B2110D-85DF-42C6-8951-861509F90504"><gtr:id>F9B2110D-85DF-42C6-8951-861509F90504</gtr:id><gtr:title>Genetic Predisposition to an Impaired Metabolism of the Branched-Chain Amino Acids and Risk of Type 2 Diabetes: A Mendelian Randomisation Analysis.</gtr:title><gtr:parentPublicationTitle>PLoS medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/590c8a9618b273cc7c1e0848dd49db27"><gtr:id>590c8a9618b273cc7c1e0848dd49db27</gtr:id><gtr:otherNames>Lotta LA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1549-1277</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A9055116-0767-446E-B4AB-4EDD73D30C48"><gtr:id>A9055116-0767-446E-B4AB-4EDD73D30C48</gtr:id><gtr:title>Association of Vasomotor and Other Menopausal Symptoms with Risk of Cardiovascular Disease: A Systematic Review and Meta-Analysis.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ea1e5ba889fd0cca140aeff5b41e4684"><gtr:id>ea1e5ba889fd0cca140aeff5b41e4684</gtr:id><gtr:otherNames>Muka T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/CB618FD2-F041-4FE0-9685-45F392B49483"><gtr:id>CB618FD2-F041-4FE0-9685-45F392B49483</gtr:id><gtr:title>Cardiometabolic effects of genetic upregulation of the interleukin 1 receptor antagonist: a Mendelian randomisation analysis.</gtr:title><gtr:parentPublicationTitle>The lancet. Diabetes &amp; endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4e4c220c3b3958f29fccb7c03f12eb86"><gtr:id>4e4c220c3b3958f29fccb7c03f12eb86</gtr:id><gtr:otherNames>Interleukin 1 Genetics Consortium</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2213-8587</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A03E0816-5C0A-47C0-A801-B6D2635251FE"><gtr:id>A03E0816-5C0A-47C0-A801-B6D2635251FE</gtr:id><gtr:title>Recurrent stroke predictors differ in medically treated patients with pathogenic vs. other PFOs.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/bdfd1197611e2c4f067931f1a080f60b"><gtr:id>bdfd1197611e2c4f067931f1a080f60b</gtr:id><gtr:otherNames>Thaler DE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F0FF999A-67BF-4414-858A-8B7E6D2732F9"><gtr:id>F0FF999A-67BF-4414-858A-8B7E6D2732F9</gtr:id><gtr:title>Whole-genome sequencing identifies EN1 as a determinant of bone density and fracture.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/2c96b78b9a01861ee81da860a632bab3"><gtr:id>2c96b78b9a01861ee81da860a632bab3</gtr:id><gtr:otherNames>Zheng HF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E9D016A1-1A8A-4633-94E3-4AFC75890035"><gtr:id>E9D016A1-1A8A-4633-94E3-4AFC75890035</gtr:id><gtr:title>The clinical and cost-effectiveness of brief advice for excessive alcohol consumption among people attending sexual health clinics: a randomised controlled trial.</gtr:title><gtr:parentPublicationTitle>Sexually transmitted infections</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/98e43f68bd12f393678f99322da358ab"><gtr:id>98e43f68bd12f393678f99322da358ab</gtr:id><gtr:otherNames>Crawford MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1368-4973</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/6EBC6CBC-BC68-4D07-86CC-944A29148E79"><gtr:id>6EBC6CBC-BC68-4D07-86CC-944A29148E79</gtr:id><gtr:title>The Role of DNA Methylation and Histone Modifications in Neurodegenerative Diseases: A Systematic Review.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/39d81fbd907266340cd711bbb9b2eac5"><gtr:id>39d81fbd907266340cd711bbb9b2eac5</gtr:id><gtr:otherNames>Wen KX</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/FBC575B7-D3D3-4810-9CA5-EBC1927A2D63"><gtr:id>FBC575B7-D3D3-4810-9CA5-EBC1927A2D63</gtr:id><gtr:title>Metabolic mediators of body-mass index and cardiovascular risk</gtr:title><gtr:parentPublicationTitle>The Lancet</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/97686a913ac915d9fd3904c6a2ba9d07"><gtr:id>97686a913ac915d9fd3904c6a2ba9d07</gtr:id><gtr:otherNames>Wormser D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/8B86D08B-704B-4EFC-AC44-601A9CE55217"><gtr:id>8B86D08B-704B-4EFC-AC44-601A9CE55217</gtr:id><gtr:title>Multivariable Mendelian randomization: the use of pleiotropic genetic variants to estimate causal effects.</gtr:title><gtr:parentPublicationTitle>American journal of epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/056163b112d2b291ecc076d094a1b4e8"><gtr:id>056163b112d2b291ecc076d094a1b4e8</gtr:id><gtr:otherNames>Burgess S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0002-9262</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A6DB1657-5898-4461-8827-9D825A2CE7A4"><gtr:id>A6DB1657-5898-4461-8827-9D825A2CE7A4</gtr:id><gtr:title>Association of Age at Onset of Menopause and Time Since Onset of Menopause With Cardiovascular Outcomes, Intermediate Vascular Traits, and All-Cause Mortality: A Systematic Review and Meta-analysis.</gtr:title><gtr:parentPublicationTitle>JAMA cardiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ea1e5ba889fd0cca140aeff5b41e4684"><gtr:id>ea1e5ba889fd0cca140aeff5b41e4684</gtr:id><gtr:otherNames>Muka T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/13D75161-4AD4-40F7-A864-95667CB5D0BB"><gtr:id>13D75161-4AD4-40F7-A864-95667CB5D0BB</gtr:id><gtr:title>The global impact of non-communicable diseases on households and impoverishment: a systematic review.</gtr:title><gtr:parentPublicationTitle>European journal of epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/677145baac84cf309e3e95f8f6916c64"><gtr:id>677145baac84cf309e3e95f8f6916c64</gtr:id><gtr:otherNames>Jaspers L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0393-2990</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/2FE6472D-1CBE-4FB6-A7AB-E01F82EE73C5"><gtr:id>2FE6472D-1CBE-4FB6-A7AB-E01F82EE73C5</gtr:id><gtr:title>Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment.</gtr:title><gtr:parentPublicationTitle>The lancet. Diabetes &amp; endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/975a6cd8832cd4672bd6ed1796bee4c0"><gtr:id>975a6cd8832cd4672bd6ed1796bee4c0</gtr:id><gtr:otherNames>Global Burden of Metabolic Risk Factors for Chronic Diseases Collaboration</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2213-8587</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B4EF0728-E890-403A-BB42-9D4B8E17BE05"><gtr:id>B4EF0728-E890-403A-BB42-9D4B8E17BE05</gtr:id><gtr:title>Independent UK Panel on Breast Cancer Screening replies to Michael Baum.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/73bd65863d785044bd9ab1f6698927cd"><gtr:id>73bd65863d785044bd9ab1f6698927cd</gtr:id><gtr:otherNames>Marmot M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/EB7E672A-BDF3-4059-ABB6-D642356F9920"><gtr:id>EB7E672A-BDF3-4059-ABB6-D642356F9920</gtr:id><gtr:title>Recruitment and representativeness of blood donors in the INTERVAL randomised trial assessing varying inter-donation intervals.</gtr:title><gtr:parentPublicationTitle>Trials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/89054595f3e8c6d961598d722c9df7c5"><gtr:id>89054595f3e8c6d961598d722c9df7c5</gtr:id><gtr:otherNames>Moore C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1745-6215</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/901B67EC-5812-4FA5-B36D-97FB43A27C55"><gtr:id>901B67EC-5812-4FA5-B36D-97FB43A27C55</gtr:id><gtr:title>The estimation and use of predictions for the assessment of model performance using large samples with multiply imputed data.</gtr:title><gtr:parentPublicationTitle>Biometrical journal. Biometrische Zeitschrift</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c1ef48f0f70f1ae9f833acbac332d735"><gtr:id>c1ef48f0f70f1ae9f833acbac332d735</gtr:id><gtr:otherNames>Wood AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0323-3847</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C8471B80-915C-43AD-BE6E-A22D2CA25053"><gtr:id>C8471B80-915C-43AD-BE6E-A22D2CA25053</gtr:id><gtr:title>Accuracy of Patient Self-Report of Stroke: A Systematic Review from the UK Biobank Stroke Outcomes Group.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/bc177bc67084e61937ac7f2b418f0334"><gtr:id>bc177bc67084e61937ac7f2b418f0334</gtr:id><gtr:otherNames>Woodfield R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/6171339C-E6F8-4C43-98F4-437E09B7609F"><gtr:id>6171339C-E6F8-4C43-98F4-437E09B7609F</gtr:id><gtr:title>An index to identify stroke-related vs incidental patent foramen ovale in cryptogenic stroke.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/227c02c48c31336cf884824c38bb8212"><gtr:id>227c02c48c31336cf884824c38bb8212</gtr:id><gtr:otherNames>Kent DM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/1F94D000-F3CF-44DD-97D0-C62D5BD12FF9"><gtr:id>1F94D000-F3CF-44DD-97D0-C62D5BD12FF9</gtr:id><gtr:title>The risk of paradoxical embolism (RoPE) study: initial description of the completed database.</gtr:title><gtr:parentPublicationTitle>International journal of stroke : official journal of the International Stroke Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/bdfd1197611e2c4f067931f1a080f60b"><gtr:id>bdfd1197611e2c4f067931f1a080f60b</gtr:id><gtr:otherNames>Thaler DE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1747-4930</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/CE95C96D-843A-4D6C-ADE0-272DBBB66F87"><gtr:id>CE95C96D-843A-4D6C-ADE0-272DBBB66F87</gtr:id><gtr:title>T-wave inversion, QRS duration, and QRS/T angle as electrocardiographic predictors of the risk for sudden cardiac death.</gtr:title><gtr:parentPublicationTitle>The American journal of cardiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/bc70ab8da1391ea96a453ecc1f8551b1"><gtr:id>bc70ab8da1391ea96a453ecc1f8551b1</gtr:id><gtr:otherNames>Laukkanen JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0002-9149</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/37DB6936-3726-4537-9D79-2506DBC6743B"><gtr:id>37DB6936-3726-4537-9D79-2506DBC6743B</gtr:id><gtr:title>Defining the role of common variation in the genomic and biological architecture of adult human height.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d5c7dfb7949253c2a1b684d1952ae3ac"><gtr:id>d5c7dfb7949253c2a1b684d1952ae3ac</gtr:id><gtr:otherNames>Wood AR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/744EFD24-4E3D-4A0C-ACF3-1A9EA457232C"><gtr:id>744EFD24-4E3D-4A0C-ACF3-1A9EA457232C</gtr:id><gtr:title>Effects of lifestyle-related interventions on blood pressure in low and middle-income countries: systematic review and meta-analysis.</gtr:title><gtr:parentPublicationTitle>Journal of hypertension</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/66a31d241fa0f92be64777739da60ad3"><gtr:id>66a31d241fa0f92be64777739da60ad3</gtr:id><gtr:otherNames>Baena CP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0263-6352</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/7EF259F8-1C52-48D5-A334-2F48B3786855"><gtr:id>7EF259F8-1C52-48D5-A334-2F48B3786855</gtr:id><gtr:title>Re: &amp;quot;Multivariable Mendelian randomization: the use of pleiotropic genetic variants to estimate causal effects&amp;quot;.</gtr:title><gtr:parentPublicationTitle>American journal of epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/056163b112d2b291ecc076d094a1b4e8"><gtr:id>056163b112d2b291ecc076d094a1b4e8</gtr:id><gtr:otherNames>Burgess S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0002-9262</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/AB8FAA57-5C26-469E-849A-C3E040A1D7DF"><gtr:id>AB8FAA57-5C26-469E-849A-C3E040A1D7DF</gtr:id><gtr:title>Multiethnic meta-analysis of genome-wide association studies in &amp;gt;100 000 subjects identifies 23 fibrinogen-associated Loci but no strong evidence of a causal association between circulating fibrinogen and cardiovascular disease.</gtr:title><gtr:parentPublicationTitle>Circulation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/7e45f9cca7951c0827d4cad2aee930fe"><gtr:id>7e45f9cca7951c0827d4cad2aee930fe</gtr:id><gtr:otherNames>Sabater-Lleal M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0009-7322</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/ABFAB30B-56F7-4A5F-B01C-A0190DCEDCFA"><gtr:id>ABFAB30B-56F7-4A5F-B01C-A0190DCEDCFA</gtr:id><gtr:title>Maps of open chromatin highlight cell type-restricted patterns of regulatory sequence variation at hematological trait loci.</gtr:title><gtr:parentPublicationTitle>Genome research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b159c2fdc40bd9f1b680388b2982bc9d"><gtr:id>b159c2fdc40bd9f1b680388b2982bc9d</gtr:id><gtr:otherNames>Paul DS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1088-9051</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/8E1C2941-2281-4C5D-AC1E-CF5A1035F872"><gtr:id>8E1C2941-2281-4C5D-AC1E-CF5A1035F872</gtr:id><gtr:title>Use of electronic health records to ascertain, validate and phenotype acute myocardial infarction: A systematic review and recommendations.</gtr:title><gtr:parentPublicationTitle>International journal of cardiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/85b253681ee31b5a777f00ca4329a557"><gtr:id>85b253681ee31b5a777f00ca4329a557</gtr:id><gtr:otherNames>Rubbo B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0167-5273</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/467BA0AA-26EB-4865-9C80-7F40898C99AE"><gtr:id>467BA0AA-26EB-4865-9C80-7F40898C99AE</gtr:id><gtr:title>Invited commentary: dietary polyunsaturated Fatty acids and chronic systemic inflammation--a potentially intriguing link.</gtr:title><gtr:parentPublicationTitle>American journal of epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/e6174ca4b9befe9d94477e7180f705a2"><gtr:id>e6174ca4b9befe9d94477e7180f705a2</gtr:id><gtr:otherNames>Chowdhury R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0002-9262</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/2FB14E9D-7516-4784-92A0-C30A59001B59"><gtr:id>2FB14E9D-7516-4784-92A0-C30A59001B59</gtr:id><gtr:title>Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ae9d784f8fedea35c8ca90abe922917d"><gtr:id>ae9d784f8fedea35c8ca90abe922917d</gtr:id><gtr:otherNames>Ng M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/737E1FD1-1AA4-4D64-BAC3-EE8452F0C7A3"><gtr:id>737E1FD1-1AA4-4D64-BAC3-EE8452F0C7A3</gtr:id><gtr:title>Genetic associations with valvular calcification and aortic stenosis.</gtr:title><gtr:parentPublicationTitle>The New England journal of medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/76d41858f4a5392d5ef045c8f13883ab"><gtr:id>76d41858f4a5392d5ef045c8f13883ab</gtr:id><gtr:otherNames>Thanassoulis G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0028-4793</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/8E1C6DC0-3DD8-4C7B-A390-FD882B272DF2"><gtr:id>8E1C6DC0-3DD8-4C7B-A390-FD882B272DF2</gtr:id><gtr:title>Statistical Challenges in Risk Prediction.</gtr:title><gtr:parentPublicationTitle>Biometrical journal. Biometrische Zeitschrift</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/9bd522716636d6c40c2c616ae992e297"><gtr:id>9bd522716636d6c40c2c616ae992e297</gtr:id><gtr:otherNames>White IR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0323-3847</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/8BBD49A1-8769-4280-A690-56532CD40C91"><gtr:id>8BBD49A1-8769-4280-A690-56532CD40C91</gtr:id><gtr:title>The many weak instruments problem and Mendelian randomization.</gtr:title><gtr:parentPublicationTitle>Statistics in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/1d8f8042ca2049a5c24361cf343c3355"><gtr:id>1d8f8042ca2049a5c24361cf343c3355</gtr:id><gtr:otherNames>Davies NM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0277-6715</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/ACE013BD-7552-45E0-B50A-91E1061D916D"><gtr:id>ACE013BD-7552-45E0-B50A-91E1061D916D</gtr:id><gtr:title>Information and Risk Modification Trial (INFORM): design of a randomised controlled trial of communicating different types of information about coronary heart disease risk, alongside lifestyle advice, to achieve change in health-related behaviour.</gtr:title><gtr:parentPublicationTitle>BMC public health</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/02f4cefb1b43fd90206d810c05991f5d"><gtr:id>02f4cefb1b43fd90206d810c05991f5d</gtr:id><gtr:otherNames>Silarova B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1471-2458</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/9A1A55E1-BF85-4FD9-BF1C-4E85CBD94394"><gtr:id>9A1A55E1-BF85-4FD9-BF1C-4E85CBD94394</gtr:id><gtr:title>Cord Blood Hepcidin: Cross-Sectional Correlates and Associations with Anemia, Malaria, and Mortality in a Tanzanian Birth Cohort Study.</gtr:title><gtr:parentPublicationTitle>The American journal of tropical medicine and hygiene</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/40fce04c808ecba0ff3bb14f2715b780"><gtr:id>40fce04c808ecba0ff3bb14f2715b780</gtr:id><gtr:otherNames>Brickley EB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0002-9637</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/66E1B611-A1EF-480E-97AF-DCCC3E6475B4"><gtr:id>66E1B611-A1EF-480E-97AF-DCCC3E6475B4</gtr:id><gtr:title>Rare variant in scavenger receptor BI raises HDL cholesterol and increases risk of coronary heart disease.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/bbca6510bdfa10166be62b369cdd718f"><gtr:id>bbca6510bdfa10166be62b369cdd718f</gtr:id><gtr:otherNames>Zanoni P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/9CDCF1F5-6B4B-46DC-9FE9-D2248086811C"><gtr:id>9CDCF1F5-6B4B-46DC-9FE9-D2248086811C</gtr:id><gtr:title>Extending DerSimonian and Laird's methodology to perform network meta-analyses with random inconsistency effects.</gtr:title><gtr:parentPublicationTitle>Statistics in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/9cab0d53161368150e28f9caa0627018"><gtr:id>9cab0d53161368150e28f9caa0627018</gtr:id><gtr:otherNames>Jackson D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0277-6715</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/AF396ED8-6B15-4420-9840-167AD884F5C1"><gtr:id>AF396ED8-6B15-4420-9840-167AD884F5C1</gtr:id><gtr:title>Validation of self-administered nasal swabs and postage for the isolation of Staphylococcus aureus.</gtr:title><gtr:parentPublicationTitle>Journal of medical microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/dec748caea258ba8ff00a61a2245c890"><gtr:id>dec748caea258ba8ff00a61a2245c890</gtr:id><gtr:otherNames>Harrison EM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0022-2615</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/366C3DB5-934C-4E51-981A-706345543149"><gtr:id>366C3DB5-934C-4E51-981A-706345543149</gtr:id><gtr:title>Birth weight percentile and the risk of term perinatal death.</gtr:title><gtr:parentPublicationTitle>Obstetrics and gynecology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/079552903cf84e2e7bcbdff3faa26a9e"><gtr:id>079552903cf84e2e7bcbdff3faa26a9e</gtr:id><gtr:otherNames>Moraitis AA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0029-7844</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/7B227BDA-6E5B-445A-8B51-727E5E2016D3"><gtr:id>7B227BDA-6E5B-445A-8B51-727E5E2016D3</gtr:id><gtr:title>Correcting for optimistic prediction in small data sets.</gtr:title><gtr:parentPublicationTitle>American journal of epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/5a336bb3c8de14a5560db098945d61c3"><gtr:id>5a336bb3c8de14a5560db098945d61c3</gtr:id><gtr:otherNames>Smith GC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0002-9262</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/80C75745-88F8-4368-A46E-1C955E483013"><gtr:id>80C75745-88F8-4368-A46E-1C955E483013</gtr:id><gtr:title>Previous caesarean delivery and the risk of unexplained stillbirth: retrospective cohort study and meta-analysis.</gtr:title><gtr:parentPublicationTitle>BJOG : an international journal of obstetrics and gynaecology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/079552903cf84e2e7bcbdff3faa26a9e"><gtr:id>079552903cf84e2e7bcbdff3faa26a9e</gtr:id><gtr:otherNames>Moraitis AA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1470-0328</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/EA8851AC-69A4-4865-9A36-4D1957C6BD32"><gtr:id>EA8851AC-69A4-4865-9A36-4D1957C6BD32</gtr:id><gtr:title>The International Human Epigenome Consortium: A Blueprint for Scientific Collaboration and Discovery.</gtr:title><gtr:parentPublicationTitle>Cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/5596e10388755ec63ed3f44030be1b02"><gtr:id>5596e10388755ec63ed3f44030be1b02</gtr:id><gtr:otherNames>Stunnenberg HG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0092-8674</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/BD8BBDE1-90A9-464E-A53D-F86F990D7A6B"><gtr:id>BD8BBDE1-90A9-464E-A53D-F86F990D7A6B</gtr:id><gtr:title>Genome-wide association study identifies a novel locus contributing to type 2 diabetes susceptibility in Sikhs of Punjabi origin from India.</gtr:title><gtr:parentPublicationTitle>Diabetes</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ee2eb96d6559e7b7d6e84d016c90cd9e"><gtr:id>ee2eb96d6559e7b7d6e84d016c90cd9e</gtr:id><gtr:otherNames>Saxena R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0012-1797</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/EF6E22F2-432A-4CB8-86AA-35893D25A3EA"><gtr:id>EF6E22F2-432A-4CB8-86AA-35893D25A3EA</gtr:id><gtr:title>A design-by-treatment interaction model for network meta-analysis with random inconsistency effects.</gtr:title><gtr:parentPublicationTitle>Statistics in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/9cab0d53161368150e28f9caa0627018"><gtr:id>9cab0d53161368150e28f9caa0627018</gtr:id><gtr:otherNames>Jackson D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0277-6715</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/CE09D9C5-DF9D-42B3-8122-53B45E5C0B68"><gtr:id>CE09D9C5-DF9D-42B3-8122-53B45E5C0B68</gtr:id><gtr:title>Inactivating mutations in NPC1L1 and protection from coronary heart disease.</gtr:title><gtr:parentPublicationTitle>The New England journal of medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a57a091e4ace6066452dca77525f788b"><gtr:id>a57a091e4ace6066452dca77525f788b</gtr:id><gtr:otherNames>Myocardial Infarction Genetics Consortium Investigators</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0028-4793</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/10E8D8D9-EFA6-47F2-A169-FA190BC07F2C"><gtr:id>10E8D8D9-EFA6-47F2-A169-FA190BC07F2C</gtr:id><gtr:title>Inflammatory markers and extent and progression of early atherosclerosis: Meta-analysis of individual-participant-data from 20 prospective studies of the PROG-IMT collaboration.</gtr:title><gtr:parentPublicationTitle>European journal of preventive cardiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c14d384b5a87c9bc3c358b7461f53714"><gtr:id>c14d384b5a87c9bc3c358b7461f53714</gtr:id><gtr:otherNames>Willeit P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2047-4873</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/16692564-36AC-4384-A7B2-F3A14F50D0BA"><gtr:id>16692564-36AC-4384-A7B2-F3A14F50D0BA</gtr:id><gtr:title>Fish intake or omega-3 fatty acids: greater than the sum of all parts?</gtr:title><gtr:parentPublicationTitle>European journal of epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/abb5205698c159e4ef56884160932bc1"><gtr:id>abb5205698c159e4ef56884160932bc1</gtr:id><gtr:otherNames>Kiefte-de Jong JC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0393-2990</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/448510E2-02EF-4350-A014-CFAEC76A28C1"><gtr:id>448510E2-02EF-4350-A014-CFAEC76A28C1</gtr:id><gtr:title>Genetic studies of body mass index yield new insights for obesity biology.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/5b2ba3cf7428e3cca65709eeacf5d199"><gtr:id>5b2ba3cf7428e3cca65709eeacf5d199</gtr:id><gtr:otherNames>Locke AE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/54390A53-0298-4574-8150-CE7AC7E820E2"><gtr:id>54390A53-0298-4574-8150-CE7AC7E820E2</gtr:id><gtr:title>Should the frequency of surveillance for small abdominal aortic aneurysms be reduced?</gtr:title><gtr:parentPublicationTitle>European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/fb46d5a2908901f6dd48363c51b7295f"><gtr:id>fb46d5a2908901f6dd48363c51b7295f</gtr:id><gtr:otherNames>Powell JT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1078-5884</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/33B5B809-949E-4A15-8E78-694CF1B5FF96"><gtr:id>33B5B809-949E-4A15-8E78-694CF1B5FF96</gtr:id><gtr:title>AplusB: A Web Application for Investigating A + B Designs for Phase I Cancer Clinical Trials.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ef3dd8d7b6622717fa234ee9778dc93f"><gtr:id>ef3dd8d7b6622717fa234ee9778dc93f</gtr:id><gtr:otherNames>Wheeler GM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/2B6A233A-FCC9-4547-9B56-FB961B9AD55E"><gtr:id>2B6A233A-FCC9-4547-9B56-FB961B9AD55E</gtr:id><gtr:title>Predictive distributions for between-study heterogeneity and simple methods for their application in Bayesian meta-analysis.</gtr:title><gtr:parentPublicationTitle>Statistics in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b4469eb28365ff976201c153df829a59"><gtr:id>b4469eb28365ff976201c153df829a59</gtr:id><gtr:otherNames>Turner RM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0277-6715</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3CC5A0A3-9230-4CE9-AFD4-472B30232AE0"><gtr:id>3CC5A0A3-9230-4CE9-AFD4-472B30232AE0</gtr:id><gtr:title>Diagnostic Yield and Clinical Utility of Sequencing Familial Hypercholesterolemia Genes in Patients With Severe Hypercholesterolemia.</gtr:title><gtr:parentPublicationTitle>Journal of the American College of Cardiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/3f02e9712cf847f443636c23444a82b8"><gtr:id>3f02e9712cf847f443636c23444a82b8</gtr:id><gtr:otherNames>Khera AV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0735-1097</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/49E0766C-A0FB-431E-8655-4F1D8A7C05D2"><gtr:id>49E0766C-A0FB-431E-8655-4F1D8A7C05D2</gtr:id><gtr:title>Dietary intake of carbohydrates and risk of type 2 diabetes: the European Prospective Investigation into Cancer-Norfolk study.</gtr:title><gtr:parentPublicationTitle>The British journal of nutrition</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b7a2d7e799abf9e6aec1bec645a41fb4"><gtr:id>b7a2d7e799abf9e6aec1bec645a41fb4</gtr:id><gtr:otherNames>Ahmadi-Abhari S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0007-1145</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3BF88C57-A6B0-4029-A6F2-79E1F211A452"><gtr:id>3BF88C57-A6B0-4029-A6F2-79E1F211A452</gtr:id><gtr:title>Meta-analysis of the current prevalence of screen-detected abdominal aortic aneurysm in women.</gtr:title><gtr:parentPublicationTitle>The British journal of surgery</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/55c6610e962d2491862cbf81fc60d707"><gtr:id>55c6610e962d2491862cbf81fc60d707</gtr:id><gtr:otherNames>Ulug P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0007-1323</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/553BF954-F41C-47D8-9C43-C92B953DD6B9"><gtr:id>553BF954-F41C-47D8-9C43-C92B953DD6B9</gtr:id><gtr:title>Identifying the odds ratio estimated by a two-stage instrumental variable analysis with a logistic regression model.</gtr:title><gtr:parentPublicationTitle>Statistics in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/056163b112d2b291ecc076d094a1b4e8"><gtr:id>056163b112d2b291ecc076d094a1b4e8</gtr:id><gtr:otherNames>Burgess S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0277-6715</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/67194A6C-1791-469B-93A1-F495959F52C6"><gtr:id>67194A6C-1791-469B-93A1-F495959F52C6</gtr:id><gtr:title>Impact of provision of cardiovascular disease risk estimates to healthcare professionals and patients: a systematic review.</gtr:title><gtr:parentPublicationTitle>BMJ open</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/6c738f04b064217a6a3e4b8447dddfc9"><gtr:id>6c738f04b064217a6a3e4b8447dddfc9</gtr:id><gtr:otherNames>Usher-Smith JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2044-6055</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A53F5658-246F-423A-970E-B19FB34B0E89"><gtr:id>A53F5658-246F-423A-970E-B19FB34B0E89</gtr:id><gtr:title>Effects of different antibiotic classes on airway bacteria in stable COPD using culture and molecular techniques: a randomised controlled trial.</gtr:title><gtr:parentPublicationTitle>Thorax</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/e951b4bd88680d58a75098fd5448ee8a"><gtr:id>e951b4bd88680d58a75098fd5448ee8a</gtr:id><gtr:otherNames>Brill SE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0040-6376</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0020C248-5A6B-4CA7-A7C3-D4914DCF25F3"><gtr:id>0020C248-5A6B-4CA7-A7C3-D4914DCF25F3</gtr:id><gtr:title>Ischaemic heart disease deaths in Brazil: current trends, regional disparities and future projections.</gtr:title><gtr:parentPublicationTitle>Heart (British Cardiac Society)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/66a31d241fa0f92be64777739da60ad3"><gtr:id>66a31d241fa0f92be64777739da60ad3</gtr:id><gtr:otherNames>Baena CP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1355-6037</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/33DD711E-DC76-4B69-BAC6-EA991F3064A2"><gtr:id>33DD711E-DC76-4B69-BAC6-EA991F3064A2</gtr:id><gtr:title>Normative values for carotid intima media thickness and its progression: Are they transferrable outside of their cohort of origin?</gtr:title><gtr:parentPublicationTitle>European journal of preventive cardiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f17706982aa319ecbbfc8165aada44de"><gtr:id>f17706982aa319ecbbfc8165aada44de</gtr:id><gtr:otherNames>Liao X</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2047-4873</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/AA0EF131-7FF0-4F84-99A2-2DBDFF3E0A20"><gtr:id>AA0EF131-7FF0-4F84-99A2-2DBDFF3E0A20</gtr:id><gtr:title>Quantitative comparison of DNA methylation assays for biomarker development and clinical applications.</gtr:title><gtr:parentPublicationTitle>Nature biotechnology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a822f18b8876dbf1bf41afea4b2e8e98"><gtr:id>a822f18b8876dbf1bf41afea4b2e8e98</gtr:id><gtr:otherNames>BLUEPRINT consortium</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1087-0156</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/1E1051BE-4A19-4AAE-9155-C40634171985"><gtr:id>1E1051BE-4A19-4AAE-9155-C40634171985</gtr:id><gtr:title>Fetal dopaminergic transplantation trials and the future of neural grafting in Parkinson's disease</gtr:title><gtr:parentPublicationTitle>The Lancet Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/9874f0754fd5baf81e418cfb417cb67a"><gtr:id>9874f0754fd5baf81e418cfb417cb67a</gtr:id><gtr:otherNames>Barker R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3A584873-947C-49B3-8688-357BE1E3C331"><gtr:id>3A584873-947C-49B3-8688-357BE1E3C331</gtr:id><gtr:title>Fetal origins of malarial disease: cord blood cytokines as risk markers for pediatric severe malarial anemia.</gtr:title><gtr:parentPublicationTitle>The Journal of infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/40fce04c808ecba0ff3bb14f2715b780"><gtr:id>40fce04c808ecba0ff3bb14f2715b780</gtr:id><gtr:otherNames>Brickley EB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0022-1899</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/1BC1DACD-9564-437A-815E-AA0E362D203C"><gtr:id>1BC1DACD-9564-437A-815E-AA0E362D203C</gtr:id><gtr:title>Genome-Wide Association Analysis of Young-Onset Stroke Identifies a Locus on Chromosome 10q25 Near HABP2.</gtr:title><gtr:parentPublicationTitle>Stroke</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/13c5ab0757ef09129146c55e2c84906c"><gtr:id>13c5ab0757ef09129146c55e2c84906c</gtr:id><gtr:otherNames>Cheng YC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0039-2499</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C56876EB-1526-4838-B187-3C38344EFE34"><gtr:id>C56876EB-1526-4838-B187-3C38344EFE34</gtr:id><gtr:title>New genetic loci link adipose and insulin biology to body fat distribution.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a085b336b6081bf206928f3cdcb91748"><gtr:id>a085b336b6081bf206928f3cdcb91748</gtr:id><gtr:otherNames>Shungin D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/341DCEED-EB67-4EE6-9E6C-30653D65E27C"><gtr:id>341DCEED-EB67-4EE6-9E6C-30653D65E27C</gtr:id><gtr:title>Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/e6e74fe070d8ab2a2013446adf8395c9"><gtr:id>e6e74fe070d8ab2a2013446adf8395c9</gtr:id><gtr:otherNames>DIAbetes Genetics Replication And Meta-analysis (DIAGRAM) Consortium</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MR/L003120/1</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>D4FDB752-4E9C-491F-9C63-B7D7F6F95417</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Cardiovascular</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>89AE580F-2437-4540-9640-37005C968E67</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>4.1  Discovery and preclinical testing of markers and technologies</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>